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SUMMARY
The lymphocyte is the principle cell responsible for the main
events which occur in the transplantation reaction. The activity of
the lymphocyte, has been studied in two ways. First, effector
lymphocytes, sensitised by allografting in rats, have been tested for
their ability to kill antigenic cells in vitro. Secondly, lymphocytes
injected into allogeneic rats have been studied in their ability to
proliferate in presence of antigenic tissues.
The flow of lymphocytes after renal allotransplantation has been
studied in sheep by measuring the total body lymphocyte flow after
thoracic duct cannulation and drainage, and the renal lymphocyte flow
by cannulation of the lymphatics leaving a transplanted kidney.
Lymphocyte cytotoxicity measured by in vitro cytotoxicity tests
has been achieved with sensitised spleen cells against allografts
of tumour and kidney but not skin grafts. Lymph node lymphocytes
are not effective as cytotoxic cells.
The ability of sensitised lymphocytes to proliferate in the
presence of antigenic tissue measured by the graft-versus-host
popliteal node weight assay has not been proved. This assay does
not show the immune competence of lymphocytes injected into either
allogeneic or xenogeneic animals.
The flow of lymphocytes is markedly increased in the area of
a renal allograft and flowing from the graft. This effect is
localised to the graft itself and is not reflected in an alteration
in the flow of lymphocytes through the whole body. The action of
immunosuppressive drugs on lymphocyte flow is also localised to the
area of the allografted organ.
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It is generally held that the Immune response to an allograft is
an immune reaction of the class known as cell mediated. The mechanism
of rejection following organ or tissue transplantation is not
completely understood. The response is divided for descriptive
purposes into the afferent arc, the central response and the efferent
arc (diagram 1). Recognition of the cells of an allograft as anti¬
genic occurs in the afferent arc. This information is transferred
centrally where lymphocytes are mobilised and large lymphoblasts are
produced. Death of a transplanted cell is thought to be the result
of direct action of specifically sensitised effector (killer)
lymphocytes and represents the efferent arc of the response. In
the primary immune response production of sensitised killer lympho¬
cytes occurs in about 5 days.
Recognition of antigen
The first step is contact of the recipient's circulating
lymphocytes with the cell surfaces of the graft which carry the
histocompatibility antigens. The small T (thymus derived) lymphocyte
alone is capable of recognition of the antigen and there is no need
for phagocytosis of the antigen by macrophages.
Proliferation of lymphoid cells
Stimulated by antigen, the immunologically competent lymphocyte
starts the process which ends in the production of sensitised
effector cells which act directly against the cells bearing the
antigen. During this part of the response there is a production of
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blast cells in turn produce the sensitised effector cells.
Action of sensitised cells on the antigenic target cell
The onslaught of sensitised T lymphocytes on the grafted organ
now occurs. The method of attack by the lymphocytes may be either
by a direct action of one cell on the other, or by the production of
some mediator by the lymphocyte.
Although allograft rejection depends on cell-mediated immunity
the role of circulating (humoral) antibodies is not negligible. The
role of the circulating antibody is not defined, but there appear to
be some antibodies which exert a harmful effect (cytotoxic antibodies)
and some which exert a protective effect (blocking antibodies).
The work presented in this thesis will study the activity of
the lymphocyte only, in transplant rejection. The work will be
divided into three sections:
In the first section the role of the T-lymphocyte will be studied
in the cell-mediated-immune response by in vitro methods. The in
vitro tests will be performed to study the individual killing capacity
of effector lymphocytes which have been sensitised against an anti¬
genic allograft in vivo. The killing capacity will be tested against
tissues bearing the same antigen as the allografts. These in vitro
lymphocyte cytotoxicity tests represent the efferent arc of the cell
mediated immune response (diagram 1).
In the second section a bio-assay will look at the ability of
the T-lymphocyte to proliferate in the presence of antigenic tissue,
by a graft-versus-host node weight assay. This assay represents the
whole of the immune response.
The third section will look at the flow of lymphocytes in the
whole body and in the grafted organ after renal allotransplantation.
The introduction of immunosuppressive drugs has altered the
pattern of organ transplantation. These drugs have an anti-lymphocyte
effect and prolong the function of an allograft. Studies will be
performed to look at the effect of immunosuppressive drugs on the
flow of lymphocytes flowing through a renal allograft and flowing
through the body, in order to determine the specificity of changes
in flow through a renal allograft.
Before embarking on the work of the thesis proper, a short
examination of the in vitro tests of lymphocyte function relating to
the transplant rejection response, will be made. The various tests
of lymphocyte function will be described below and the supposed areas
of the cell-mediated immune response which these tests measure are
shown in diagram 1. Many of these tests show alterations in allograft
rejection confirming that the lymphocyte plays an important role. The
value in the diagnosis of clinical rejection episodes will be
mentioned.
Peripheral blood T lymphocyte
The aftility to form spontaneous rosettes with sheep red cells is
a function of T cells in man. Human T lymphocytes have the capacity
to adhere to sheep erythrocytes, and the sheep red blood cells form
rosettes around the lymphocyte without any prior sensitization; this
is called spontaneous cyto-adherence. Like the cells that recognise
antigen, the cells forming spontaneous rosettes are small lymphocytes,
they require no preliminary action by macrophages, and this ability
to form rosettes would appear to reflect the afferent arc of the
immune response.
The number of rosette forming cells in the peripheral blood in
patients after transplantation are not increased (Wood and Gray,
1973).
Phytohaemagglutinin (PHA) responsiveness
Certain plant mitogens such as PHA can react with T cells and
these cells then proliferate to blast cells. This reaction is similar
to that seen after antigenic recognition, but with PHA it is entirely
non-specific. The ability of the T cell to transform with PHA
reflects the T cell activity and is routinely used in many laboratories
in the assessment of immune status of the body. PHA responsiveness
has been used in man as a predictive test prior to transplantation
(Rubin, Stenzal, Hirschhorn and Bach, 1964). Human patients were found
to have an increased PKA responsiveness after renal transplantation
(Tennenbaum, St. Pierre and Cerilli, 1968) which can be decreased by
increased doses of immunosuppressive drugs. In clinical work the
results have too wide a range to be a useful measurement.
Rosette Inhibition Assay
The phenomenon of sheep cell rosetting has been used to follow,
in the human transplant patients, the metabolism of immunosuppressive
drugs, and to determine at a specific time what degree of immuno¬
suppressive activity has been obtained by the drugs (Hamburger, 1970).
The minimal inhibitory concentration of anti-lymphocyte globulin
(A.L.G.) which is required to diminish rosetting by human peripheral
blood lymphocytes in vitro, has bean studied by Wood and Gray (1973)
and Bewick, Ogg et. al., (1972). Wood and Gray (1973) found that the
measurement of the rosette inhibitory titre of A.L.G. did not give a
predictive test of rejection episodes, and was not an indication of
the amount of immunosuppression used, Bewick et. al., (1972) found
that the lower the amount of A.L.G. required to diminish rosetting
in vitro, the more stable the course of the transplant recipient.
Those patients who were rejecting became exposed to a very great risk
of infection if the dose of routine immunosuppression was increased
to the levels suggested by this test.
Nucleoside Incorporation
3 3
The uptake of H thymidine and H uridine by peripheral blood
lymphocytes is a measurement of DNA and RNA synthesis. The
production of rapidly dividing cells during the central part of the
cell-mediated immune response requires an Increase in DNA and RNA
3 3
Activity, therefore the uptake of H thymidine and H uridine
reflects to the rate of division of lymphocytes in the presence of
3
antigen. H thymidine incorporation by peripheral blood lymphocytes
has been shown to be increased in allograft rejection in rats (Blarney,
Nicol, Baxter and Deane, 1974) and to predict clinical rejection
episodes in man (Blarney, Bennett, Singer, Nicol and Harrison, 1975)
but the increased uptake is not specific to rejection as there is
3
also an increase in the presence of infection. H uridine uptake has
been shown to be of less value by the same workers.
Mixed Lymphocyte Colture (M.L.C.)
The in vitro recognition of antigen and the stimulation of
production of transformed cells has been reproduced almost exactly by
an in vitro test - mixed lymphocyte culture. Two sets of allogeneic
lymphocytes are cultured together, one set of lymphocyte is treated
with either mitomycin or irradiation to prevent division of these
cells, which act as the antigen and are termed the stimulator cells.
The other set of lymphocytes, termed the responder cells, after 5
days will have transformed to blast cells that have synthesised
increased amounts of DNA and this can be measured by an increased
3
uptake of H thymidine. The amount of transformation will be depend¬
ent on the degree of antigenicity of the stimulator cells (Hamburger
and Bach, 1973).
This test has great value for prediction of donor and recipient
compatabiltty before transplantation. As a measurement of the degree
of transplant rejection in following the course of transplantation
the length of duration of the test would make it of little value
clinically, and in practice it has been found that there is no oo
correlation between the degree of rejection and transformation in
M.L.C. of recipient lymphocytes against donor cells (Bach, 1974).
When the recipient lymphocytes did not transform before trans¬
plantation they did not acquire the capacity to do so afterwards, and
recipient lymphocytes kept their ability to respond to donor
lymphocytes in vitro if they had done so prior to transplantation.
Leucocyte Migration Inhibition
Sensitised lymphocytes release chemical mediators which are
termed lymphokines. One of these causes the inhibition of cell
migration and is named migration inhibition factor (M.I.F.).
Lymphocytes (usually mixed with macrophages) introduced into a
capillary tube will tend to migrate through the open end of the tube,
but if the cells have been previously sensitised to an antigen, the
presence of that antigen in the medium inhibits the migration. This
is due to the release of M.I.F. This in vitro test has bean shown
by Wood, Gray, Briggs and Bell (1973) to be a useful monitor of the
strength of the immune response. Using donor specific antigen from
spleen, lymph node and liver, but not kidney, they tested human
transplant peripheral blood lymphocytes for migration inhibition, and
found a good correlation between impending rejection and the
production of M.I.F. This test would appear at present to be the
most useful clinical test. It is not however entirely dependent on
specificity against HL-A histocompatibility antigens; Weeke, Weeke
and Bendixen (1970) obtained no inhibition of migration if tissue
extracts from the donor (other than parenchymal renal extract) were
used as antigen. Presumably these tissues have the same major trans¬
plantation antigens as the kidney.
Leucocyte Aggregation
The sensitised effector lymphocytes come in contact with the
antigenic target cell in order to kill it. The aggregation of the
lymphocytes around the target cell appears to be the earliest stage
of lymphocytes cytotoxicity (Kahan, Tom, Mittal and Bergan, 1974).
They performed an in vitro test observing leucocyte aggregation using
donox" skin target cells and peripheral blood lymphocytes from human
transplant patients. Although the test could predict rejection
episodes, when clinical rejection was established the lymphocytes
became unresponsive towards the donor cells. They suggested that
this might be due to the accumulation of immune cells within the
graft, rather than circulating in the peripheral blood.
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2. Cell populations used in in vitro cytotoxicity tests
3. The effect of antibody on cytotoxicity in the
allograft response
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Introduction
The capacity of the sensitised effector lymphocyte to kill
antigenic target cells of an organ has been demonstrated in vitro
but has been difficult to achieve. In vitro cell mediated
cytotoxicity represents the effector phase of the allograft response,
because both have target cell destruction in common. In studying
the background of lymphocyte cytotoxicity, work with tumour and
tissue grafts will both be considered. Many of the in vitro methods
used in attempts to show cytotoxicity in the transplant situation
were originally used to show cytotoxicity against tumour specific
antigen. The methods of these tests will now be discussed.
Previous work on the allograft response
1. Methods
a. Destruction of monolayers
The actions of lymphocytes and sera from dogs which had received
an allografted kidney were studied by Govaerts (1960). Using the
second kidney of the donor he obtained tissue cultured epithelial
target cells. He observed under the microscope the effect of recipient
thoracic duct lymphocytes and peritoneal macrophages on the target
cells, before, during and after immunization. Target cells in the
presence of recipient lymphocytes and serum, taken at the time of
rejection which occurred between the seventh and twelfth day, showed
cell retraction, agglutination and the target cells were surrounded
by lymphocytes. The method was slow and inaccurate due to subjective
evaluation of the cell damage.
b. Colony inhibition
A colony inhibition test was described by Hellstrom (1967).
Tumour target cells (Moloney virus induced mouse leukaemia) were
plated in petri dishes. After twenty-four hours incubation lympho¬
cytes, sensitised by allogeneic transfer of tumour from the donor
mouse to an H-2 incompatible recipient,were added for 4 days. The
ability of the lymphocytes to prevent the target cells from growing
into colonies was considered evidence of killing. This is a very
sensitive test and the effector lymphocyte to target cell ratio may
be low. The disadvantage for clinical purposes is that the test
takes 5 days to perform and can only be applied to certain types of
cell as targets, those which grow in monolayers,
a. Cell counting (Microcytotoxicity Tests)
In the methods described as microcytotoxicity tests, target cells
are allowed to adhere to glass or plastic. The detachment of these
target cells after the addition of lymphocytes denotes cell
destruction.
In animal experiments a method of microscopic counting of targets
after staining with trypan blue has been compared by Brunner, Mauel
and Schindler (1966) with a cloning1 efficiency assay equivalent to
colony inhibition. They studied the effect of allogeneic sensitised
spleen lymphocytes from C57BL mice, which were immunised by injection
of mastocytoma cells from DBA/ mice, on mastocytoma target cells.
A
The lymphocytes produced a 67% to 96% reduction in the DBA/
a
mastocytoma cells after incubation together in tubes for 48 hours,
and a 95% decrease in the cloning efficiency at 12 hours. This effect
1
Cloning - the ability of target cells to form colonies.
was achieved with a very small ratio of effector to target cells
3:1. Comparing the two methods the maximum reduction in cloning
efficiency occurred by 12 hours and in the cell counting at 48 hours.
Brunner et. al. , (1966) presumed that the loss of cloning ability
was an earlier stage of cell death.
A method of cell counting has also been described by Blesecker,
Fitch, Rowley, Scollard and Stuart (1973) using Brown Norway (B.N.)
ascites tumours as targets plated as monolayers in wells. Lewis (L.)
rats were immunised by intraperitoneal injection of B.N. spleen cells
or unilateral renal transplantation with Lewis x Brown Norway F
hybrid (LBNF^) kidneys, and killing was obtained with the immunised
lymphocytes from 5 to 50 days after the primary immunization.
Lucas and Walker (1974) described a similar cell counting
microcytotoxicity test using effector cells from rats sensitised by
skin and renal allografting. The target cells plated in the wells of
microtest plates were both lung fibroblasts and tumour cells. This
work was done in conjunction with a chromium release assay and the
results will be mentioned later (see below).
For experiments designed to measure lymphocyte cytotoxicity
obtained by organ grafting against normal non tumour tissue, a
microcytotoxicity test (M.C.T.) has been devised by Pierce,
Quadracci et. al., (1971). This M.C.T. has bean applied to the
clinical situation. They studied 26 recipients who had received
living related donor allografts and were on routine immunosuppressive
therapy with azathioprine, prednisolone and anti-lymphocyte
globulin (A.L.G.). Donor skin fibroblasts were tissue cultured and
used as target cells and plated in microtest plates containing 96
wells of 0.3 ml. capacity. Peripheral blood lymphocytes from the
recipient were added to pre-incubated target cells at a ratio
3,000 : 1 and incubated for a further 36 hours and stained. Control
lymphocytes were obtained from normal human volunteers. Cytotoxicity
was demonstrated by the reduction in target cells by 20% in the
wells containing recipient lymphocytes as compared with control.
Out of 42 tests in 26 patients, lymphocytes in 85% of the tests
were cytotoxic in the first 12 months, but then only 13% of the
lymphocytes were cytotoxic after this. In the first month there was
poor correlation, but from the second to twelfth month excellent
correlation between the amount of cytotoxicity and the number of
rejection episodes, and the amount of prednisolone required to
reverse these episodes. This test only gives information about the
immune status of the recipient at the time of the experiment there¬
fore frequent observations are required and are only possible if
live donor target cells are available.
Pudifin et. al., 1973 have also reported a specific cytotoxic
effect on the part of recipient lymphocytes in humans. Target cells
were obtained fresh from the liver of human cadaver donors and tissue
cultured. The lymphocytes from one recipient were found to be
cytotoxic and from a second not cytotoxic, three weeks after trans¬
plantation. The first recipient had a transplant nephrectomy two




Incubation, in vitro, of target cells with Chromium ( Cr.)
51
allows the uptake of Cr. into the cell, and binding of this isotope
to cytoplasmic protein (Pees, 1975). Death of the cell allows release
51 51
of the Cr. into the surrounding media. The Chromium release test
was considered by Perlmann and Holm (1969) to be the most reliable
51
method of determining cytotoxicity: the measurement of the Cr. is
quantitative and not dependent on subjective evidence such as cell
51
counting. Also they stated there is no reutilization of the Cr.
at cell death, and as cytotoxicity occurs within a few hours after
incubation with immune lymphooytes, longer culture conditions which
allow for promotion (feeder effect) or inhibition of growth of target
cells are not present.
51
The Chromium test has been used by Biesecker (1973) in a rat
model (see cell counting). The target cells chosen were B.N.
fibrosarcoma ascites forming tumour cells which gave a spontaneous
release (when targets were incubated with media alone) of 15 to 30%
at 6 hours. Having immunised Lewis rats with (LBNF^) kidneys or
B.N. fibrosarcoma allografts the sensitised spleen cells were
incubated with the target cells. The primary response was first
51
detected by an increase in Cr. release on the third day with a
peak at day 5, disappearing on day 12. The secondary immune response
was also detected on the third day, was maximum on the fourth day
51
and disappeared on the sixth day. The results of the Cr. release
corresponded closely to the appearance of clinical rejection in
allografted rats. On day 4 and 5 a rise in blood urea nitrogen was
detected in those rats receiving an allograft whose contralateral
normal kidney was removed. Biesecker et. al., (1973) also compared
51
their Cr. release results with the M.C.T. The cell mediated
51
immunity demonstrable on Cr. release was transient, whereas with
the M.C.T. cytotoxicity could be demonstrated from 5 to 50 days. They
could give no reasons for the difference between these two tests.
51
Brunner, Mauel, Cerottini and Chapus (1968) also described a Cr.
release assay in the animal model described in cell counting (see
above). They again compared the efficiency of the assay with the
inhibition of cloning efficiency. The percentage release of chromium
from the target cells on addition of sensitised lymphoid cells in
12 tests was:- 19% to 50% at three hours, 41% to 90% at six hours,
indicating that most of the target killing in this test had occurred
within six hours. These workers obtained a reduction (21% to 64%)
in cytotoxicity with prior incubation of the sensitised lymphocytes
with drugs, actinomycin D and cyclohexamide which block protein
synthesis.
In the allograft situation in which tissue rather than tumour
sensitization was used, Husberg (1972) described a similar technique
51
of Cr. release. Using donor kidney cultured fibroblasts from rats
as target cells and immune thoracic duct lymphocytes as effector
cells he found immune lymphocytes alone destroy allogeneic kidney
cells. The addition of immune sera and complement made the
destruction more aggressive. In this work Husberg found no
alteration in the killing ability of the sensitised lymphocytes from
rats receiving immunosuppression with cyclophosphamide. There was
a quantitative effect on the lymphocytes, with a reduction from
3 3
6,600/cm to 3,000/cm in the peripheral blood lymphocytes in the
rats who had received cyclophosphamide.
In man, Wolf, Fawley and Hume (1971), used kidney cells
obtained from a rejected kidney at the time of transplant nephrectomy
as target cells. Lymphocytes were obtained from recipient peripheral
blood. With e chromium release assay they showed, in 16 patients,
destruction of the renal cell monolayer when reacted with recipient
lymphocytes, in the absence of human serum or complement. The
reaction was complete in 12 hours when an average of 47% (range 30%
to 70%) release was obtained as against a 20% release from target
cells alone.
A chromium release assay was used by Lucas et. al., (1974)
86
comparing the results with a cell counting method and Rb incorpor¬
ation into target cells (at cell death K+ leaves the target cells and
86
Rb is taken up into the dead cell). The study demonstrated that
51
both short ( Cr. release) and long term (M.C.T.) assays measured
the same actions. However the chromium release assay,with low ratios
of lymphocytes to target cells and high spontaneous release, was
thought to present such formidable conditions that only a cell
counting method would have sufficient sensitivity to detect
cytotoxicity in the primary response to both skin and renal
allografts.
2. Cell populations used in in vitro cytotoxicity tests
Target8
The target cells are obtained from the donor animal or donor
Inbred strain. In the tests already described the targets have been
either tumour or normal tissue. Tumour cells In animals are easy
to obtain and culture. Established cell lines are an advantage as
they are easy to culture as monolayers and consist of one cell type.
Fibroblasts are also easy to culture and are commonly used as normal
tissue targets, but these cells are difficult to kill in comparison
with tumour cells. Skin fibroblasts have been used in cytotoxicity
test for human lymphocyte activity, and this is satisfactory when
live donor kidneys are being transplanted. There is a problem in
obtaining target cells when human cadaver kidneys are grafted,
although tissue cultured cells of organs removed at death can be used
for a short time.
Effector cells
The cells from sensitised recipients, in the experiments already
described and in this work are obtained by in vivo sensitization.
The effector cells used are lymphocytes, cytotoxicity is a function
of live lymphocytes and therefore it is essential that 90 to 100% of
the lymphocytes are viable (Perlmann and Holm, 1969). The efficiency
of various types of effector cells has been compared by Takasugi and
Klein (1970). Spleen cells and peritoneal cells were the most
effective; followed by peripheral blood lymphocytes, thymocytes;
lymph node lymphocytes were the least effective as killer cells.
In vitro cytotoxicity is due to immune T lymphocytes and is
largely independent of B lymphocytes, alloantibody producing cells
or macrophages. This was shown by Brunner and Cerottini (1971).
In vitro cytotoxicity was abolished in mice by treatment of immune
spleen cells or peritoneal cells with anti 0 serum and complement, b
but was unaffected by the removal of macrophages using adherence
columns, or by pre-treatment with anti-macrophage serum and complement.
Cytotoxicity by immune T cells was also confirmed by transfer of
thymus cells into irradiated mice. Other workers, Golstein,
Blomgren, Svedmyr and Wigzell (1973) have shown that T cells are
necessary for anti-allogeneic cell mediated immunity and they alone
are sufficient without the participation of other cells.
Although T cells have been shown to destroy target cells in
vitro it has recently become apparent that lymphoid cells other than
T cells can exert a cytotoxic effect on target cells. A cytotoxic
cell has been found which is a non T cell, removed through an anti¬
immunoglobulin coated column, and is called a K cell (Allison, 1974).
Perlmann and Holm (1960) felt that thoracic duct cells should
be used for cytotoxicity experiments as the lymphocyte populations
should be free of monocytes (macrophages) and polymorphs which can
themselves be cytotoxic. This has been confirmed by Lucas and Walker
(1974), who found that both sensitised and control (non sensitised)
spleen cells had a cytotoxic effect on allogeneic target cells
although the sensitised spleen cells had a greater added specific
cytotoxicity; the absorption of spleen cells to remove the macro¬
phages eliminated the non specific cytotoxicity and only the
sensitised cells then demonstrated cytotoxicity.
Other work has been performed to identify the killer cells by
extracting cells from a rejecting graft. Strom, Tilney, Carpenter
and Busch (1975) extracted the cells from failed (rejected) human
allografts. Using a Cr. release method described by Brunner et.
al.f (1968) and using donor peripheral blood lymphocytes as target
cells they found good correlation between the extent of in vitro
cytotoxicity by the extracted lymphocytes and the histological
grading. Methods were described using E rosettes, EA rosettes and
EAC rosettes* to determine which mononuclear cells appeared to be
doing the damage. In early graft failure the T cell was the prominent
killer cell, but later in rejection a mixture of T and non T cells
were cytotoxic. Also the recipient graft cells had a greater
capacity for killing than the recipient peripheral blood lymphocytes
taken and tested at the same time.
Perlmann and Holm (1969) have shown that lymphoid cells which
are from non sensitised (normal) donors can be induced to kill in
vitro by activation into blast cells with PHA.
1 see glossary
3. The effect of antibody on cytotoxicity in the allograft response
Blocking factors directed against cytotoxic lymphocytes have been
demonstrated by Hellstrom and Hellstrom (1972).in the colony
inhibition test, and by Pierce et. al., (1971) with a M.C.T. Pierce
et. al., (1971) found that in humans the addition of post transplant
recipient serum decreased in vitro lymphocyte cytotoxicity. This in
vitro effect was reflected in vivo in a group of patients, in whom
M.C.T. showed cytotdxic lymphocytes the effect of which was blocked
by serum: clinically these patients had a smooth course. Hellstrom
and Hellstrom also monitored human recipients of kidney grafts; they
found that the lymphocytes of patients who were clinically without
signs of graft rejection, behaved in one of two ways. One third of
the patients lymphocytes were not cytotoxic, two thirds had cytotoxic
lymphocytes, but the cytotoxic effect was blocked by serum from the
graft recipient. Patients in whom there were one or several
rejection crises showed cytotoxic lymphocytes with no blocking serum.
Cytotoxicity in the tumour response
Experimental animal tumours express antigens capable of eliciting
tumour immune rejection responses. This has been clearly established
in in vivo studies where exposure to syngeneic tumour results in the
development of immunity. Lymphoid cells of mice carrying graft of
methylcholanthrene induced (M.C.) sarcomas were transferred to
syngeneic mice (Rosenau and Morton, 1966). Direct challenge of
tumour to the recipient mice did not lead to growth of the tumour.
Also lymphoid cells from immune mice were incubated with a suspension
of tumour and transferred into irradiated syngeneic mice and no growth
of the tumour occurred. For obvious ethical reasons evaluation in
vivo of immunity in human cancer patients against transplanted
cancer cells is not possible.
Tumour specific antigens on most chemically-induced tumours are
characteristic for the individual tumour, whilst most virus-induced
tumours show specificities related to the oncogenic virus. In vitro
tests indicate that most human tumours express antigens which are
characteristic of the histological type of tumour (Baldwin and Robins,
1976).
Considerable evidence from in vitro studies has been held to
confirm the immune response to experimental animal tumours. A number
of methods have been used to study lymphocyte cytotoxicity against
tumour specific antigen.
Rosenau and Morton (1966) used a cell counting technique; they
found that the lymphoid cells from mice bearing tumour grafts did
inhibit the growth of tumour target cells by 71%, the in vitro test
was not as sensitive as the in vivo test in which the suppression of
tumour growth was 100%. The colony inhibition assay was first
described by Hellstrom (1967) to allow measurement of the effects of
immune lymphoid cells on target tumour cells in culture. The target
cells in this test were seeded at low density on to petri dishes and
after attachment the medium was replaced by lymphoid cells. The
dishes were incubated for 3 to 7 days, then the colonies stained and
counted. Target killing was said to have occurred when there was a
reduction in colonies after exposure to sensitised lymphocytes
compared with those in the appropriate controls. Another micro-
cytotoxicity assay has been developed in which the tumour cells are
seeded into wells of microtest plate, and after incubation with
effector cells for 36 to 72 hours the numbers of individual tumour
cells surviving on each well are counted. This micro-assay (M.C.T.)
was developed by Takasugi and Klein (1970) where sensitised spleen
cells were obtained from mice hyperimmunised to M.C. sarcoma. The
mice received weekly intraperitoneal (i.p.) injections of irradiated
sarcoma cells. The immunised spleen were cytotoxic against the
tumour; moreover the sensitised cells were specifically cytotoxic
as they showed no effect against other tumour target cells.
This M.C.T. has been extensively used by Baldwin, Embleton and
Robins (1973), and the techniques of these workers have been closely
followed in the experimental work of this section. They sensitised
syngeneic rats either by multiple injections of irradiated chemically
induced hepatomas (4-dimethylaminoazobenzene, DAB) or by primary
transplanted tumour grafts. The lymphocytes from the rats bearing
primary grafts were cytotoxic in 5 out of 7 tests, and the lymphocytes
from hyperimmunised animals in 13 out of 17 tests. No cytotoxic
antibody was found in the animals with primary grafts until the
grafts were excised. Repeated immunization of the rats gave high
levels of cytotoxic antibody.
Further modifications of M.C.T. have been introducted using
125 125
isotopically labelled 1-iododeoxyuridine ( IUdR) cells (Seeger
125
and Owen, 1973). The IUdR may be incorporated into the target
125
cells prior to their incubation with lymphocytes. The IUdR can al
also be used in 'post labelling* techniques; the targets and lympho¬
cytes are incubated together for at least 48 hours and washed. The
125
remaining target cells are labelled with IUdR for a further 24
hours and counted on a if counter. This post labelling technique
avoids the problems of visual counting and the problem of
reutilization of isotope (Ghaffer, Cullen, Dunbar and Woodruff, 1974)
and at present appears to be the most satisfactory of the micro-
cytotoxicity tests.
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The release of chromium from labelled tumour cells has also
been used as an index of lymphocyte cytotoxicity in animal tumours
3
(Pearson, Hodis and Friberg, 1969), and also the release of H proline
as a method of studying cytotoxicity in human bladder tumours,
(Bean, Pees, Rosen and Oettgen, 1973).
The results of in vitro studies with human tumours must however
be considered more critically. The early enthusiastic reports of
in vitro cytotoxicity in human tumours are now doubted (Takasugi,
Mickey and Terasaki, 1973) as much of the cytotoxicity appears to be
non specific. Many of the technical problems related to the in vitro
+ests in the tumour immune response have been discussed by Pees (1975)
mainly in relation to human tumours. He suggests that primary
cultures of target cells are better than long term cell lines. The
tumour cells after at least one passage in vitro are usually free of
blocking factorp. He reiterates the problem of target cell
proliferation in M.C.T. and therefore favours the use of isotope
release assays, where growth and cell division have only an
insignificant influence.
The T lymphocyte has been shown to be the cytotoxic effector
cell in allograft rejection (see above). The role of T lymphocytes
in tumour immunity is less clear. Pees (1975) maintained that for
cytotoxicity against tumour associated antigen, T cells are required
in association with non T cells. Macrophages may become effector
cells either by specific immunization, or non immune macrophages
may become effector cells by virtue of reaction with factors
(specific macrophage arming factor, S.M.A.F.) liberated by the
sensitised lymphocytes (Evans and Alexander, 1971). Tumour cell
killing by normal lymphoid cells in the presence of antibody has
been implicated in a number of tumour systems, and it has been
suggested that the antibody dependent cytotoxic cell is a "null"
or "K" cell (Greenberg and Shein, 1973). Serum from tumour bearing
individual has been shown to interfere with cellular immunity
(Hellstrom and Hellstrom, 1969); this blocking activity is thought
to be due to antigen : antibody complexes (Baldwin, Price and
Robins, 1972) which protects tumour cells from attac-k by sensitised
lymphocytes.
Conclusion on the published work from other centres
Cytotoxicity has been demonstrated with ease against tumour
specific antigen in both in vivo and in vitro animal experiments
although not with human tumours. Lymphocyte cytotoxicity has been
obtained in vitro in the allograft response, in both animals and
humans, although much of the work reported has been with tumour
allografts or using tumour cells as target cells. The cell counting
techniques and the isotope release assays do not, in the same systems,
necessarily correlate well and most workers appear to favour isotope
release methods as being more accurate due to lack of subjective
observation, also the tests are short term and therefore cell growth
and division do not influence the results.
The immune response in vivo to an allograft whether an organ or
tumour graft is much stronger than the response to syngeneic tumour,
yet the virulence of the in vivo response to an allograft is not
mirrored by the in vitro cytotoxic response. The in vivo immune
reaction against tumour is weak with relatively little or no
infiltration of tumour with lymphoid cells, whereas in vitro lympho¬
cyte cytotoxicity has been demonstrated by sensitised lymphocytes
against tumour target cells in both laboratory animals and man with
greater ease.
B. AIMS
The efferent arc of the immune response to an allograft is
represented by the direct cytotoxic action of specifically sensitised
effector T lymphocytes on the cells of the graft.
The present work has been performed to make full investigation
into the cytotoxic properties of the individual lymphocyte. The
recipient animal has been sensitised in vivo by either allograft or
tumour. The in vitro tests measure the capacity of the recipient
lymphoid cells primed in this way to kill either donor tissue cells
or tumour cells. Direct comparison of the in vivo effect, with in
vitro cytotoxicity may then be made.
In vitro cytotoxicity has been demonstrated by several previous
workers either using hyperimmunised cells as killer cells, or by using
easily lysed cultured tumour cell lines as target cells. The
intention of the experiments which follow is to reproduce cytotoxicity
in these situations - and then by changing one parameter at a time
(either killer cells or target cells) to move towards a reproduction
of target cell killing in the allograft response (killing of target
cells derived from the allograft by cells from the animal rejecting
the allograft). (Diagram 2)
C. METHODS
All the experiments have been performed In rats: two in vitro
methods of evaluating cytotoxicity, cell counting and a chromium
release assay have been used. In Appendix la a full description of
the methods is given.
Experiment 1 (Diagram 2)
Wistar rats were immunised with syngeneic tumour - hepatoma or
methylcholanthrene induced sarcoma - from the same strain of line
inbred Wistar rats (Appendix lb). The effector lymphocytes were
removed from the recipient (Appendix Id) and tested for cytotoxicity
against tissue cultured tumour target cells (Appendix lb).
Experiment 2
The same hepatoma and methylcholanthrene induced tumours from
inbred Wistar rats were excised and transferred as a primary tumour
graft (Appendix Ic) into either allogeneic outbred Sprague-Dawley
(S.D.) rats or inbred A.S. rats thus altering the sensitising
antigens from tumour specific antigens to transplantation antigens.
The recipient lymphocytes were tested for cytotoxicity against the
same tumour target cells as experiment 1.
Experiment 3
a) The target cells were altered to tissue cultured fibroblasts
of the donor Wistar strain (Appendix Ic). The effector cells remain
the same as in experiment 2 and are from allogeneic recipients
sensitised by transfer of tumour from the donor strain.
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METHODS OF SENSITIZATION IN LYMPHOCYTE CYTOTOXICITY TESTS
Numbers in brackets indicates the numbers of the experiments.
Diagram 2
(experiment 1 and 2). The effector cells were obtained by
sensitization of allogeneic A.S. rats by the transfer of a skin graft
from the donor Wistar strain and the recipient lymphocytes were
tested for cytotoxicity against the tumour target cells.
Experiment 4
The target cells were again tissue cultured fibroblasts of the
donor strain. The effector cells were obtained from S.D. rats who
had received primary kidney or skin grafts (Appendix Ic) from the
inbred Wistar donor strain. This experiment again measures the
cytotoxicity in the primary response against transplantation antigen.
Experiment 5
Cytotoxicity in the hyperimmune situation was also compared with
that of the primary response. The target cells were again tissue
cultured fibroblasts of the donor strain. The effector cells were
obtained from either outbred S.D. or inbred A.S. rats, who had
received three skin grafts, at intervals of two weeks, and two intra¬
peritoneal injections of lymphocytes from the donor Wistar strain.
Techniques of tissue culturing, immunization by syngeneic and
allogeneic tumour, skin and kidney grafting and preparation of
lymphocytes are described in Appendices lb, Ic and Id.
Target Cells
All the target cells in these experiments were from short term
tissue cultures of tumour or fibroblasts. The tumour cells were
found to grow optimally in Eagles Hepes medium plus 10% foetal calf
serum (FCS) and the fibroblasts in Waymouths plus 10% PCS. The
target cells were used for the cytotoxicity tests after about two
weeks from the start of culturing, when the division of the cells
had settled down to a slow but steady rate. If the target cells
were used before two weeks, overcrowding in the test plates occurred.
Effector cells
The effector cells in these experiments were either lymph node
lymphocytes, obtained from mesenteric, cervical and axillary lymph
nodes; spleen cells, thoracic duct lymphocytes or blood lymphocytes.
The preparation of these cells is described in Appendix Id. The
cells obtained were mostly lymphocytes, although the lymph node and
spleen preparations contained macrophages. The red cells were
separated from the spleen preparations. In most of the experiments
no effort was made to identify the different T, B and macrophage
populations and their capacity to kill target cells. Some experiments
were performed with T cell and B cell enriched populations obtained
by fractionation on a nylon wool column (see Appendix Id). These
separate fractions were tested for cytotoxicity.
Controls
In these experiments lymphocytes of non sensitised animals
were used as effector cell controls. In the syngeneic tumour
experiments (1) the control cells were obtained from non immunised
syngeneic Wistar rats. In the experiments involving allogeneic
transfer of either tumour or grafted tissue (2, 3, 4, 5) the control
lymphocytes were obtained initially from animals syngeneic to the
donor.
In later experiments the controls were changed to the use of
















The results of the microcytotoxicity test using a direct cell
counting method are considered first in each experimental group. A
complete microcytotoxicity experiment is shown in Appendix Ie with
the method of immunization, plating of microtest plates and the
calculation of cytotoxicity. Significant killing is considered
to have occurred when there is a reduction in the remaining target
cells after incubation with immune lymphoid cells, compared with the
number of target cells after incubation with non immune control
lymphoid cells: a Student's T test for unpaired data is applied
to each experiment as the test of significance. Cytotoxicity is
thus considered to occur only when there is a reduction of viable
cells in the test wells of approximately 20%.
Experiment 1 Syngeneic Tumour
Wistar rats were immunised with syngeneic tumour and the effector
cells from these rats were tested against target cells of the tumour
which had been raised in tissue culture.
Rats were immunised with D23 hepatoma and their lymphocytes were
tested against cells of this tumour. The results are shown in Table I.
Using unfractionated lymph node lymphocytes (LNL) as killer cells
cytotoxicity was obtained in only 4 out of 16 experiments. Against
this in 2 experiments there was apparent killing by control cells in
that the number of target cells in the wells at the end of the
experiment were reduced in comparison with the wells to which test
lymphocytes had been added. One experiment was carried out using
spleen cells as the effector lymphocytes and cytotoxicity was
obtained in this experiment. When fractionation of the lymph node
lymphocytes was used, killing was obtained in 3 out of 8
experiments by T (eluted) lymphocytes. It was noteworthy that in
5 of the 8 experiments where B (retained) lymphocytes were used,
"control killing" was obtained. Two other tumours (MC7 and MC57)
were used to hyperimmunise rats and the lymphocytes from the rats
were tested for cytotoxicity against the cells of these tumours which
had been tissue cultured. The results are shown in Table II. Using
lymph node lymphocytes as the effector cells in only 3 out of 17
experiments was killing of tumour cells demonstrated and against this
killing by the control unsensitised lymphocytes was obtained in 4 out
of 17. When spleen cells were used as the effector cells, killing
was obtained in 1 out of 2 tests. Fractionation of the cells gave
no killing and in fact 5 out of 6 tests with retained cells (B cells)
showed control killing, 2 out of 6 tests with eluted cells (T cells)
also showed control killing.
Tables I and II
Cytotoxicity achieved with lymphocytes and spleen cells from














































































Experiment 2 Allogeneic Tumour
In these experiments a primary grafted tumour was transferred
to an allogeneic rat. The lymphoid cells were removed at various
times after grafting and used to test for cytotoxicity against the
tissue cultured tumour cells. The results are shown in Tables III,
IV and V. Killing was not consistently achieved with immune LNL but
was achieved in 50% of the tests carried out between the fourth and
eighth day after sensitization. Thereafter the number of tests
showing any cytotoxicity fell away and no cytotoxicity was
demonstrated on the part of cells taken later than 12 days after
sensitization. In only 4 of the tests was there "control killing"
and it is perhaps noteworthy that 2 of these were on the fourth day
after sensitization. When spleen cells were used as the effector
cells killing was only occasionally obtained and appeared to require
a higher ratio of effector to target cells. There was a difference
between the results dependent upon the tumour used - very little
cytotoxicity was obtained against the MC57 and D192 tumour cells.
Tables III and IV
Cytotoxicity achieved with lymphocytes and spleen cells from
rats immunised by a primary allogeneic tumour graft.
Cytotoxicity achieved between the 5th and 12th day after
grafting.
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TableV
Experiment 3
This series of experiments was divided into 2 parts.
a. Rats were sensitised by primary tumour allograft and lympho¬
cytes from these rats were used as effector cells against fibroblasts
cultured from embryos of the tumour bearer strain.
b. Rats were sensitised /by primary skin allograft and
lymphocytes from these rats were used as effector cells against
tumour cells from a tumour which had been induced in the donor strain.
Experiment 3a (Table VI)
In 3 out of 8 experiments carried out with lymph node lymphocytes
between the fifth and the twelfth day after sensitization, killing
was obtained against fibroblasts of the tumour bearer strain. In
1 out of 8 tests using spleen cells killing was obtained.
Experiment 3b (Table VI)
No cytotoxicity whatever was obtained in 8 tests using both
lymphocytes and spleen cells sensitised by primary skin grafting
against cells from a tumour which had been induced in the donor
strain.
VI
Cytotoxicity with lymphocytes and spleen cells from rats in
•cross-over' experiments.
a) The rats were immunised by an allogeneic tumour graft
and the effectors were tested against fibroblasts of the
donor strain. Some cytotoxicity was achieved.
b) Immunisation was by primary skin grafting and the
effectors were tested against tumour cells of the donor
strain. No cytotoxicity was achieved.
RATIO
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Experiment 4 Primary allogeneic tissue grafts
In these experiments either skin or renal grafts were trans¬
ferred to allogeneic rats (Table VII).
No cytotoxicity against donor strain fibroblasts was achieved
after skin grafting using either lymph node lymphocytes, thoracic
duct lymphocytes (T.D.L.) or spleen cells except in one experiment
4(2), where a reduction of 16% of the target cells occurred after
the addition of LNL at a ratio of 2,000 : 1.
After renal allografting however there was definite cyto¬
toxicity achieved using spleen cells in 3 out of 4 experiments,
but not LNL (0 out of 4 experiments), at 7-8 days post grafting -
experiment 4(4 and 6). It was also noted that the spleens of
these rats on removal were considerably enlarged in comparison with
the spleen of the rat which had received a skin graft at the same
time. The control effector cells in these experiments were obtained
from non immunised rats of the same strain as the recipient rat.
Table VII
Cytotoxicity with lymphocytes and spleen cells from rats
immunised by primary skin and renal allografts. Cytotoxicity

























































Experiment 5 Allogeneic Hyperimmunlzation
In these experiments the recipient rats were immunised with 3
skin grafts and 2 i.p. injections of donor lymphocytes (Table Villa
and b). Very little cytotoxicity was achieved using LNL either
unfractionated or fractionated. However using spleen cells there
was consistent cytotoxicity and cytotoxicity with peripheral blood
lymphocytes was also achieved. In many of the experiments using
spleen cells there was a reduction in the target cells after the
addition of control spleen cells (non specific cytotoxicity), but
there was a greater reduction of the remaining targets after the
addition of immune spleen cells (specific cytotoxicity).
Two further experiments were performed in this group:
1. Hyperimmune serum was used as the effector in place of the
hyperimmune lymphocytes. No cytotoxicity was demonstrated.
2. Hyperimmune serum plus hyperimmune lymphocytes was used as
the effector. There was no alteration in the cytotoxicity achieved
in comparison with that achieved by hyperimmune lymphocytes alone.
Hyperimmune serum, plus control lymphocytes were not tested.
The final table in the results section (Table IX) is shown rather
to demonstrate in greater detail the results obtained within each
experiment. This is experiment 5 (13). Further reference to this
table will be made in the discussion section.
VIII
Cytotoxicity achieved with lymphocytes and spleen cells from
rats hyperimmunised by allogeneic tissue grafts or donor
fibroblasts. Cytotoxicity was consistently achieved when spleen
cells were effectors.
RATIO
TARGETSEFFECTORSSENSITIZATIONFEC ORS:TARGET L.N.L.Allogeneic4,000:1 BLASTSFIBRO-Hyperimmunised2>0()0.±
1,000:
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Summary of Results in Microcytotoxicity Tests (Diagram 2a)
1 a) Unfractionated lymph node lymphocytes sensitised against
syngeneic tumour in ratios varying from 1,000 to 4,000 : 1 effector
to target cells were cytotoxic in 4 out of 16 tests using D23
hepatoma, 3 out of 17 tests using M C - sarcomas.
b) Control lymphocytes especially B cells and macrophages were
able to produce a non specific reduction in target cells.
2. Lymph node lymphocytes, sensitised against primary tumour
allografts were cytotoxic, especially between the fourth and
twelfth day after sensitization.
3. Cytotoxicity was achieved with cross over grafting (experiment 3)
when tumonr grafts' and not skin grafts were transferred.
4. Lymphocytes, both spleen and lymph node, sensitised against
primary skin allografts are not cytotoxic. Spleen cells sensitised
against primary renal allograft are cytotoxic, but not lymph node
lymphocytes.
5. Cytotoxicity was easily achieved with spleen cells from hyper-
immunised animals, but no cytotoxicity was obtained with lymph node
lymphocytes.
6. Throughout all the experiments the addition of lymph node
lymphocytes to the target cells usually caused promotion of growth
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RESULTS IN LYMPHOCYTE CYTOTOXICITY TESTS
The fractions denote the number of tests where killing was obtained over
the number of tests performed.
Diagram 2a
7. In: many experiments the addition of non immunised spleen cells
gave a non specific reduction in target cells. There was however
a greater reduction after the addition of immune spleen cells which
we consider is the specific cytotoxic effect.
2. Chromium release assay
A chromium release assay was performed concurrently with many
51
of the cell counting M.C.T. The results of the Cr. assays are
shown in Table X. A complete assay is shown in Appendix Ie of the
experiment 2(1), the rats being immunised by transfer of allogeneic
D23 tumour. No cytotoxicity on the part of immune killer lymphocytes
was achieved in this experiment which is also shown in figure 1.
The spontaneous release of chromium from the labelled target cells
ranged from 4.3% at the start of the experiment to 40.5% at 24
hours. There was no increase in the release of chromium with the
addition of immune lymphocytes over a 24 hour period. In the con¬
current M.C.T., 24% cytotoxicity was achieved with immune lymphocytes
at a ratio of 4,000 : 1, the ratio of effector to target cells in
51
the Cr. assay was much lower at 200 : 1.
The results in Table X show that cytotoxicity was not demonstrated
with this assay except in one experiment. The spontaneous release in
all the experiments varied from 25% to 75% at 24 hours, the amount of
release in each of the triplicate tubes over a 24 hour period was
remarkably cnnsistent. It was possible to obtain a high release on
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Conclusion regarding microcytotoxicity tests
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2. Allogeneic tissue grafts
DISCUSSION
Microcytotoxicity Test
The results obtained in experiment 5 show clearly that the
system used is satisfactory for the demonstration of cytotoxicity and
that cytotoxicity can be achieved against fibroblasts using spleen
lymphocytes as effectors. With this point established the whole
experimental plan proceeded as set out in diagram 2. The results
have been given in a previous section and are summarised in diagram
2b and will be considered experiment by experiment.
Experiment 1 Cytotoxicity against syngeneic tumour
The technique has been followed measuring cytotoxicity against
syngeneic tumour used by Professor Baldwin and his team of the Cancer
Research Campaign Laboratories, Nottingham. The method has given
consistent results in the past (Baldwin et. al., 1973, Zoller, Price
and Baldwin, 1975). This cytotoxicity test was studied by the present
experimenters in Professor Baldwin's laboratory and was followed
precisely in all respects - the tissue culture conditions, the choice
of media, the effector to target cell ratios and the length of time
incubation of the cells. In addition to the lymph node lymphocytes
which were used as effector cells by Baldwin et. al., experiments here
have also been performed using spleen cells as the effector cells.
The experiments performed here have only infrequently demonstrated
cytotoxicity using LNL and in fact where 7 out of 33 tests showed
killing on the part of immune cells against the tumour cells, 6 out
of 33 experiments showed apparent killing by control cells.
This "control killing" which has been referred to several times
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CYTOTOXICITY OBTAINED IN MICROCYTOTOXICITY TEST
Diagram 2b
includes 2 separate phenomenon. The first of these is that some¬
times control (unsensitised) cells do demonstrate killing. As there
is considerable reduction in the number of target cells remaining
at the end of the experiment in the veils to which control lymphocytes
have been added in comparison with wells which only hold target cells
and media. The second phenomenon is that of the feeder effect. This
occurs when there is an .increase in the number of target cells found
at the end of the experiment in those wells to which lymphocytes have
been added (Table IX). Either immune or control lymphocytes can
demonstrate this effect. It is clear from this that a variety of
effects can be obtained which leads to difficulty in the final
interpretation of the experiments. Thus what has been referred to
as "control killing" in the results section, can either be true
killing by control cells or on occasions can be a greater stimulatory
effector on the part of immune cells than on the part of control
cells. It is noteworthy that the retained cells (B cells plus
macrophage fraction) consistently demonstrated this stimulatory
effect.
Experiment 2 Cytotoxicity against allogeneic tumour
It might be expected that the greatest ease in obtaining
cytotoxicity would be by the transfer of tumour from one animaltto
a non identical animal across a major histocompatibility Carrier
(Ag-B in the rats). The inbred Wistar donor strain (WAG) used has
w
known gepes a,c,H-1 ,HBA; the recipient inbred A.S. strain has
c,H-l^ (Testing and Staats, 1973). The antigenic makeup of the
outbred S.D. strain is not known. Even though M.L.R. performed
between WAG and AS lymphocytes by Dr. Colin Brooks of the Cancer
Research Campaign Laboratories, Nottingham (Appendix 2b) showed
very little incompatibility, the tumour grafts, skin grafts and
kidney grafts made across these strains all rejected acutely.
The first experiments in this group were performed using D23
and MC7 tumours. These tumours have been passaged for 11 and 5
years respectively. Therefore 2 newly induced hepatomas, D192 and
D202 have also been used as it was felt that newly induced tumours
were morerlikely to have retained antigenic makeup. Symes (1965)
has shown that immunological stimulation in spontaneous mouse
tumours decreases with an increasing number of passages of the tumour.
The method of immunization used in this experiment (transfer
of tumour into the buttocks plus intraperitoneal injection of tumour)
has proven to be a satisfactory immunization procedure in many other
experiments.
In this experiment cytotoxicity was demonstrated with reasonable
consistency using cells taken between 4 and 12 days after
sensitization. This confirms the results of Biesecker et. al., 1973
who found cytotoxicity against ascites tumour cells in the third to
the seventh day only after primary sensitization and the results of
Zoller et. al., 1975 who found cytotoxicity against DAB hepatomas
was only shown by lymphoid cells taken between 2 and 12 days after
sensitization.
This experiment has then clearly demonstrated cytotoxicity on
the part of primarily sensitised cells against allogeneic tumour
cells. It would seem likely that the cytotoxic effect is being
exhibited against the transplantation antigens as cytotoxicity has
been obtained consistently in this experiment whereas cytotoxicity
was not consistently obtained in experiment 1 where any cell killing
was directed against tumour associated antigen.
Cytotoxicity in cross over grafting experiments
Experiment 3a
The only difference between this experiment and experiment 2
was in the target cells used. The method of sensitization (allogeneic
tumour) was the same as that in experiment 2 but the target cells in
the wells were fibroblasts rather than tumour cells. Both fibro¬
blasts and tumour cells bear the same transplantation antigens,
however, cytotoxicity was again obtained in 50% of the tests carried
out with lymphocytes taken between 5 and 12 days after primary
sensitization, agreeing with the previous experiment.
Experiment 3b
The difference between experiment 3b and experiment 2 is in the
method of sensitization of the lymphoid cells. The target cells used
are the same in both experiments (allogeneic tumour). In experiment
2 the lymphocytes were sensitised by grafting the tumour itself. In
experiment 3b the lymphocytes have been sensitised by skin grafting
from a strain of origin of the tumour. Again it is stressed that both
the skin graft and the tumour graft bear the same transplantation
antigens. In experiment 3b however there was no killing of the tumour
cells in any of the tests made.
The discussion now anticipates the results of experiment 4 which
will be discussed in the next section. Experiment 4 in fact confirms
that cytotoxicity against fibroblasts of the donor strain could not
be obtained by cells primarily sensitised by skin grafting. This series
of experiments was set up to show where this breakdown in cytotoxicity
occurred and it is clear from experiments 3a and 3b that the break¬
down is not in the failure of lymphoid cells to kill fibroblasts but
rather the failure of lymphoid cells sensitised by skin grafting to
kill target cells of the donor strain in vitro.
Experiment 4 Cytotoxicity against allogeneic tissue grafts
No cytotoxicity was obtained with LNL nor with spleen cells
which had been immunised by primary skin allografting. No
cytotoxicity was obtained by lymph node lymphocytes after primary
renal allografting. Cytotoxicity was obtained in 3 out of 4 tests
using spleen cells sensitised by primary renal allografting. As
has been discussed under experiment 3, it is clear that the break¬
down in cytotoxicity has occurred because of the method of
sensitization. Further work is required using allogeneic organ
grafts but allogeneic skin grafting does not appear to sensitise
the lymphocytes sufficiently for them to kill target cells of the
donor strain in vitro. Blarney et. al., (1973) found a previous
skin grafting did not speed up the rejection of a renal allograft
in rats although second set rejection did occur in further skin
grafts and it would appear from a variety of other experiments
that skin graft rejection may occur in situations where orgap grafts
are not rejected (Calne, Sells, pena, Davis, Millard, Herbertson,
Binns and Davies, 1969, Salaman et. al., 1971). The difference here
may well lie in the different methods of vascular connection in an
organ graft and in a tissue graft.
Overall conclusion regarding microcytotoxicity testing experiments
The consistent demonstration of cytotoxicity on the part of
spleen lymphocytes which had been hypersensitised by allogeneic grafts
confirmed that there was nothing wrong with the overall methodology.
The aim of this whole section of the thesis has been to investi¬
gate whether cytotoxicity could be demonstrated on the part of
lymphocytes,sensitised by primary allografting, against cells of the
same histocompatibility antigenic makeup as those of the allograft.
Experiment 4 clearly showed that no such demonstration was possible
when the lymphocytes had been sensitised by a primary skin allograft.
However cytotoxicity could be demonstrated on the part of splenic
lymphocytes when the cells had been sensitised by primary organ;
graft. Here then may lie an important difference in the sensitization
produced by these two different kinds of grafts and further work on
this subject is required.
The experiments have examined why cytotoxicity could not be
demonstrated by cells sensitised by primary skin allografting against
tissue cells bearing the same antigens as those of the skin allo¬
graft. At the outset of the experiments there appeared to be two
possibilities: firstly, in the method of sensitization of the
lymphocytes and secondly, that cells tissue cultured from the cells
of normal tissues were too difficult to kill. The cells tissue
cultured from thmour are much easier to kill. Satisfactory
cytotoxicity has been demonstrated on the part of cells primarily
sensitised by allogeneic tumour tested in vitro against those tumour
cells. In experiment 3 however an important difference emerged.
When the method of sensitization remained the same as in experiment
2, that is cells were sensitised against allogeneic tumour, but
\
were tested for cytotoxicity against fibroblasts of the same makeup
as the allogeneic tumour - experiment 3a - cytotoxicity was
demonstrated. This shows that the reason for the failure to
demonstrate cytotoxicity does not lie in the target cell itself.
Experiment 3b showed that the failure to demonstrate cytotoxicity
lay in the method of sensitization for whilst the target cells were
the same as those used (and killed) in experiment 2, no cytotoxicity
could be demonstrated on the part of lymphocytes which had been
primarily sensitised by skin grafting rather than tumour grafting.
This brings us back to the discussion in experiment 4 revolving
around the degree of sensitization produced by various types of
grafting. Skin grafting appears to produce the least satisfactory
sensitization, tumour grafting very good sensitization, organ
grafting may well lie between these two. The results in cytotoxicity
experiments appear to mirror the degree of sensitization produced by
these various types of graft.
There is one further point that should be added and that
revolves around the type of effector used. In all groups of experi¬
ments we have shown that lymph node lymphocytes are not as effective
as killer cells. Removal of inappropriate nodes and damage during
preparation might be the reasons but Takasugi and Klein (1970) also
found these lymphocytes to be the least effective. Spleen cells and
peripheral blood lymphocytes, when used, showed a greater capacity
for killing in the cell counting method. Non immunised spleen cells
also showed a non specific killing effect, killing was increased
with immunised spleen cells. A single experiment 5(14) in which
spleen lymphocytes were fractionated did not show whether the B cell
plus macrophage or the T cell fraction were responsible for either
the specific or non specific effect. Lucas and Walker (1974)
reduced the non specific effect by the removal of macrophages. The
reasons for the effectiveness of spleen cells in this cell counting
method are not clear. There are different proportions of each type
of cell in the spleen and other lymphoid organs and there may be
greater numbers of cytotoxic lymphocytes within the spleen.
Chromium release assay
1. Allogeneic tumour
The chromium release assay used probably measures the total
breakdown of a cell with the contents of the cytoplasm escaping -
this is the very end point of cell to cell cytotoxicity.
No cytotoxicity was obtained in the chromium release assay,
using lymphocytes sensitised against primary allografts of tumour.
The failure to achieve any cytotoxicity may be due to many reasons.
The ratio of lymphocytes to target cells was 200 : 1 which was much
less than in the cell counting techniques and there may not have been
a sufficient number to cause killing. More important however is the
contact between the lymphocytes and target cells in 0.4 mis. of
media. Attempts to increase the contact of the cells was made by
placing the tubes containing lymphocytes and target cells on a
shaker during incubation. This shaking only served to increase the
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spontaneous release of Cr. from the cells and was therefore
abandoned. The other method to make definite contact between the
lymphocyte and target cell, by spinning the cells down together
prior to Incubation, was not tried.
A fairly high spontaneous release from the human cells was
observed during incubation, indicating that these cells are readily
damaged under the conditions of culture. The spontaneous release
at 0 hrs. at the beginning of the experiment was 4% to 33%
increasing to 41% to 64% at 24 hours. The total release after
intentional killing of the target cells by heating ranged from 84%
at the beginning of the experiment to 97% at 24 hours, therefore
additional lymphocyte cytotoxicity over and above spontaneous release
should have been demonstrable if present.
With the addition of either immune or control lymphocytes there
was usually a decrease in the release obtained at any one time as
compared with the target cells alone. This may be due to a
protective effect on the target cell by the lymphocyte. Or there may
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be some reutilization of the Cr., after release from the target
cell; a small amount of the chromium may possible be taken up by the
lymphocytes, which sediment with the target cells on spinning.
2. Allogeneic tissue grafts
No cytotoxicity was demonstrable by this assay using lymphocytes
Immunised by skin grafting, or hyperimmunised lymphocytes. Even the
addition of immunised spleen cells at a ratio of 200 : 1, which had
proved cytotoxic in the cell counting method, caused no increase in
the release of chromium. The average spontaneous release (60% at
24 hours) from the tissue cultured fibroblasts was high. The reasons
why this assay may not have demonstrated cytotoxicity even in the
hyperimmune experiments are the same as mentioned above.
F. CONCLUSION
As cytotoxicity has been difficult to achieve in these experiments
- with some exceptions such as marked cytotoxic effect of hyper-
immunised spleen cells - it leads us to believe that the in vitro
methods cannot reproduce killing by lymphocytes in vivo.
Is in vitro cytotoxicity a good representer of in vivo cyto¬
toxicity? Fortner, Kuperman and Lucas (1975) showed that in vivo
rejection of tumour did not correlate with in vitro splenic
lymphocyte cytotoxicity. There may be several reasons for this
In in vitro tests there is a limited time and space in which the
sensitised lymphocyte can work. Clearly in vitro there is a lack of
additional help from non specific cells which may be recruited in
vivo to assist in graft rejection. Also any effect of tissue
localisation is lost in vitro. Another method which has been advanced
as measuring lymphocyte activity in allograft rejection in the graft-
versus-host assay. Tfcis has therefore been chosen in order to
incorporate these missing features from the in vitro experiment.
This graft-versus-host study will be presented in Section II.
Another explantation might be that each individual lymphocyte
has a small cytotoxic effect which is not evident in the in vitro
tests. This effect may be multiplied many times by an enormous
increase in the number of lymphocytes flowing through a graft at the
time of rejection. Studies on lymphocyte flow through a rejecting
kidney will be shown in Section III.
APPENDICES I
Methods of in vitro cytotoxicity tests
1. Cell counting
2. Chromium release assay
Method of immunization with syngeneic tumour
Methods of immunization with allogeneic tumour or graft
Preparation of lymphocytes
Result of Microcytotoxicity experiment 5(9) and chromium
release assay experiment 2(1)
Cell counting method comparing control cells
APPENDIX 1(e)
f£wo methods of measuring in vitro lymphocyte cytotoxicity are used.
1. Cell counting
2. Chromium release assay
1. Method of cell counting
Tissue cultured target cells were obtained either as DAB or MC -
sarcoma tumour cells (Appendix lb) or fibroblasts (Appendix Ic). The
cells were removed from tissue culture bottles with trypsin and washed
twice and were plated in microtest plates containing 96 wells of
0.3 ml. size. A hundred viable cells were plated into each well in
0.2 mis. media in which they were tissue cultured (either Eagles Hepes
or Waymouths) containing 20% heat inactivated foetal calf serum (FCS).
The plates were placed in sealed boxes which had been gassed for five
minutes with 5% carbon dioxide in air and incubated at 37° C. between
24 and 48 hours. The target cells settled and adhered to the base
of the well.
After incubation the media was removed from all the wells.
Lymphocytes were added to the wells in 0.2 mis. of appropriate media
in varying ratios from 1,000/1 effector cells to target cells, up to
4,000/1. Media was readded to the wells containing targets cells only.
The end wells were not used for counting.
Control and immune lymphocytes were added in corresponding
columns from the ends of the plate. Two columns of target cells and
media alone were also plated (diagram 3).
The plating of the lymphocytes varied with each plate in order
that observer bias at counting was reduced. The person who plated
the lymphocytes was not the same as the one who counted the cells.
One hour after adding the lymphocytes, a drop of FCS was inserted
Diagram 3





















Microtest plate II 96 wells 12 across x 8 down
Column 1 and 12 not used
Target cells + mediaColumn 2 and 11
Column 3 and 4
Column 5 and 6
Column 7 and 8
Column 9 and 10
Non immunised (control) lymph node lymphocytes
(LNL) and Target cells
Control spleen cells and Target cells
Immunised (test) spleen cells and Target cells
Test LNL and Target cells
100 Target cells are plated in each well
A different plate is used for the different ratios of effector
5
lymphocytes for example 1 x 10 lymphocytes added to these
target cells gives a ratio of 1,000 : 1 effector to target cells.
in each of the wells and the plate was gassed in 5% CO in air at
A
o
37 C. for 48 hours.
Staining plates
The plates were washed by a gentle flow of 0.9% saline in order
to remove debris and dead cells but leaving the viable cells attached
to the well surface. The saline was drained with a gentle shake and
the cells fixed with pure methanol for 15 minutes. The methanol was
then shaken off and 0.5% crystal Violet added to the wells for five
minutes. The plates were then rinsed and dried. The number of
cells remaining in each well are counted under an Olympus cell
counting microscope.
Significant cytotoxicity was achieved when there was a
statistically significant reduction of the mean of immune as compared
with control wells. This corresponded to a reduction in mean counts
of 20% (Appendix Ie).
2. Chromium release assay
Tissue cultured target cells were removed from tissue culture
bottles with trypsin and washed three times. The cells were
51
resuspended in 0.2 mis. media. 50 p Ci. of Chromium in 0.3 ml. of
media was added to give a final volume of 0.5 mis. The cells were
51
incubated with the Chromium for three hours, then washed three
times with media, resuspended in 0.2 mis. of media and counted. The
number of viable cells were counted by trypan blue exclusion. The
cells were kept at 4° C. for half an hour to allow the less viable
cells to die and then the cells were recounted.
3
Five x 10 viable labelled cells in 0.2 mis. of media were
pipetted into small tubes. There were four groups of tubes.
Group 1 Target cells + media
Group 2 Target cells * immune (test) lymphocytes 1 x 106
Group 3 Target cells + non immunised (control) lymphocytes
1 x 106
Group 4 Target cells (killed by heating) + media
The lymphocytes were added in 0.2 mis. of media and incubated at
o
37 C. The first set of tubes demonstrated the spontaneous release
51
of Chromium from viable cells over the period of the test. The
51
fourth set demonstrated the amount of Chromium released when the
cells were destroyed (total release).
The small tubes (in triplicate) were spun at 350 g. for 5
minutes at 0 hr., 2 hrs., 4 hrs., 8 hrs.,and 24 hours. Half the
supernatant and then removed and put in separate ignition tubes
(which were marked). The tubes were then placed in ^counter
(Wallac 80,000 Gamma sample counter) and counted for 10 minutes.
as
The percentage of chromium release was calculated for each tube
counts in supernatant x 2
counts in supernatant + pellet counts
In both lymphocyte cytotoxicity tests the tissue culture media
used (either Eagles Hepes or Waymouths) contained 20% FCS and
gentamycin 0.05 mgs/ml.
APPENDIX 1(b)
Methods of Immunization with Syngeneic Tumour
Animals
Inbred Wistar rats (Cancer Research Department, Nottingham) have
been used for the tumour experiments. These have been brother sister
mated since 1952, and were syngeneic by routine skin grafting. Rats
were fed on Oxo cube diet 41B with tap water ad libitum.
Tumour induction
Hepatomas
Hepatomas were induced by feeding rats for three months on a low
protein rice diet containing dimethylaminoazobenzene, made up as
follows:
890vg ground unpolished rice
80'g dried carrot powder
20 g corn oil
0.06g 4-dimethylaminoazobenzene
Animals were then transferred to a basal rice diet and most rats
deveoped hepatomas within five months of the initial exposure to the
carcinogen.
Fibrosarcomas
Fibrosarcomas were induced by the injection into the right flank
of 5 mgm. of 3-methylcholanthrene (Koch Light and Co.) dissolved in
0.5 mis. trioctanoin (Eastmann Organic Chemicals Ltd.) or by the
subcutaneous implantation of a solid pellet of carcinogen in
cholesterol. Tumours arose five to eight months after initial exposure.
Carriage of tumour transplantation lines
Tumour bearing animals were killed by cervical dislocation and the
skin sterilized by immersing the rats in 1% savlon. The tumours were
removed aseptically and transplanted subcutaneously (s.c.) into rats
of the same sex as the donor. The recipient rats were chosen so that
they were no more than four generations removed from common ancestry
with the tumour donor. Transplants were made under ether anaesthesia
by subcutaneous implantation of small tumour fragments using a number
4 or 5 guage trocar through a small incision made in the skin. The
skin was closed with Michel clips.
Immunization by surgical excision of subcutaneously growing tumour
transplantations
Primary s.c. tumours or transplant grafts were allowed to grow to
a mean diameter 1 to 2 cms. Under ether anaesthesia the skin around
the tumour was incised and the tumour mass freed from the body well
and removed. The skin was closed.
Immunization by implantation of irradiated tumour grafts
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Ice cooled fragments of tumour tissue were exposed to Co
irradiation (10,000 to 15,000 rads). A 1,000 curie source in the
Department of Chemistry was used for this irradiation. The tumour
tissue was placed in McCartney bottles surrounded by ice, clamped
10 cms. from the irradiation source and irradiated for 15 minutes.
The tissues were subsequently implanted s.c. into anaesthetised rats.
Grafts were given at 2 to 4 week intervals, each animal receiving up
i
to 5 grafts. Further challenge with viable tumour cells was made
4 5
at intervals to the rats, starting at 5 x 10 cells up to 5 x 10
tumour cells. Viable tumour was injected into untreated controls at
the same time. The test animals were known to be immune as the viable
tumour did not grow.
Preparation of tumour cell suspensions
Freshly removed tumour was minced and washed with Hank's balanced
salt solution containing penicillin 100 units/ml. and streptomycin
100 ug/ml. Trypsin 0.25% solution in Hank's was added to the tumour
and incubated for 15 minutes at 37° C. The tumour was washed and
further trypsin plus 0.02% deoxyribonuclease was added and incubated
with a plastic coated magnet and agitated on a 600 r.p.m. stirrer for
30 minutes. The supernrtant was decanted and tumour cells removed
from the supernatant trypsin by centrifugation 30xg for 3 minutes then
resuspended in Eagles medium with Dnase and washed four times. The
tumour cells were filtered through a 120 mesh stainless steel screen.
Cell viability was assessed by trypan blue dye exclusion (1 vol. 4.2%
NaCl to 4 vols. 0.2% aqueous dye). The number of unstained cells were
counted in a haemocytometer and dilutions for culture or injection were
made in Eagles Hepes medium.
APPENDIX 1(c)
Methods of Immunization with allogeneic tumour or graft
Animals
Inbred Wistar rats (W.A.G. Bantin and Kingman Ltd., Grunston,
Nr. Alborough, Hull), inbred A.S. (Charles Salt Laboratories, Agnes
Jones/Robert Hunt Hospital, Oswestry) and outbred Spraque Dawley
rats (S.D.) (Joint animal breeding unit, J.A.B.U., University of
Nottingham School of Agriculture, Sutton Bonington) have been used
for these experiments. These line Inbred strains have been brother/
sister mated for at least 20 generations. The inbred Wistar rats
are syngeneic by routine skin grafting. The animals were fed on 41B
diet with tap water ad libitum.
Transfer of allogeneic tumour
Primary subuctaneous tumour D23, D192 and D202 hepatomas or MC57
methylcholanthrene induced sarcoma were removed from Wistar rats
obtained from Cancer Research Department, Nottingham (see Appendix lb).
The tumour was removed aseptically and divided into eight small
pieces, 5 mm. in diameter, and 1 larger piece. The larger piece was
disrupted by pressing with a glass rod through 120 stainless steel
mesh into a petri dish containing Eagles Hepes medium. The cells which
had passed through the mesh were drawn up into a sterile container and
media was added to make up 20 ml. The cells were not counted but
divided arbitarily into four 5 ml. aliquots. Four A.S. or S.D. rats
for each experiment were anaesthetised with ether, both buttocks of
each rat were cleaned with savlon. A small incision was made in the
skin and a piece of tumour was tucked under the skin which was closed
with 2/0 silk. Each rat then received an intraperitoneal injection of
tumour cells. The four rats In each experiment were killed on
different days following the transfer of the tumour, ranging from 4
to 21 days, for removal of lymph nodes and spleen.
Method of skin grafting
Full thickness skin grafting was performed between inbred female
Wistar donor rats to recipient female S.D. or A.S. rats. The recipient
rat was anaesthetised with ether and the skin on its back close clipped
and cleaned with savlon. A 3 cm. square patch of skin was removed.
The remaining skin was then either sutured to cover the defect or the
animal sacrificed. The panniculus carnosus was scraped of the under-*
side of the graft. The recipient rat was anaesthetised and the skin
again clipped and cleaned. An area of skin comparable in area to the
graft was then removed from its back, taking care to dissect the
panniculus carnosus off the skin and leaving it intact on the recipient.
The skin graft was applidd to the recipient and sutured in place with
4/0 silk (plate la). A dressing (circumferential) wasaapplied to the
rat to prevent it rubbing off the graft. The dressing was removed
on the seventh day. Rejection was judged to have occurred if the graft
became hard and impliable (plate lb). Skin grafting between syngeneic
inbred Wistar rats was performed to see if the technique was correct
and the skin remained soft and eventually grew hairs (plate lc).
Method of intraperitoneal infection of lymphocytes
Injection of intraperitoneal lymphocytes was used in the
hyperimmune experiments, the S.D. or A.S. rats had previously been
sensitised with three skin grafts from inbred Wistar rats. The
lymphocytes taken from the Wistar rats were prepared in the manner
Plate 1 a) SKIN GRAFT IN THE RAT AFTER OPERATION
Plate 1 b) REJECTING SKIN GRAFT 7th DAY Plate 1 c) NON REJECTING SKIN TOth DAY
described below; 1 x 10 lymph node lymphocytes were injected in 5 mis.
of Waymouths through a size 19 guage (G) needle into the peritoneal
cavity.
Method of renal transplantation
The technique used has been described by Blarney, Baxter, O'Brien
and Bennett (1974).
Female rats around 200 gms. were used for this procedure. Inbred
Wistar donor kidneys were transplanted into S.D. recipients.
The donor rat was anaesthetised with ether. The animal was laid
out on its back on a cork board with the limbs stretched. The skin of
the abdominal well was shaved and cleaned. A midline laparotomy
incision from above the pubis to the sternum was made. The gut was
moved to the right side of the abdomen and packed away. A Nikon
double operating microscope was now used.
The left kidney was then exposed (plate 2). The ureter was
identified and ditided at the junction of the middle and upper third.
The fat was cleared from the kidney and the renal vessels. The
ovarian and adrenal vessels were coagulated and divided. The renal
vein was divided at the inferior vena cava, the renal artery was
ligated as it arose from the aorta, a small incision was made in the
artery just distal to the ligature and a fine silastic tubing 0.6 mms
external diameter was inserted and tied into the artery. The renal
artery Has then divided close to the aorta and removed. Approximately
5 mis. of ice cold dextran 40 in-saline, containing 4 units of heparin/
ml. and 3 mgs. of papaverine/ml. was then perfused into the kidney
via the tubing. The ureter was identified and a short length of
silastic tubing 0.6 mms. external diameter was inserted up the lumen,
(plate 3a)
Plate 2 RENAL TRANSPLANTATION IN THE RAT





Plate 3a) RENAL TRANSPLANTATION IN THE RAT
DONOR KIDNEY PERFUSED
Magnification x 30
The recipient rat was now prepared. A tail vein was cannulated
with a 25 guage needle attached to polythene tubing for the infusion
of normal saline containing 1 unit heparin/ml. to replace blood loss
during the operation. The left kidney was dissected in the same
manner. The ureter was divided at the renal pelvis. Microvascular
clamps (Scoville-Lewis) were placed at the origins of the renal
artery and vein and the vessels divided at the hilum.
The donor kidney was placed orthotopically. The ureteric
anastomosis was performed by placing part of the silastic tubing in
the donor ureter into the recipient ureter and oversewing the loose
connective tissue of each ureter together with 7/0 silk, so that
both lumens came together over the splint.
The renal veins of the donor and recipient were sutured together
through the full thickness of the wall with 10 interrupted 10/0 nylon
sutures on an atraumatic needle. Suturing front and back walls of
the renal vein together was a possible hazard at this point, and was
prevented by blowing up the donor vein by further perfusion of the
donor renal artery. Similar end to end anastomosis was performed
between the two arteries using 6 interrupted 10/0 sutures. When the
anastomosis was completed first the venous and then the arterial
clamps were removed. Bleeding was controlled by packing. (Plate 3b)
The kidney was well perfused with arterial blood. The wound was
closed with 2/0 silk and the anaesthesia discontinued.
The method of preparation of fibroblasts for tissue culture
The fibroblasts for these experiments were obtained from Wistar
embryos. A twenty day pregnant rat was anaesthetised with ether and





Plate 3 b) RENAL TRANSPLANTATION IN THE RAT.
TRANSPLANTED KIDNEY IN RECIPIENT AFTER VASCULAR
ANASTOMOSIS COMPLETED
Magnification x 30
savlon. In an aseptic manner the peritoneal cavity was opened and
the embryos removed. The placenta and amniotic sacs were discarded
and the embryos chopped finely and washed in Hanks to remove blood.
The chopped embryos were incubated in trypsin with a plastic coated
magnet and agitated on a 600 r.p.m. stirrer for 30 minutes at 37° C.
The supernatant was decanted and spun at 160 g. for 15 minutes. The
pellet was washed three times in Waymouths media to remove the
trypsin. The cells plus fragments were passed through 120 steel mesh.
The cells obtained were placed with Waymouths with 10% FCS and
gentamycin 0.05 mgs/ml. in tissue culture bottles and incubated.
When the cells required subculturing, they were removed from
the tissue culture bottle with trypsin. The cells were washed three
times and aliquots added to new tissue culture bottles with Waymouths
plus 10% foetal calf serum, and gentamycin.
APPENDIX 1(d)
Method of preparation of lymphocytes
1. Removal of lymph nodes and spleen
The immunised and non immunised control rats were anaesthetised
with ether. The animals were killed by cervical dislocation and
pinned out on a board, lying supine. The skin was clipped and
cleaned. In an aseptic manner the skin was opened in the midline from
pubis to neck. The skin on the neck and thorax was dissected off.
The cervical and axillary lymph nodes were removed (see diagram 4)
and cleared of fat. The peritoneal cavity was opened and the
mesenteric lymph node chain removed and also cleared of fat. The
lymph nodes were placed on 120 stainless steel mesh in a petri dish
and chopped finely with scissors. A small amount of media was placed
in the petri dish and the cells of the lymph nodes squashed through
the mesh with a glass rod. The cells were then drawn up from the
petri dish, the viable lymph node lymphocytes were counted in a
haemocytometer by trypan blue exclusion.
The spleen was removed and spleen cells obtained in a similar
fashion. The spleen cells were placed on Ficoll Triosil and spun at
700 g. for 20 minutes to separate red cells from the white cells. The
lymphocytes were then removed from the layer in between the Ficoll
Triosil and the medium, and washed three times in medium. The viable
cells were counted.
2. Preparation of blood lymphocytes (Diagram 5)
The rats were anaesthetised with ether. A 21 gauge needle was
inserted directly into the heart of the rat and up to 10 mis. of
blood was withdrawn into a heparinised syringe (1,000 units


















layer of lymphocytes, a few polymorphs,
3S2E2ESSS5XBBES — ^ platelets
Separation of lymphocytes by Ficoll Triosil gradient
Ficoll Triosil is made up:
Solution A Triosil 20 mis. plus 24 mis. water
Solution B Ficoll 4.5 G. in 50 mis. water
Add 20 mis. solution A to 48 mis. Solution B
preservative free heparin). The blood was then placed on a Ficoll
Triosil gradient and spun at 700 g. for 20 minutes. The lymphocytes
were removed from the interface between the Ficbll Triosil and the
serum. They were washed three times in medium and the viable cells
were counted.
3. Method of thoracic duct cannulation for collection of thoracic
duct lymphocytes
The method used for cannulation of the thoracic duct in the rat
was described by Bollmann et. al., (1948). The immune and control
rats were anaesthetised with ether. The rat was pinned out supine
with lower limbs spread out and the left upper limb on the right
side of the head. The operation was performed under aseptic conditions.
A left subcostal incision was made from the midline anteriorly to the
level of the mid-axillary line. A 12 ins. piece of polythene tubing
(external diameter 0.75 mm.) was fashioned with an umbrella handle
tip. This was placed in the abdomen with the tip inside and the rest
of the cannula brought out on the left posteriorly.
The left kidney was mobilised and placed over the right hand side
of the abdomen. The abdominal contents were then packed away from the
site of operation, the upper part of the abdominal aorta. The thoracic
duct was exposed as it lay on the left side of the aorta and 6/0
ethilon ligature placed around the thoracic duct but left untied. The
cannula was filled with heparinised saline (1 unit/ml.) an incision
made across half the lumen of the thoracic duct proximal to the
ligature and the cannula inserted and pushed distally. The ligature
was tied around the duct and cannula. The curve of the umbrella
handle lay neatly under the diaphragm and was fixed to the posterior
abdominal wall with a 6/0 suture.
The wound was closed with 4/0 silk. A tail vein was cannulated
for infusion of heparinised saline.
The animal was placed in a restraining cage. The thoracic duct
cannula was placed in a cooled sterile flask containing 1,000 units
of heparin. The intravenous infusion of saline was given at the rate
of 40 mis./day with a constant infusion pump.
The thoracic duct lymphocytes when collected were washed three
times in media and counted.
4. Method of fractionation of lymphocytes
The method used here for separating T cells from macrophages and
B cells has been described by Julius, Simpson and Herzenberg (1973).
Those cells which are adherent are B cells and macrophages.
Stetile nylon wool (Leuco-pak) was used for separation of the
lymphocytes. The nylon wool had to be washed to remove a toxic
product which otherwise decreased the survival of the lymphocytes.
The wool was washed in 0.2 N HCL and rinsed five times in tap water,
deionised and distilled water. The wool was dried and 0.6 gram
allquots packed into the barrel of 10 ml. plastic syringes. The
syringes were then autoclaved.
The syringes were placed in a vertical position and washed
through with 25 mis. tissue culture media plus 5% FCS. When washed
the syringes were filled with media till the wool was covered and
o
incubated at 37 C. for one hour.
The lymphocyte cell suspension were counted and approximately
g
1 x 10 viable cells in a volume of 1 ml. was added to the columns,
and an additional 1 ml. of media added after. The columns were
incubated at 37° C. for 45 minutes. The column effluent was
collected at a rate of 1 ml./minute. The cells which came through
with the effluent (the eluted cells) were recounted with trypan
blue. To obtain the adherent cells (ret&ined cells) the wool was
removed from the column and the cells squeezed off the wool. These





Inbred Wistar (I.W.) fibroblasts (tissue cultured)
plated 31.7.75 100 cells per well
IMMUNE CELLS
2.5.75)
From S.D.Q > received skin grafts from I.W. 20.5.75) Added
*
2.6.75)
received I.P. L.N.L. from I.W. 23.6.75) 1.8.75
23.7.75)
CONTROL CELLS
From I.W. O Added 1.8.75
12 3 45 6 7 8 9 10 11 12
76 78 72 70 50 24 58 81 71 58
74 68 102 85 66 19 50 96 76 62
73 79 93 72 71 25 62 57 80 90
67 102 112 88 64 26 55 92 102 63
87 97 99 77 55 9 42 61 95 89
89 67 90 69 29 10 55 70 70 74
68 66 74 104 72 41 66 79 79 66
77 70 86 61 61 32 64 89 89 46
Row 2 + 11 Targets + media
Row 3 Targets + non immune L.N.L. 1 x 105 cells
Row 4 Targets + non immune L.N.L.
5
2 x 10 cells
Row 5 Targets + non immune spleen cells 1 x 105
Row 6 Targets + non immune spleen cells 2 x 105
Row 7 Targets +
5
immune spleen cells 2 x 10
Row 8 Targets +
5
immune spleen cells 1 x 10
Row 9 Targets + immune L.N.L. 2 x 105 cells
Row 10 Targets + immune L.N.L. 1 x 105 cells
All wells contained FCS
RESULTS
Experiment 5(9) remaining target cells
after 48 hrs. incubation
Test
L.N.L. (1 x 10 )
Control
mean - S.E. = 82.6 - 4.1
= 78.4 - 4.9
N.S.
Test
L.N.L. (2 x 10 )
Control
= 80.9 - 5.3
= 91.0 - 4.8
N.S.
Test
Spleen (1 x 10 )
Control
56.5 - 2.8
= 80.6 - 4.1
p < 0.001
Test
Spleen (2 x 10 )
Control
= 23.3 - 3.8
= 58.5 - 5
p <0.001
Media alone = 72.4 - 3.1
Cytotoxicity Percentage (Control - Test)
Control
Cells (Lymphocyte Immune v. Control Immune cell v. Control cells
: Target) Lymphocytes media alone v. media
L.N.L. 1,000 :: 1 - 5% -14% - 8%
L.N.L. 2,000 :: 1 +11% -11% -25%
Spleen 1,000 :
cells
: 1 +30% +22%: -11%
Spleen 2,000 :; 1 +60% +68% +19%
cells
N.S. = not significant.
The p has been calculated by Student T test for unpaired data.
A - in the percentage cytotoxicity of cells v. media indicates a
feeder effect on addition of lymphocytes to the target cells.
Cytotoxicity achieved with immune spleen cells at ratios 1,000





D23 tissue cultured tumour cells
IMMUNE CELLS









Target cells 5,000/tube incubated with Cr.
1. Target + media (spontaneous release)
6
2. Targets + control L.N.L. 1 x 10 /tube (ratio 1 : 200)
6
3. Targets + test L.H.L. 1 x 10 /tube (ratio 1 : 200)






















































% release = counts supernatant x 2
x 100
counts pellet + supernatant
Percentage of cytotoxicity is estimated from
( % release from - % release from )
( immune cells control cells)
x 100
( % total release - % release from )
( control cells)
e.g. at 16 hours 29.9 - 28.3
x 100 = 3% cytotoxicity
81.2 - 28.3
There was no cytotoxicity achieved in this experiment although
cytotoxicity was achieved in a concurrent M.C.T. at a ratio of
4,000 : 1 effectors to targets.
Appendix 1(e)
Cell counting comparing controls cells
Controls
TARGETS- 1) D23 tissue cultured tumour from inbred Wistar strain
2) Inbred Wistar tissue cultured fibroblasts
CONTROL Non immunised ? inbred Wistar (I.W.)
CELLS Non immunised Q outbred S.D.
CONTROL TARGETS 1 TARGETS 2

















Spleen cells I.W. 68.0 46.1
1,000 : 1 p<0.001* N.S.
S.D. 40.5 41.9
I.W. 24.9 41.6




N.S. = not significant
The numbers shown are the mean of the number of cells remaining
in 16 wells.
A reduction in targets cells is obtained in non-immunised Spraque
Dawley rats with spleen cells, as compared with inbred Wistar spleen
cells. Against Targets 1 (D23 tumour) both non immunised syngeneic
and allogeneic spleen cells cause a reduction in the remaining target
cells as compared with targets and media alone.
This comparison of control cells was performed as the initial
choice of control effector cells (I.W. syngeneic to the donor)
was unsatisfactory. The control cells during the experiments
were changed to lymphocytes to animals syngeneic to the recipient.
The lymph node lymphocyte LNL gave similar results when tested
against the same targets. Non immunised allogeneic spleen cells
had a non specific 'cytotoxic' effect - this was likely to make
cytotoxicity with immunised spleen cells more difficult to achieve.
Results in the experiments have therefore all been accepted as
valid.
SECTION II
LYMPHOCYTE ACTIVITY IN ALLOGRAFT REJECTION
GRAFT-versus-HOST RESPONSE
A. BACKGROUND
B. G-v-H reaction to measure immune responsiveness.
C. G-v-H response as an index of activity of the injected cells.
D. Preliminary experiments
E. Rat experimental system
Methods
Results




Theory of graft-versus-host response
G-v-H activity in rat allogeneic systems
G-v-H activity in xenogeneic systems
H. APPENDICES
a) Method of g-v-h popliteal node weight assay
b) Method and results of mixed lymphocyte culture
A. BACKGROUND
A graft-versus-host reaction is a reaction of lymphoid cells
injected into the host against the host. This occurs when the host has
antigens present which are different from the injected graft cells and
the host is unable to react against the donor inoculum. Examples of
these reactions ocnur when lymphoid cells from an allogeneic donor are
injected into new-born rats, and irradiated rats (Gowans, McGregor and
Cowen, 1962) and when lymphoid cells from a parent rat are injected into
the F^ hybrid. The reaction occurs because the host fails to reject the
graft cells and therefore the latter can react against the host antigen.
The range of reaction varies from a local proliferation of cells to a
total wasting disease.
The small lymphocyte is held responsible in initiating this
reaction since in experiments large lymphocytes were eliminated
before injection (Gowans, 1972). The identity of the initiator
cell has been more clearly defined since then as a T-lymphocyte .
B cells were removed from a rat thoracic duct cell population by
passing the lymphocytes through a glass bead column, without
diminishing the g-v~h activity (Hunt, 1973). The degree of g-v-h
activity is directly proportional to the number of reactive cells in
the inoculum of lymphocytes (Atkins and Ford, 1972). The donor cells
after injection pass to the local draining node and this is the basis
of the spleen weight and popliteal node weight assays (see below).
The fate of the donor cells has been studied by Ford, Burr and
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Simonsen (1970) by injecting H uridine labelled lymphocytes in the
footpad. All the recipients were killed 48 hours after injection
and the distribution of radioactivity detdrmined : 20% of the cells
injected into the footpad had entered the recirculating lymphocyte
pool of the spleen and lymph nodes: 6% were retained In the
draining popliteal node. Several hours after administration of
these lymphocytes there is an increased number of transformed cells
in the lymphoid tissue (Ford, 1973).
Most of the work on g-v-h activity has been performed from
parental strain cells injected into the hybrid, e.g. DA -> DALF^.
In this system there is no host-versus-graft reaction involved.
There are several methods of demonstrating a g-v-h reaction:-
1. Spleen weight assay
The spleen weight assay was developed in the mouse (Simonsen,
1962). An intravenous injection of parental spleen cells at a dose
of 10 million cells was given to the F^ hybrid. The spleen weight
was measured 8 to 10 days later and was considerably enlarged
compared with non injected controls of the same age. Microscopically
the spleens showed an accumulation of pyroninophilic lymphoid cells
and large collections of disintegrated polymorphs. The increased
number of cells in the spleen was found by chromosome studies to be
almost entirely due to dividing donor cells (Gowans, 1962).
2. Elkins method
Elkins (1964) found that local inoculation of lymphoid cells from
inbred parental strain rats under the capsule of the kidney of F^
hybrid rats was followed by local infiltration and destruction of the
renal parenchyma. The maximum response was observed seven days after
inoculation. Histological examination of the kidney revealed marked
lymphocyte infiltration together with numerous primitive looking
cells and frequent mitoses. The appearance in this localised g-v-h
reaction was histologically very similar to the appearance of a
rejecting primary renal allograft.
3. Popliteal node weight assay
This assay was developed by Ford, Burr and Simonsen (1970).
Injection of parental strain (A) or (B) thoracic duct lymphocytes
into the footpad of (A x B) F^ hybrid recipients was found to cause
a marked increase in the weight of the popliteal node on the side of
injection as compared with the opposite popliteal node. The control
footpad was injected with cells syngeneic to the recipient. The
weights of the popliteal nodes were measured 7 days after inoculation.
The test popliteal nodes weighed up to 70 mgs., in comparison with the
control nodes of 2.2 mgs.
B. G-v-H REACTION TO MEASURE IMMUNE RESPONSIVENESS
The popliteal node weight assay was modified by Salaman, Millar
and Brown (1975) and claimed to measure the immune responsiveness in
normal and immuno-depressed patients. Injecting human peripheral
blood lymphocytes into the footpads of rats they were able to obtain
a definite increase in the enlargement of the popliteal nodes, but
there was very little difference between the response obtained with
normal and irradiated cells, so it was felt that this response was
largely the product of a host-versus-graft reaction. Irradiation of
the recipient rats with 300 rads was found to abolish this host-
versus-graft element, but still allowed for a threefold increase in
the node weight with injected live xenogeneic cells in comparison
with formalised dead cell controls. This latter increase in node
weight was therefore thought to represent the g-v-h component of the
reaction on the part of the injected cells.
C. G-v-H RESPONSE AS AN INDEX OF ACTIVITY OF THE INJECTED CELLS
Extending the argument of Salaman et. al. (above):- if the degree
of reactivity of the injected cells is reflected by the degree of
g-v-h measured as weight of the local lymph node, then cells from
an immunosuppressed subject should give a lower lymph node weight
than do normal subjects.
Also cells from an individual with heightened reactivity should
show increased g-v-h activity.
These postulates have been examined in this thesis in a rat
experimental system, and with some observations using sheep cells and
human cells.
D. PRELIMINARY EXPERIMENTS
The technique of popliteal node weight assay is described in
Appendix 2(a). In order to measure graft-versus-host activity of
injected cells in an allogeneic or xenogeneic system it is preferable
to diminish the host response in the recipient rat. Figure 2 shows
the effect of host irradiation on the g-v-h response. A dose of
0
2 x 10 human blood lymphocytes was injected into rats receiving
radiation from 100 rads to 500 rads and also rats receiving no
irradiation. The test node weights were considerably larger in those
animals which either were not irradiated or received a small dose.
The control nodes however were also larger in these unirradiated
animals: (table XIa) possibly due to a generalised lymphatic response
after injection of foreign cells into a rat still capable of host-
versus-graft, or due to the reduction of node size in rats which were
irradiated. A dose of 200 to 400 rads appeared to give the maximum
ratio between test/control cells (Figure 2). A dose of 300 rads was
therefore selected as the dose to abolish host-versus-graft activity
in recipient rats. Table XIa also confirms that the injection of
0.1 ml. of media in the footpad as a control does not alter the size
of the recipient node weight either with or without irradiation.
Figure 2 The effect of host irradiation on the G-v-H response
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2 x 10 peripheral blood human lymphocytes were injected
into the left footpad of Wistar rats. The right footpad
was injected with media. The popliteal nodes were weighed
seven days later. Each dot • represents the ratio of the










Nil 0.9, 1.2, 1.0
2.4, 1.4, 2.0
R.P.M.I. 1.0, 1.0, 1.5
3.0, 1.5, 2.0
Weights of popliteal nodes after injection of 0.1 ml. media into
the footpad of rats. The nodes were removed on the seventh day
after injection.
Table XI a
The usual duration of time between injection of cells and
removal of lymph nodes is seven days. The suggestion by Dorsch and
Roser (1974) that four days would be a more satisfactory time for
removal in allogeneic systems was considered and figure 3 shows
the ratio of test : control node weights in rats either irradiated
with 300 rads or non irradiated, receiving either xenogeneic or
allogeneic cell inoculation. The recipient rats receiving either
human or rat cells (on day 4 or day 7) were identical in age and
weight. In the unirradiated rats the ratios were higher after
xenogeneic injection on the fourth day and after allogeneic injection
on the seventh day. In the irradiated rats the maximum increase in
ratio was on the seventh day. The nodes in the rest of these
experiments were therefore removed on the seventh day after
inoculation.
Figure 3 also shows that lack of irradiation of the recipient
did not alter the popliteal node weight ratio when allogeneic rat
donor cells were injected. Non irradiated recipients in the first
series of experiments (see rat experimental system) were therefore
not used.



























Day 4 Day 7
Figure 3 The ratio of popliteal node weights on the 4th and 7th
day after the Injection of lymphocytes Into the recipient
rat footpad. Media controls used. Each e represents the
ratio in one rat.
The amount of g-v-h activity is related to the number of cells
in the donor inoculum. A few experiments were performed to compare
the node weights in both irradiated and non irradiated rats using
xenogeneic human peripheral blood lymphocytes as the donor inoculum.
0
Figure 4 confirms that a dose of 2 x 10 cells increased the node
weight ratio in both irradiated and non irradiated recipients. This
dose was selected wherever possible depending on the availability
of lymphocytes. Table Xlb shows the node weight ratios using the
parent to F hybrid combination in unirradiated recipients. The
6
dose of 2 x 10 donor cells gave the greatest increase in node weight.
RATIO OF NODE WEIGHTS IN RATS AFTER INJECTION OF XENOGENEIC HUMAN CELLS
• Recipient Irradiated












Dose of lymphocytes injected
x 10
Figure 4
Each • represents the node weight ratio in one rat. Media
controls used.
XRT
Dose of cells in donor inoculum
1 x 106 2 x 106 4 x 106
2.8 3.1 6.8
2.4 6.7 3.4
Popliteal node weight ratios in response to increasing numbers
of donor lymphocytes from l.V. rats into (IWASJF^ recipients.
Each number represents 1 rat. Media controls used.
Table Xlb
Some experiments were also performed using irradiated donor
cells. The node weights after test and control cell injection are
shown in Table XIc.
Human donor cells were injected after irradiation with 20,000
rads; in non irradiated rats the node weights were the same - 1.2 mgs.
to 3.0 mgs. Using a dose of 2,400 rads to obtain control cells,
there was some increase in node weight in the non irradiated
recipients.
The use of large doses of irradiation 20,000 rads to the donor
cells would appear to not only prevent the lymphocytes from dividing
but also destroy their antigenicity as compared with a dose of
2,400 rads where the cells may have lost their ability to divide
but were still antigenic (Hodis and Terry, 1974, Kasakura and
Lowensteln, 1968). The cells after a larger dose of irradiation
could be used as adequate control cells. This effect however is only
seen in unirradiated recipients in which the host-versus-graft
(h-v-g) element has not been abolished. In the irradiated recipients
there appears to be very little difference between the node weights
when media or irradiated cells were used as controls.
In view of this throughout the rest of the experiments, where
host-versus-graft had been abolished by recipient irradiation, media
controls were used.














































































0.4 0.8 1.0 2.7 2.6 3.5
media control 0.9 0.5 1.0 1.6 2.0 1.6
Effect of irradiation of the recipient on the popliteal node
weight using human peripheral blood lymphocytes as donor cells. The
■ode weights after test and different control cells injections are
shown.
Table XIc
The effect of immunosuppression of the donor rat by irradiation
has also been looked at in an allogeneic system. Donor rats received
300 rads of radiotherapy thirty minutes prior to the removal of
lymphocytes. These lymphocytes were injected into the footpad of
allogeneic rats which were either irradiated or not irradiated.
The results of donor rat irradiation are shown in Table Xld.
Donor irradiation served to obliterate all g-v-h response. The node
weights were slightly increased without recipient irradiation, but
were the same as controls when any host-versus-graft response had
been obliterated with recipient irradiation.
Donor XRT Recipient XRT Ratios Test : Control Mean
I.W. A.S. - 2.9 2.4 2.7 - 0.2
or - or
A.S. I.W. + 1.7 1.3 1.5 - 0.2
I.W. A.S. - 1.8 1.3 1.6 - 0.2
or + or
A.S. I.W. + 1.1 0.9 1.0 - 0.1
The effect of donor irradiation on popliteal node
weights. Each ratio is the mean ratio of 3 rats.
Table XId
In the experiments in which donor parent lymphocytes are injected
into hybrid , IW - (IWAS)F^ , there should be no recognition by
the recipient that the donor cells are antigenic, i.e. no h-v-g
reaction. Table Xle shows the results where either parent I.W. or
A.S. lymphocytes were injected into (IWAS)F1 footpads, and also
(IWAS)Fl lymphocytes were injected into I.W. footpads for comparison.
The increase in node weight ratio after the injection of F1 hybrid
cells into the non irradiated parent is a pure host-versus-graft
reaction which is almost obliterated by host irradiation. This
confirms that 300 rads host irradiation removes the h-v-g component
in our experiments. The greater increase in the ratios after
injection of parental cells in the F system is pure g-v-h whicn will
be discussed later (section HE).













10.5, 2.9, 2.5 5.3 - 2.6










The ratio of poplitealnnode weights in the parent to F^ hybrid
system to determine the degree of host-versus-graft activity.
Each ratio represents the mean of 3 rats. Media controls used.
Table XIe
Conclusion
From the results of the preliminary experiments and from other
papers quoted, certain parameters have been taken for the experiments
which follow
1. The recipient popliteal nodes have been removed on the
seventh day after injection of donor inoculum into the recipient
footpad.
0
2. The number of lymphocytes in the donor inoculum was 2 x 10
cells in 0.1 ml. of media.
3. Media <0.1 ml.) was injected into the opposite recipient
footpad as the control.
4. The dose of irradiation of 300 rads to the recipient rat
was used to remove the host-versus-graft reactivity in the allogeneic
and xenogeneic systems.
E. RAT EXPERIMENTAL SYSTEM
When lymphocytes from a donor (graft) animal are injected Into
an other non identical recipient (host) animal, the lymphocytes
recognise the host as foreign and proliferation of the cells occurs.
In the assay used in these experiments the proliferation of cells
occurs in the popliteal node after injection of donor lymphocytes
into the footpad. The present work has been performed to study the
T cell activity (i.e. proliferation) in relation to the allograft
response. In an allogeneic system the effect of presensitization of
donor lymphocytes by prior skin and organ grafting will be studied
by observing the weight of the popliteal node after injection of
these presensitised cells. The alteration of this effect by the
use of immunosuppressive agents in the donor animal will also be
studied.
Methods
The technique of the popliteal node weight assay is described
in Appendix 2(a).
1. The first set of experiments were performed by injecting lymph
node lymphocytes from a donor strain of rats into allogeneic rats.
The recipient rats received 300 rads irradiation prior to injection
to abolish any h-v-g- reactivity present.
There were 5 groups of cell donors. Diagram 6
a) NORMAL RATS - lymph node lymphocytes from an allogeneic donor
strain were injected into the footpad of the recipient rats.
b) IMMUNOSUPPRESSED RATS - the rats of an allogeneic donor
strain were immunosuppressed with cyclophosphamide 5 mgs/100 g. and
cortisone 5 mgs/100 g. intra-muscularly (i.m.) on alternate days for
two weeks prior to removal of lymph nodes. The lymphocytes were then
injected into the recipient rat footpad.
c) PRIMARY ALLOGRAFTED RATS - a skin allograft was transferred
from an inbred rat of the recipient strain to the donor fat. Seven
days later the 'specifically' presensitised lymph node lymphocytes
of the rat bearing the graft were injected into the footpad of the
recipient rat.
Also cells were used from animals grafted with skin from rats
allogeneic to both donor and recipient strain. The donor cells were
then considered to be 'non specifically' presensitised.
d) ALLOGRAFTED AND IMMUNOSUPRRESSED RATS - skin was allografted
from an inbred rat of the recipient strain to a donor rat also
receiving immunosuppressive drugs during the period of the graft.
Seven days later the lymph node lymphocytes of the immunosuppressed
Diagram 6 Scheme of Host-versus-Graft experiments in allogeneic rats.
The donor rats lymphocytes were injected into the footpad
of the recipient rats. Four groups of donor rats are
shown: (A) NORMAL, (B) IMMUNOSUPPRESSED, (C) PRIMARY
ALLOGRAFTED. The skin graft being taken from the recipient






rat bearing the graft were injected into the footpad of a rat of the
recipient strain.
e) Further experiments were performed whereby the donor of the
cells was specifically hypersensitised by transferring three skin
grafts and two intraperitoneal injections of lymphocytes at intervals
from a rat of the recipient strain to the donor strain.
2. The second set of experiments eliminated any host-versus-graft
activity which might be manifest in the popliteal nodes, by using
cells from inbred Wistar or A.S. parent into (inbred Wistar x A.SOF^
hybrid - (IWASJF^
There were two groups of cell donors.
a) NORMAL RATS where either parent (I.W. or A.S.) lymphocytes
were injected into (IWASJF^ footpads.
b) PRIMARY ALLOGRAFTED RATS
i. (IWAS)F1 skin was grafted onto I.W. or A.S. rat. The
lymphocytes from this rat were injected into the footpad of (IWAS)F^
recipient either seven or 2*3 days after grafting.
ii. Skin from an A.S. rat was grafted onto I.W. and then
the lymphocytes from the I.W. were injected into the footpad of
(IWAS)F1 at 7 days.
Results
First series of experiments
The results of the g-v-h experiments after allogeneic lymphocyte
Inoculation from A.S. to Wistar rats are shown in figure 5 and table
Xlla - the recipient rats all received 300 rads irradiation, each
experiment was performed in 3 rats.
The popliteal node weight ratios were increased to a mean of
2.9 after injection of allogeneic cells. This increase was not
maintained after specific presensitization of the donor cells with a
skin graft, the ratios of test : control popliteal nodes were 0.8 to
1.3 (except one ratio of 4.3 which was only achieved because of the
abnormally small size of a control node which weighed 0.2 mgs.).
When the donor cells were from animals specifically hyper-
sensitised, against the recipient, the ratios were again increased
to a mean of 2.6.
The results of the ratios when the donor cells were from
immunosuppressed animals, are a little lower than the ratios with
cells from normal donors. This may be due to the smaller number of
cells in the donor inoculum.

















. Ratio of node weightsDonor No. of rats „ ^ „Test : Control
Allogeneic unsensitised 11 2.8-0.6
Specifically presensitised 11 1.7 - 0.5
Specifically hypersensitised 15 2.6-0.3
Allogeneic immunosuppressed 9 1.7-0.4
The ratio of popliteal node weights from donor rats into
irradiated allogeneic recipients. The ratio is estimated
from the separate weights of each rat, rather than from each
test of three rats. There is no significant difference between
the mean ratios in each group.
Table Xlla
Second series of experiments
The results of the g-v-h experiments after allogeneic lymphoeyte
inoculation from parent to rats are shown in table XIlb.
There was a considerable increase in node weight in both those
recipient rats which received irradiation, and those which received
no irradiation.
Presensitization by skin grafting served to increase the node
ratios even more and there was a greater increase in the irradiated
rats who received lymphocytes from the donor presensltised 28 days
prior. There are two reasons for this, firstly, the control nodes
(media control) were much smaller in the irradiated recipients.
Secondly, the 'test' node weights from the irradiated rats often
were truly greater after presensitization especially after 28 days
(see discussion).
No.
Donor „ . . Recipient _ Ratios Test :






























(IWAS)F1 12.1 8.0 7.7 9.3 - 1.4









The ratio of popliteal node weights. The donor inoculum is
from parent rats into F^ hybrid. Each ratio represents the
mean of 3 rats.
Table XIlb
F. XENOGENEIC CELL INJECTIONS
The hypothesis has been advanced that the popliteal node weight
assay in the rat may be used to determine the degree of immune
competence of the cell donor in the assay (Salaman et. al., 1975).
Peripheral blood lymphocytes from patients with renal failure and
controls were injected into the footpads of irradiated mice. Those
patients whose lymphocytes initiated a large response were called
'responders' and those with a small response 'non responders'. They
suggested that by this assay it could be determined which patients
waiting transplantation might be most suited as allograft recipients.
The follow up of these patients after transplantation has not
yet been long enough to have sufficient evidence as to whether this
hypothesis is correct.
As there appears to be a paradoxical Inverse relationship
between antigenic strength and g-v-h activity (Ford and Simonsen,
1971). this particular xenogeneic system might be considered of
limited value as a measurement of T cell activity.
The next experiments were set up using lymphocytes from
xenogeneic animals and injecting the cells into host rats in order to
see whether animals either after immune stimulation or immunosuppression
had am altered g-v-h reactivity. In other words to see whether this
assay could be used as a measurement of immune competence of the donor.
Methods
The technique of popliteal node weight assay is described in
Appendix 2(a). The experiments were performed by injecting donor
lymphocytes into both irradiated and non irradiated rats.
1. Sheep cells
The thoracic dufct lymph was obtained from sheep used in the
experiments in Section III of this thesis:-
a) Lymphocytes from sheep in which the thoracic duct alone was
cannulated were injected into the rat footpad ('normal sheep').
b) Lymphodytes from the thoracic duct of sheep receiving i.v.
prednisolone 100 mgs/day and azathioprine 400 mgs/day were injected
in the rat ('immunosuppressed sheep').
c) Thoracic duct lymphocytes were obtained from sheep, who had
received a renal allograft, and injected into the rat ('rejecting
allografted sheep').
d) Thoracic duct lymphocytes were obtained from sheep, who had
received both a renal allograft and immunosuppressive drugs, and
injected into the rat ('immunosuppressed allografted sheep')&
2. Human cells
a) Peripheral blood lymphocytes were obtained from healthy adults
and used as the donor cells ('normal human').
b) Blood lymphocytes from a patient with a functioning and non
rejecting renal transplant on routine immunosuppression were used as
the donor cells ('non rejecting allografted human').
c) Blood lymphocytes from a patient with a renal transplant
during a rejection crisis were used as the donor cells ('rejecting
allografted human').
d) Blood lymphocytes from patients receiving multiple combined
chemotherapy for widespread malignant disease (carcinoma of breast
and stomach) were used as donor cells. The dose of chemotherapeutic
agents given to these patients is methotrexate 0.3 mgs/Kg., 5 fluoro-
uracil 15 mgs/Kg., vincristine 0.015 mgs/Kg. i.v. weekly,
cyclophosphamide 2.5 mgs/Kg. orally daily. The blood was removed 7
days after i.v. injection ('immunosuppressed human').
Results
Xenogeneic sheep cells
The results of g-v-h activity using xenogeneic sheep as donors
are shown in figure 6. Very little increase in node weight ratio
was obtained in irradiated recipients, which contrasts fairly
strongly with the increased ratios in the non irradiated recipients.
There appeared to be very little difference in g-v-h activity
whether lymphocytes came from a sheep with a rejecting renal allograft
or from a normal sheep.
Xenogeneic human cells
The g-v-h activity was usually increased twofold after the
injection of xenogeneic cells (Figure 7). There was no alteration
in the activity Whether the lymphocytes from a patient with a rejecting
allograft, or from a patient who was not rejecting his graft.
Surprisingly the lymphocytes in the peripheral blood from the patients
on combined chemotherapy gave considerable g-v-h activity.
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G. DISCUSSION
The theory of graft-versus-host response
In the graft-versus-host assay the immuno-competent cells are
Injected, the target cells are fixed and there is an unlimited
aupply of non specific cells, which can be recruited from the host
circulating pool, to assist in the reaction. The reaction is
proliferation and recruitment of cells in response to the recognition
by the injected cells that the host cells are foreign. The assay
thus should be a reconstruction of what happens in vivo during
allograft rejection-.
The effect of presensitization on G-v-H response
There appears to be a paradoxical inverse relationship between
the antigenic strength of the animal and the g-v-h activity. In
rats the augmentation of g-v-h activity increases with the weakness
of the antigenic barrier (Ford and Simonsen, 1971). With weak
strain combination of rats (AgB identical strains) the donor rats
were immunised with two skin grafts of the recipient strain. The
injection of cells from immunised donors gave a g-v-h activity that
was double that of the non-immune donors. Using AgB different
strain (strong strain combination) the Immunization of the donor
considerably reduced the g-v-h activity as compared with non-immune
donors.
A decrease in g-v-h activity between allogeneic strains of rats
in comparison with parent F.^ hybrid has also been shown by Dorsch
and Roser (1974). They did however have definite lymph node weight
enlargement which was maximum on the fourth and not seventh day
after inoculation (figure 8). They believed that the allogeneic cells
Figure 8 Lymph node weight response to allogeneic cells:
•—• allogeneic cells, o o control syngeneic cells.
Dorsch and Roser (1974)
were ultimately rejected by the host. Presensitization of the donor
cells reduced the weight of the popliteal node, the peak of the
weight increase being even earlier, on the second day. They suggested
that the reduction of the response in the sensitised animals was
mediated by a circulating antibody produced by the host.
In contrast to these findings Bain and Alton (1966) found that
injection of C57L spleen cells, sensitised against C H tissue, into
o
C^H mice caused splenomegaly at five days. In comparison injection
of non-sensitised C57L spleen cells caused less splenomegaly, and
the increase in size of the spleen took longer.
The reduction of G-v-H by suppression of the host
If steroids are given to the host (F^ recipient) within 24 hours
of inoculation with parental cells the g-v-h activity is decreased
(Cohen and Cloman, 1971). Cyclophosphamide was also found to decrease
g-v-h activity when given to the host
The reduction of G-v-H by suppression of donor cells
Dorsch and Roser (1974) determined the contribution made by
g-v-h to enlargement of popliteal nodes by allogeneic transfer of
cells. They compared the response to normal allogeneic cells with
mitomycin C - treated allogeneic cells. Normal cells gave a lymph
node weight of 18 mgs. and cells treated with mitomycin C in vitro,
a weight of 9.0 mgs., concluding that the g-v-h element was responsible
for half the increase in node weights. Ford and Simonsen (1971)
irradiated donors with 300 rads and found no alteration in g-v-h
activity.
The host component in G-v-H activity
In the parent to F^ hybrid combinations, there will be no
host-versus-graft element. When allogeneic cells are used as we have
seen there is a marked host-versus-graft reaction which allows for
considerable generalised lymph node enlargement (Salaman et. al.,
1975) which can be abolished by host irradiation.
There has been recent evidence in the parent to hybrid strains
that there is a considerable host component in the enlargement of the
popliteal node. The grafted cells nay release factors which stimulate
the host cells to be trapped into the node, rather than the increase
in node weight being due to donor cell division. This has been shown
by Rolstad (1976) whereby using alio antisera with specificity for
the donor it was found that about 90% of the live cells suspended
from the node were of host origin. Also by labelling host cells with
51
Cr., re-injection of these cells into the g-v-h recipient gave a
51
considerable accumulation of Cr. in the stimulated node as compared
with the unstimulated control node in the same rat.
G-v-H reactions have proved useful for the study of the reaction
of lymphoid cells to transplantation antigens in vivo. The g-v-h
measures lymphoid cell proliferation and not host cell damage and in
this is comparable to the M.L.C. It is thought that although g-v-h
and target cell destruction are both functions of T cells there are
probably two types of cell involved. The cell involved in the g-v-h
has been called an initiator lymphocyte and in cell mediated immunity
a cytotoxic lymphocyte (Ford, 1973). The fact that immunization
against strong AgB antigen by skin grafting in the rat gives no change
in the g-v-h response (see hbove) suggests that, in this situation,
there is no increase in initiator cells produced by allografting; or
any effect may have been reduced by the effect of suppressor cells from
the host; or the effector lymphocyte whether an initiator or cytotoxic
lymphocyte may be trapped within the skin graft itself. It is probable
however that cytotoxic lymphocytes are derived from these initiator
lymphocytes.
In the light of previous work on the popliteal node weight g-v-h
assay the results from the present work will be considered.
G-v-H activity in rat allogeneic systems
Unsensit-Csed rats
When allogeneic cells were injected there was a definite g-v-h
response. This is however much smaller than that when parental
cells were injected to the F1 hybrids.
When host rats were not irradiated in the first series of
experiments, there was no additional activity attributable to a host
versus graft reaction. No host-versus-host reactivity was expected
in the second series of experiments between parents to hybrids,
and additional host irradiation indeed made no alteration in node
weight ratios, although there was a decrease in the control node
weights.
In M.L.C. there was very little reactivity between lymphocytes
of the Wistar and A.S. strains used. As it is known there is an
increase in g-v-h activity the more compatible the strains (Ford
and Slmonsen, 1971) greater g-v-h activity might have been expected
in the present experiments (Appendix 2b).
Presensitized rats
By prior skin grafting from the host to donor strain, the
transferred cells were considered to be presensitised on removal
after 7 days. It is possible at seven days that many of the immune
lymphocytes are still in the graft or adjacent nodes, therefore
in the second series of experiments the lymphocytes were removed
from the presensitised donor at 4 weeks.
In the allogeneic system A.S. to I.W. there was no increase in
g-v-h activity with presensitization of the cells. The node weight
ratios was even decreased after 1 skin graft, although after
hyperimmunization the ratios were the same as the normal rate.
This agrees with the findings of Ford and Simonsen (1971) , who
transferred the cells from specifically hypersensitlsed animals 10
to 21 days after the second skin graft. This lack of reactivity
might be due to lymphocyte accumulation in the graft after primary
grafting but is unlikely to be so after hyperimmunization with 2
skin grafts and one intraperitoneal injection of cells.
The results of presensitization in the parent to hybrid
also show that there is no increase in the node weight ratios as
compared with the unsensitised rats except in the Irradiated rats
receiving presensitised lymphocytes at 28 days. These experiments
do clarify the situation as to the timing of removal of lymphocytes.
There was no difference in the node weight ratios in non irradiated
rats when lymphocytes were removed at either seven or twenty-eight
days after grafting indicating that the lymphocytes removed from
the general lymphoid tissues at both times were 'immunised' in an
identical fashion.
The interesting feature of these experiments is the considerable
increase in the node weight ratios after irradiation of the host which
was an actual increase in weight as well as a decrease in control
node weight. These F^ rats would not be expected to have a host-
vemus-graft element in the response, therefore irradiation presumably
should have no effect except to any host component (i.e. recruitment)
of the popliteal node weight increase. This particular experiment
therefore refutes strongly the work of Rolstad (1976) that there is
a considerable host component in the enlargement of the popliteal
node.
The enlargement of the popliteal nodes in irradiated (IWAS)F^
rats, after both 7 and 28 days prior sensitization of the A.S. rat
with (IWAS)F^ skin grafts, deserves further thought. The A.S. rat
is immunised against the I.W. component of the hybrid graft, and
when the immunised cells are injected into the hybrid presumably
the A.B. cells are reacting as a second set reaction against the
I.W. component in the recipient rat.
There is also another inexplicable point raised in these
experiments. All other workers have stated that there is no host-
versus-graft in the parent to F^ situation. This may not be true as
with transfer of F^ cells to parent we have shown some increase in
node weight ratio.
Irmunosuppressed rats
The decrease in the node weights after immunosuppression may be
an artefact due to the lesser number of cells used, which ranged
6 6
from 0.05 x 10 to 0.6 x 10 per injection. The small number of
cells was due to marked lymphoid atrophy after cortisone and
cyclophosphamide but Ford et. al., (1970) obtained a maximum
6
response of g-v-h activity with 0.3 x 10 cells, an increase in the
number of cells did not increase the response thereafter. Irradiation
of the donor, prior to removal of lymphocytes, also decreased the
popliteal node weight ratio in irradiated recipients as compared with
unirradiated recipients but not in comparison with normal rats.
It is likely that immunosuppression of the donor may decrease
the ability of the lymphocytes to initiate a g-v-h response in this
allogeneic system, confirming the work of Cohen and Claman (1971)
in the parent -> F^ system. No work has been done in this study using
immunosuppression or donor suppression in the parent -) F^ experiments.
G-v-H activity in xenogeneic systems
Most work in g-v-h activity has been performed in either parent
to F^ hybrid or allogeneic systems. The reason for considering
xenogeneic systems is to find a method of measuring the immune
competence of lymphocytes injected into irradiated hosts in order to
determine whether the animals from whom the donor lymphocytes are
obtained are 'responders'. In order to confirm this hypothesis we
have injected lymphocytes frpm both sheep and humans, in whom there
was a rejecting allograft, with no increase in the popliteal node
weight ratios as compared with normal sheep and human controls. This
refutes this hypothesis as presensitised animals are presumably
•responders' and more likely to reject a further allograft.
The other part of this theory is that lymphocytes from animals
with decreased immune competence are less likely to respond in the
g-v-h assay. Using irradiated recipient rats '(Salaman et. al.,)
found that injection of antihuman ALG to the recipient reduced the
g-v-h response with human peripheral blood lymphocytes. Again we
have shown by removing lymphocytes from sheep on azathioprine and
prednisolone, and from patients on multiple chemotherapy, and
injecting them into xenogeneic irradiated rats, that a decrease in
immune competence does not result in a decrease in g-v-h activity.
The effect of host irradiation
In the allogeneic rat experiments very little alteration was
obtained by host irradiation to obliterate any h-v-g except in
the parent to hybrid presensitised animals which has been
discussed.
When xenogeneic human and sheep cells were injected there was
a large increase in the weight of the popliteal node which was
reduced by host irradiation. The radiation either blocks the host-
versus-graft response or may abolish the non specific recruiting
effect of the g-v-h response or possibly a combination of both.
Conclusion
As a measurement of T cell activity in the allograft situation
this assay has limited value. Although g-v-h can be obtained between
allogeneic rats which can be reduced by immunosuppression, there has
been no augmentation of the reaction when grafted cells were
presensitised as one would expect in a second set rejection of a graft.
The hypothesis advanced that the popliteal node weight in the
rat might be used to determine the degree of immune competence of
the cell donor of the assay is also doubted. As a predictive test
for renal transplantation in humans the full use of this assay has
yet to be determined.
Two additional findings of interest have come from the experiments
when parental rats and hybrids were used. Firstly, we have shown
there is a host-versus-graft reactivity when F^ hybrid cells are
injected into parental rats, which was obliterated by host irradiation.
Secondly, we have shown that irradiation of the host increases
reactivity when parent cells are injected into F^ hybrids and there¬
fore it would appear that it is less likely that there is any host
component participating in the g-v-h response.
APPENDIX 2(a)
Method of graft-versus-host popliteal node weight assay
The methods used for the graft-versus-host (G-v-H) assay have
been described by Ford et. al., (1970) with modifications described
by Salaman et. al., (1975).
Animals
The recipient rats used in these experiments were inbred Wistar
(I.W.) A.S. and (IWAS)F^ hybrids. The donor lymphocytes were also
from the same rats and were also from sheep and humans.
Cell preparation
The donor lymphocytes were prepared from lymph nodes of rats
(Appendix Id). The strains of rats from which the cells for injection
were obtained were all allogeneic or semi - allogeneic to the recipient.
The donor cells were also obtained from the thoracic duct lymph of
sheep (Section III Methods), these cells were washed three times in
R.P.M.I. to remove the lymph. Lymphocytes were also prepared from
human heparinised peripheral blood. The blood was layered on Ficoll
Triosil and spun at 700 g. for 20 minutes. The lymphocytes were
collected from the interface between the senum and Ficoll Triosil and
washed three times in R.P.M.I.
The cells were all counted with trypan blue to obtain viable cell
counts and the appropriate number of cells for injection were
resuspended in 0.1 ml. of media. The dose of cells in the inoculum
0
was variable but usually 2 x 10 cells in 0.1 mis. were injected.
In some experiments irradiated cells were used as controls. After
the cells were washed they were exposed to a dose of Y rays from a
60
Co. source of either 2,400 rads or 20,000 rads.
After completion of irradiation the cells were again counted.
Injection of cells and removal of popliteal nodes
In each experiment age, weight, and sex matched inbred rats were
used. The recipient rats were anaesthetised with ether.
The 6.1 mis. test cell suspension were injected into the left
foot of the rat. A 25 gauge needle was inserted into the heel on the
ventral surface of the footpad. The needle was advanced subcutaneously
into the loose tissue of the sole of the foot and the inoculum
injected. Pressure was applied to the injection site for one minute
to prevent bleeding. Either 0.1 mis. of media alone or control cells
were injected similarly into the right footpad.
The recipients were killed seven days later with ether. Both
popliteal nodes were found (Diagram 7) cleaned of surrounding fat and
placed in saline in a microtest plate. The nodes were then blotted
immediately prior to weighing to an accuracy of 0.1 mg.
Suppression of Host-versus-Graft response
In these experiments half of the rats (three) were irradiated
60
with rays from Co. source (T.E.M. Mobiltron) at a source to
target distance of 60 cms. A dose of 300 rads was given to the midline
of the body in order to suppress the recipient host-versus-graft res
response.
Presensitization and immunosuppression of allogeneic rat donors
Presensitization of the donor rats was performed by skin grafting
from the recipient inbred strain to the donor rat (Appendix Ic). In
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addition in some experiments the rats were hypersensitised with three
skin grafts and two intraperitoneal lymph node lymphocyte injections
from the recipient strain.
Some of these presensitised rats were given immunosuppressive
drugs. Cyclophosphamide 5 mgs/100 g. and cortisone acetate 5 mgs/
100 g. i.m. wasggiven alternate days for the period of grafting.
Assay method
The weight of the popliteal nodes in each animal was obtained.
The ratio of the test node/control node weight was calculated for
each animal and the mean of the three rats in each experiment was
calculated.
APPENDIX 2(b)
Mixed Lymphocyte Culture (M.L.C.)
The M.L.C. experiments have been performed by C. Brooks of
the Cancer Research Campaign Laboratories, Nottingham. The full
method has been described by Brooks (1975).
Rat lymph node cells (LNC) were cultured in flat bottomed
microplate wells for 48 hours, 72 or 96 hours. In the two way
0
reactions each culture contained 1 x 10 LNC, mixed cultures having
two cell types at a 1 : 1 ratio. The one way reactions cultures
0 0
contained 1 x 10 responder LNC plus 0.5 x 10 irradiated (2,000
rads) stimulating allogeneic cells. Control cells were unstimulated
autologous cells. After culture the cells were labelled with
3
H thymidine for approximately 16 hours and counted in a B
scintillometer.
The results are shown in table XIII. The numbers in columns 3
and 4 are counts per minute. The counts in column 4 are the
additional counts on stimulation in M.L.R. over the unstimulated
control. The index of transformation is obtained by dividing the
counts on stimulation by the control counts. The greater the index
of transformation the stronger the reactivity between the 2 sets of
lymphocytes. From these results one can conclude that Wistar and
A.S. strains are weakly Incompatible for M.L.C. antigens^oompared
with A.S. and A.S.2. However since there is some reactivity the




































381 - 79*** 6.77
479 - 198* 1.53
-318 ± 327NS 0.86
686 - 246* 1.53
609 - 421* 1.17
4- N*?
1,079 - 594 1.29
4»
105 - 475 1.01
<-> Two way reaction
x Stimulator cells
* p <0.05 ** p<C
Index of transformation
01 *** p< 0.001
1.0 = Zero reactivity
1-2 = Weak reactivity
2 = Strong reactivity
M.L.C. results between A.S. and A.S. , WAG and A.S. rats.
Table XIII
SECTION III
LYMPHOCYTE FLOW IN ALLOGRAFT REJECTION
A. INTRODUCTION
B. BACKGROUND
1. Technique of thoracic duct cannulation in various species.
2. Flow rates and cellularity of lymph.
3. Differences in the composition of lymph from the thoracic
duct and other sites.
4. Route of circulating lymphocytes.
5. The effect of lymph lymphocyte depletion on blood
lymphocytes.
6. The response of the body lymphocyte flow to immune-
stimulation.
7. Thoracic duct depletion as a means of immunosuppression.
8. The mode of action of immunosuppressive drugs.
Azathioprine and steroids.
C. AIMS OF THE PRESENT WORK
D. MATERIALS AND METHODS
1. Groups studied.
2. Method of thoracic duct cannulation.
3. Method of renal transplantation.
4. Investigations performed on lymph and venous blood.
E. RESULTS
F. DISCUSSION
1. Renal transplantation in sheep.






In allograft rejection, as previously described in the
introduction to this thesis, there is a massive in vivo response
against the graft. There is a large inflex of white blood cells,
mainly lymphoid and plasma cells, into the graft from the blood,
these cells causing damage to the transplanted organ.
In the first part of this thesis we have seen that an ijn vitro
killing effect of each individual lymphocyte is difficult to achieve
and does not mirror the marked in vivo response. Perhaps the small
cytotoxic effect of each individual lymphocyte is multiplied by a
massive increase in the number of lymphocytes in the graft and
flowing through a graft.
In the next section experiments have been performed to measure
the number of lymphocytes flowing through a renal allograft, by
cannulation of the lymphatics of that graft. Also the number of
lymphocytes flowing through body have been measured, by thoracic
duct drainage, during the period of allograft rejection.
The effect of immunosuppressive drugs on this flow of lymphocytes,
both through the grafted kidney and through the whole body, has also
been studied in order to determine where the drugs act.
B. BACKGROUND
Lymph has been collected in various animals for different
experiments and studies, and also for therapeutic reasons. This
work covers many aspects; here a selection of the work is reviewed
which is relevant to the flow and cellularity of lymph.
1. Techniques of thoracic duct cannulation in various species
Surgical techniques for the collection of lymph from sheep have
been described by Lascelles and Morris (1961). They described the
technique of cannulating the thoracic duct through a right thoracotomy.
The right thoracotomy approach was chosen in preference to the left
neck exploration as many sheep have accessory lymph ducts and
aberrant communications between the thoracic and right lymphatic
dcuts; also Lascells and Morris maintained that fixation of cannulae
was difficult in the neck. They described a method of setting up
a lymphovenous shunt in order to prevent loss of weight from protein
depletion which would result from the loss of lymph from the body.
Their work was a study of the flow of lymph from certain organs
(i.e. collection from hepatic, intestinal and mammary lymph ducts
as well as the thoracic duct). The technique used in the present
work for cannulation of the thoracic duct is that described by
Shnain, Kassai and Jabbin (1973), and entails exploration of the
lower left neck for cannulation of the thoracic duct.
The technique for collection of lymph in the calf was described
by Fish, Mattingley, Ritzmann, Sarles and Remmers (1969c), who
cannulated the thoracic duct in the left side of the neck, this
method was later modified for use in humans (Fish, Sarles, Mattingley.,
Ross and Remmers, 1969d). The purpose of their work was not only the
study of cell population in lymph, but also the effect of depletion
of lymphocytes on the body as a means of immunosuppression. Their
work gives insight into the difficulties of maintaining a thoracic
duct fistula. Initially they had a high failure rate (Fish et. al.,
1969c): of 23 cannulations 10 failed, either at operation owing to
inability to cannulate the thoracic duct, or subsequently from
blockage of the cannula. The use of heparin infusion into a side
wing of the inserted cannula reduced this complication in later work,
and Lascelles and Morris (1961) too stressed the need to use heparin
intravenously to prevent clotting of the cannula. Fish and his
co-workers also had a large initial complication rate in their 13
remaining calves in the above experiments, 8 died, 2 after
re-operation for malfunction, 2 of thrombotic occlusion of the
superior vena cava, 4 of infection, and 5 calves had wound infections.
However in following papers 1969a, 1969d, 1970a, 1970b and 1972
they showed that chronic thoracic duct fistulae could be maintained
in both calves and humans for up to periods of 150 days. The
reinfusion of lymphocyte free lymph, by continuous flow
centrifugation was essential for the maintenance of health (Fish
et. al., 1969b), and they stressed that the loss of protein would
otherwise lead to an abnormal physiological state.
The collection of lymph in rats has been described by Bollman,
Cain and Grindley (1948): the thoracic duct is cannulated below
the diaphragm and continuous reinfusion of lymph is given through
the femoral vein. This technique has been modified by Gowans (1957).
2. Lymph flow rates and cellularity of lymph
Flow rates
The flow of lymph varies considerably according to the animal,
the technique, the prevention of clotting and the replacement of
extracellular fluid which has been drained.
The flow of lymph in sheep from the thoracic duct was shown by
Lascelles and Morris (1961) to vary from 60 to 170 mls/hr. (1,440 to
4,080 mis/day). They were replacing the lymph through a lymph venous
fistula with the addition of 1 ml./hr. of saline containing one unit
of heparin in each ml. The flow of lymph was also increased by oral
fluids and feeding. The flow obtained from sheep by Shnain et. al.,
(1973) was of the same order 1,380 to 3,440 mis/day without intravenous
replacement of fluid.
In man, with intravenous reinfusion of lymphocyte free lymph,
Fish et. al., (1969d) obtained an initial flow rate of 3,200 to
9,800 mis/day; after 6 weeks removal of the lymphocytes the number of
g
lymphocytes collected each day was 0.6 to 1.2 x 10 . These workers
achieved a reduction of 90% of the number of lymphocytes obtained at
the time of cannulation by the twenty-first day following drainage.
In the rat (Gowans, 1957) the flow rate of lymph, with reinfusion
of either intravenous heparinised fluid or cell-free lymph into the
femoral vein, was 24 to 60 mis. on the first day and this flow
remained steady through the 7 days of collection. The number of
6 6
lymphocytes dropped from 24 to 32 x 10 /hr. to 4 to 6 x 10 /hr.
g
(approximately 5.8 to 0.96 x 10 /day) on the 7th day. The maximum
depletion occurring in the first 48 hours when a reduction of 70%
had occurred (see Figure 9).
0 1 2 3 4 5 6 7
Days after cannulation
Figure 9 - Thoracic duct lymphocyte flow in the rat.
Gowans, 1957.
The daily output of thoracic duct lymphocytes was sufficient to
replace those in the peripheral blood eleven times. A profound fall
in lymphocytes could be prevented by reinfusing lymph and live cells
back into the femoral vein of the rat which suggests that continuous
entry of lymphocytes from the blood into the lymph is essential for
maintaining the number of thoracic duct lymphocytes (Gowans, 1957).
Cells in thoracic duct lymph
The main cell in thoracic duct lymph is the lymphocyte.
Polymorphs are not present, but there is usually a very small number
of monocytes (macrophages) (Roser, 1970). Red cells are also present
in the thoracic duct lymph (Heath, Lascelles and Morris, 1962)
although usually in small numbers, and are thought to enter the
lymph through lymphovenous channels.
Lymphocytes
The main lymphocyte in rats (Gowans, 1957) and sheep (Hall and
Morris, 1963) is the small lymphocyte. The medium lymphocyte in
sheep corresponds to the small lymphocyte in other animals (Hall et.
al., 1963). The proportions of T and B cells in thoracic duct lymph
in the mouse have been studied by Sprent (1973); By using T and B cell
markers in the mouse he found 82% T cells and 16% B cells. The ratio
altered to 40% T cells and 50% B cells after 3 days depletion of
thoracic duct lymph. This indicates that T cells are mobilised more
rapidly by thoracic duct drainage, and this was confirmed by rapid
depletion of the T cell dependent area (paracortical) in the lymph
nodes.
The thoracic duct lymph also contains a number of large
basophilic cells-. This cell has various names, "transformed cell,
plasmoid cell, large pyroninophilic lymphocyte, immunoblasts". The
percentage of large basophilic cells in the lymph varies in different
animals: sheep 2% (Hall.^t. al., 1962), in rats 5% (Gowans, 1957) and
in calves 10% (Townsend, Fish, Vyvial, Kianar and Ritzmann, 1970).
In calves Townsend et. al. found the lymph contained small lymphocytes,
large basophilic cells and large pale lymphocytes. On the first day
of thoracic duct drainage most of the lymphocytes were small, but by
the seventh day of drainage the large pale lymphocytes were more
plentiful. The large basophilic cells stayed at 10% of the cell count
7
even though the total lymphocyte count fell from 3.3 x 10 to 0.4 x
7
10 /ml. over the seven days.
Large basophilic cells do not recirculate in the lymph to any
significant extent. This has been shown by Delorme, Hodgett, Hall
and Alexander (1969) who obtained 'immunoblasts' from the thoracic
3
duct lymph of rats, labelled the cells with H-thymidine, and
reinjected them intravenously into a syngeneic recipient. During
a 48 hour collection of thoracic duct lymph of this recipient
none of the labelled cells appeared in the lymph, whereas on
3
labelling small lymphocytes with ' H-uridine in a similar experiment
20% reappeared in the lymph.
3. The differences of composition of lymph from the thoracic
duct and from other sites
There is a difference between the rate of flow, cell population
and composition of lymph draining different sites of the body.
There is a difference in the composition of lymph going to a
lymph node and draining from the same lymph node - afferent and
efferent lymphatic vessels respectively. The afferent lymph contains
red cells and white cells, the number of polymorphs is 10%,
macrophages 10% as well as lymphocytes 80%. The number of
lymphocytes - 500 to 3,000/cu.mm. - in the afferent lymph (Hall and
Morris, 1963) is less than in the efferent lymphatic of that node -
5,000 to 20,000/cu.mm. (Hall and Morris, 1962). Gowans (1962)
suggested that the large cellular output from a single node was due
to removal of lymphocytes from the blood.
There are also differences in the lymphocyte population found
in lymph from different regions in the body. In thoracic duct and
intestinal lymph dividing cells were common, both immature and mature
plasma cells were present in the lymph. The output of cells in the
hepatic, lumbar and mammary lymph duct was 2 to 4 times greater than
the output from the intestinal duct alone (Heath, Lascelles and
Morris, 1962). Simultaneous cannulation of the thoracic duct and
right lymphatic duct in dogs, drained for 5 hours, showed marked
differences in rate of flow, lymphocyte concentration and
morphological types suggesting that there is a definite functional
as well as an anatomical difference between these two lymph channels
(leeds, Unley, Busch, Rosenbaum and Yoffey, 1971).
4. The route of circulating lymphocytes
The lymphocytes in the thoracic duct come from the peripheral
blood. This was shown by Gowans (1959) who obtained lymphocytes from
3
the thoracic duct, labelled them with H-thymidine, and infused them
back into the rat intravenously. After a few hours 97% of the small
lymphocytes in the thoracic duct lymph were shown to have taken up
3
the H label, Indicating that lymphocyte circulating was from lymph,
to blood, to lymph. This work did not indicate which route was taken
by the lymphocytes passing from the blood back into the lymph. A
route through the tissue spaces would increase the time taken for the
removal of lymphocytes from the blood. This was confirmed by Gowans
(1964). Some lymphocytes may pass into the lymph from the blood via
the tissue spaces, as the number of lymphocytes is increased, after
immune stimulation, in the afferent lymphatic draining from the tissue
spaces into a lymph node. This is discussed in more detail in (6)
(see below).
The recirculating lymphocyte pool in normal adult rats contains
0
2 x 10 small lymphocytes (Gowans and Knight, 1964). This was
determined by labelling the RNA of thoracic duct lymphocytes with
tritiated adenosine. These cells were reinfused intravenously, the
number of labelled cells in the thoracic duct was counted, and the
number of labelled cells in the lymphoid tisaue was estimated by
autoradiography after 2 days. The pool of the animal's own cells
with which the labelled cells had mixed was identified as the recir¬
culating pool. The average lifespan of circulating thoracic duct
lymphocytes has been studied in mice by Sprent and Basten (1973).
They found that the lifespan of B lymphocytes was 5 to 7 weeks, and
that of T lymphocytes was much longer, 4 to 6 months; the B
v,. • SJ ■ *
lymphocytes were identified by labelling with radioactive immune
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5. The effect of thoracic duct lymph depletion on the circulating
blood lymphocytes
As the lymph circulates back to the blood, then depletion of the
thoracic duct lymphocytes will reduce the number of circulating blood
lymphocytes. A reduction of lymphocytes by 94% in calves (Fish et. al.f
1969c) led to corresponding reduction in blood lymphocytes by 57%.
This also showed that the blood lymphocyte population was not entirely
dependent on lymphocytes entering through the lymphatic ducts. These
workers assumed that the bone marrow contributed to the maintenance of
the lymphocytes in the blood. Other workers have shown that thoracic
duct depletion reduces blood lymphocytes: Fitts, Majeski, Sharbaugh,
Hargest, Graber and Henniger (1972) showed that 85% reduction of
thoracic duct lymphocytes in calves over 11 days, reduced the blood
3 3
lymphocytes from 10,000 mm to 4,400 mm1'. Townsend, Fish, Vyvial,
Kianar and Ritzmann (1970) also showed in calves a reduction from
3
3,000 to 1,800 mm over 7 days depletion. Sprent (1972) showed
that T cells recirculate rapidly from blood to lymph in mice. Seven
days depletion of thoracic duct lymphocytes decreased the number of
T cells in the body and therefore in the blood to a greater extent
than B cells.
The flow of lymphocytes is therefore a circulation from blood
to lymph, to blood. If this is altered by massive thoracic duct
depletion, the bone marrow forms a large number of new lymphocytes to
replace those lost to the body, possibly with the additional help by
the mobilization of lymphocytes from other lymphoid tissues.
6. The response of the lymphocyte flow to Immune stimulation
Lymphocyte flow from ccn allograft
The lymphocyte is an essential part of the immune response. We
are concerned with cell-mediated immunity in which the T lymphocyte
is considered of importance. The meeting of antigenic allografted
cells and the lymphocyte may take place in the graft, i.e. the
lymphocytes may migrate from the blood into the graft and be activated
peripherally, or antigenic material from the graft may pass via
afferent lymphocytes to the local draining node, and the lymphocytes
be this activated centrally. In renal allografts there is evidence
of peripheral activation: study of lymph from renal transplants has
been made by Pederson and Morris (1970), who cannulated the main
lymphatic leaving a kidney and draining towards the renal node (renal
afferent lymphatic), in both autotransplanted and allotransplanted
kidneys. From the autograft the lymph flow increased over the first
48 hours to a maximum of 3.3 mis. per hour; this compared with the
increase from the allograft, which reached a maximum of 60 mis. per
hour a few days later. The initial increase in the lymph flow was
probably due to oedema from non-immune tissue damage, and after 48
hours the flow subsided in the autograft, whereas in the allograft
the continuing marked increase in lymph flow was accompanied by a
corresponding increase in the cell count (Figure 10). Most of the
cells were lymphocytes and transformed cells. There were usually
about 3 to 10% macrophages, identified on Leischman stained smears,
in the lymph throughout the response. At the peak of the response
up to 60% of the total number of cells were transformed, with a
corresponding increase in these cells on histology of the renal
cortex after the fourth day. If the cells were diverted from the
body there was a decrease in reaction in the draining nodes, with a
coincident but slight increase in the length of survival of the
graft. Also if the cells, leaving a rejecting kidney, were injected
into a distant site, they evoked a significant cellular and antibody
response in previously unstimulated nodes.
After skin grafting in sheep there was little or no increase in
the number of lymphocytes passing from the graft up the afferent
lymphatic to the draining node (Hall, 1967). This difference is
perhaps due to the method of vascular connection established by
grafted skin.
The collection of lymph from human allografts (Hamburger,
Dimitrui, Banklr, Debray-Sachs and Auvert, 1971) with rejection held
in check by immunosuppressive drugs, has shown a rise in the number
Days






(Pederson and Morris, 1970.)
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of lymphocytes flowing from the kidney to a maximum of 19 x 10 on
the sixth day. There was a corresponding increase in the percentage
of transformed cells, which was maximum on the sixth and remained
steady at 15% for the period of cannulation of seven days.
Second set rejection of renal allografts was studied by Pederson
and Morris (1974) who showed that rejection was accelerated with an
increase in the numbers of red blood cells and polymorphs, but a
decrease in the lymph flow and lymphocyte count.
Lymphocyte flow from the draining node
There is an increase in lymphocyte activity in the node draining
an allograft (Brent, 1958). In the skin graft the initial response is
in the primary follicles of the node immediately proximal to an
allograft, although other distant nodes were affected (Hall, 1967).
Hall Showed that the flow of small lymphocytes was increased, and
there was an even greater increase in the transformed cells which
reached 40% as compared with 5 - 10% in the resting node; of these
large cells 60% took up thymidine on in vitro incubation. This
response began on the eighth post-transplant day and was maximum on
the fifteenth. After a renal allograft, transformed cells appeared
in the draining nodes at about 4 days (Pederson et. al., 1970). This
is two days after their appearance in the afferent lymph, but in
these experiments the flow of this lymph had been diverted from the
body; the transformed cell response may either be from direct
absorption of the cells from the area around the graft, or some factor
may be transmitted to the node by the blood.
There is other evidence for the increased activity in the node
following stimulation with non-transplantation antigen. Hall et. al.,
(1962) showed that the efferent lymph node drainage after antigenic
stimulation with human serum globulin increased the number of
transformed cells at 50 hours. The same authors (1963) showed a
difference between the primary and secondary response. In the
secondary response the transformed cells appeared earlier, coinciding
with the production of antibody.
Lymphocyte flow -in the thoracic duct
The lymph draining from a stimulated node will pass to the
thoracic duct. Delorme, Hodgett, Hall and Alexander (1969) were
unable to cannulate the popliteal efferents in rats, but did cannulate
the thoracic duct below the diaphragm. They injected a number of
antigenic materials into the lower half of the body: allogeneic
tumour, syngeneic tumour, B.C.G. and fluorodinitrobenzene (F.D.N.B.)
to initiate T cell responses. The flow of lymphocytes was not
mentioned but the number of transformed cells was studied instead.
The experiments were performed in germ-free rats. The numbers of
transformed cells in control germ-free rats was 2%. this increases
to 3 - 8% in rats which have not been reared in a germ-free unit and
the authors stressed the importance of using germ-free animals if the
increase in transformed cells was expected to reflect evidence of an
immune reaction. There was a slight increase in the percentage of
transformed cells from 2% in controls to a 5% peak on the fifth day
after challenge with B.C.G. Irradiated syngeneic tumour (the
antigenic stimulus here being tumour specific antigen) gave a greater
increase of 6% on the fifth day. The greatest increase was after
irradiated allogeneic tumour which was 17%, the maximum increase
coming earlier - on the second day. The response to transplantation
antigen was therefore brisker than with other antigenic stimuli.
It is postulated that, rather than by the transfer of antigen,
the immune response is carried around the body in the lymph by
transformed cells (Hall,,1967). The immune response is therefore
activated centrally by information provided by the transformed cells,
and intact lymphatic pathways, in addition to other vascular
connections, are necessary for the movement of transformed cells.
7. Thoracic duct depletion as a means of immunosuppression
A reduction of the effector cells (lymphocytes) by thoracic duct
drainage has been used as a means of suppressing allograft rejection.
Chronic thoracic duct fistulae have been performed on 14 patients
receiving cadaver kidney allografts (Fish et. al., 1969a). The
fistulae were made 10 to 108 days before transplantation. A
significant lymphocyte depletion of 90% and a loss of thymic areas of
lymph nodes was shown in these patients. Routine immunosuppressive
drugs were withheld for 19 to 50 days, when maintenance immuno¬
suppression was given. Eight patients have survived with functioning
kidneys. Similar work on calves (Fish et. al., 1970a) showed that 14
days depletion prior to transplantation as compared with 7 days, gave
a much greater reduction in the rejection process. There was no
difference in these two groups in the number of cells removed prior to
transplantation, the single determinent being the longer period of
depletion.
Tilney and Murray (1967) also used lymphocyte depletion as a
means of immunosuppression, although the patients were also on routine
immunosuppressive drugs after transplantation: the doses of the drugs
were azathioprine 2-3 mgs/Kg/day and prednisolone 2 mgs/Kg/day. They
suggested that the addition of lymphocyte depletion to conventional
immunosuppressive regime would allow a maintenance dose of immuno¬
suppression to be used sooner after transplantation.
8. The mode of action of immunosuppressive drugs
Azathioprine1
Immunosuppressive drugs are synthetic products which are able to
suppress immune responses. At present azathioprine is the most
commonly used agent and has so far proved the most effective in human
transplantation, and has been used for suppression of allograft
rejection since 1961. Azathioprine is an anti-metabolite, it
interferes with purine metabolism and therefore DNA, RNA and protein
synthesis. In man the usual dose is 3 mgs/Kg/day. The activity of
azathioprine depends on the production of metabolites release on
breakdown by the liver. Both azathioprine and its active metabolites
are degraded rapidly in less than 4 hours and therefore the drug is
safe to use in renal failure as there is no summation of effect. In
clinical practice azathioprine reduces the number of white cells in
the peripheral blood, and may produce bone marrow asplasia in a few
patients.
The effect of azathioprine on the lymphocyte
The method of action of azathioprine is not completely understood.
The main effect of azathioprine is on the T lymphocyte. The
inhibition of formation of sheep cell rosettes in humans - rosette
inhibition activity - (see Main Introduction) has been a method
of measuring the immunosuppressive activity of the drug (Bach and
Dardenne, 1970). Azathioprine proved, in vitro, to inhibit the
formation of spontaneous rosettes at a minimal inhibitory
concentration of 0.5 ms/ml. The peak of inhibitory activity in vivo
occurred 1 hour after injection of azathioprine intravenously. They
1. Imuran (Wellcome, Beckenham)
also found that the in vivo activation of azathioprine is more
efficient in man than in mouse, thus immunosuppressive doses in mouse
require to be much higher.
Azathioprine has been shown in vitro to reduce the transformation
of lymphocytes in mixed lymphocyte culture (Laborde and Bach, 1971).
They showed that the incorporation of thymidine in M.L.C. was inhibited
at non cytotoxic concentration (10 mg/ml.). At weaker concentrations
(0.001 mg/ml. to 0.1 mg/ml.) azathioprine exercised a stimulatory
effect. When azathioprine was introduced 24 hours after the beginning
of the culture there was a reduction in the inhibitory effect. These
workers concluded that the activity of azathioprine is exercised in
the course of the first 48 hours, that is to say at the beginning of
the immune response before an increase in DNA synthesis (i.e. cell
proliferation).
It has been postulated that azathioprine may act on all three
limbs of the immune response in vivo (Hamburger, Crosnier, Dormant
and Bach, 1972). Azathioprine may prevent recognition of the antigen
by the T lymphocytes (the efferent arc). This is supported by the
inhibition of sheep rosetting and M.L.C. described above. Secondly
azathioprine may inhibit DNA and RNA synthesis and therefore reduce
the number of transformed sensitised cells (central response). Tfiirdly
there may be a direct effect on the efferent mechanism, on the
sensitised lymphocytes. The effect of azathioprine in the afferent
arc is considered the most likely and most important as in vitro the
effect of azathioprine is lost if not given immediately after contact
between antigen and lymphocyte.
Steroids
Steroids are anti-inflammatory drugs and prolong graft survival
without having a true immunosuppressive effect. Steroids when given
alone to prevent renal allograft rejection have little success.
Cortisol is a naturally occurring glucocorticoid and prednisolone,
prednisolone and methylprednisolone are synthetic glucocorticoids.
Prednisolone is commonly used for immunosuppressive therapy, initially
prednisolone is used in high doses orally, 3 mgs/Kg/day, reducing to
a maintenance dose of 0.25 mgs/Kg/day. Large doses (one gram) of
methylprednisolone1 given intravenously at the time of rejection have
been found to be effective at abolishing rejection episodes (Bell,
Briggs, Colman, Quin, Wood, Paton and Macpherson, 1973) ,
The effect of steroids on the lymphocyte
Steroids have been shown in vitro to inhibit, DNA, RNA and protein
synthesis. If added to M.L.R. at the beginning of culture steroids
inhibit lymphocyte transformation (Bach, 1975). Rosenau and Moon
(1962) showed that in vitro lymphocyte cytotoxicity against tumour
was also reduced. Steroids have also been shown in vivo to cause
lympholysis, repeated injections at high doses causes atrophy of
most lymphoid organs. Schnappauf and Schnappauf (1968) showed that
prednisolone decreased the flow of lymphocyte in the thoracic duct
but they did not know whether this was due to a generalised lymphoid
depletion, or a specific inhibition of lymphocyte migration. In
allotransplantation of skin grafts steroids prolong graft survival.
Corticosteroids appear to exert a suppressive effect on the immune
response. There is no evidence that recognition of antigen is
1. Solumedrone (Upjohn, Crawley)
prevented, but the inflanmatory response initiated after recognition,
is reduced (Melby, 1974).
C. AIMS OF THE PRESENT WORK
The aims of the work are twofold:
1. To study the quantitative change in the lymphocyte mass at the *.
time of immune stimulation with a renal allograft. The work will be
divided into two parts:
a) To confirm the increase in the number of lymphocytes leaving
the lymphatic of a rejecting kidney - renal lymphocyte flow.
b) To see if this increase in the number of lymphocytes leaving
the kidney is specific to the kidney or whether there is an increase
in the total body lymphocyte flow.
The total body lymphocyte flow has been measured by thoracic duct
cannulation and drainage.
2. To study the effect of immunosuppressive drugs on total body
lymphocyte and renal lymphocyte flow; and to determine whether
immunosuppressive agents alter either the total number of lymphocytes,
or the number of transformed lymphocytes (dividing cells) in the
thoracic duct and renal lymph. The effect of immunosuppressive
drugs will be studied alone, and also in combination with a renal
allograft with rejection abrogated.
D. MATERIALS AND METHODS
1. All the experiments were performed in male sheep, Suffolk cross
or Hereford cross. The sheep were wethers of approximately 30
kilograms in weight. The sheep were brought from the field to
individual pens one week prior to operation in order to become
acclimatised to their surroundings. They were fed on pregnant ewe
nut. They were also allowed water ad libitum. During the week of
acclimatization they were sheared.
a) Thoracic duct cannulation to measure total body lymphocyte flow
For the experiments five different groups of sheep were used:
1. Normal
2. Immunosuppression
3. Post renal transplantation - autograft
4. Post renal transplantation - allograft
5. Post renal transplantation - allograft and immuno¬
suppression
Group 1
These sheep had thoracic duct cannulation alone performed.
Group 2
These sheep received immunosuppressive drugs: prednisolone 200
mgs/day and azathioprine1 3 mgs/Kg/day either orally or intravenously.
The thoracic duct was cannulated two weeks after the start of the
drugs.
Group 3
These sheep had a left nephrectomy performed, and the kidney was
transplanted into the neck of the same sheep. The thoracic duct was
cannulated during the same operation, or one week later.
1Imuran (Wellcome, Beckenham)
Group 4
A nephrectomy was performed on a sheep and the kidney trans¬
planted into an unrelated sheep. The thoracic duct was cannulated
in the latter either at this operation or one week later.
Group 5
These sheep also received an allografted kidney. During the
2
operation they received one gram of methylprednisolone ; thereafter
they received prednisolone commencing at 200 mgs/day and reducing
by 10 mgs. each day, and azathioprine 3 mgs/Kg of body weight/day.
The thoracic duct was cannulated either in the first or the second
week after transplantation.
b) Renal lymphatic cannulation to measure renal lymphocyte flow
Four groups of sheep were used for these experiments.
1. Renal autograft
2. Renal allograft
3. Allograft and immunosuppression
4. Allograft and prednisolone
Group 1
A nephrectomy was performed and the kidney transplanted into the
neck of the same sheep. The renal lymphatic was cannulated at the
same operation.
Group 2
A kidney from one sheep was transplanted into the neck of an





These sheep received a renal1 allograft and also one gram of
methylprednisolone during the operation, thereafter prednisolone
commencing 200 mgs/day and reducing by 10 mgs each day and
azathioprine 10 mgs/Kg of body weight/d,ay.
Group 4
These sheep received a renal allograft and prednisolone. The
dose of prednisolone was the same as group 3.
2. Method of Thoracic Duct Cannulation
Preparation
The sheep were starved of food but not water for the 24 hours
prior to operation.
Anaesthesia
The sheep were anaesthetised with veterinary nembutal (60 mgs/ml)
the dose varying according to the size of the sheep, average dose
being 900 rags, for a wether. The animal was intubated with a cuffed
endotracheal tube, size 9, and % litre/mln. of oxygen, 250 mls/min.
nitrous oxide with halothane i% were administered through a Boyles
machine on closed circuit. The animals breathered spontaneously.
Position
The animal was placed on its right side in a left lateral
position, the fore limbs drawn towards the lower limbs and tied
securely, and the neck extended to give the maximum exposure of the
lower left side of the neck. (Plate 4)
Preparation of the skin
The skin on the left prescapular region was close shaved. The
skin was first cleaned with a savlon 1% with a soft scrubbing brush,
and then cleaned with chlorhexidine 0.5% in 70% spirit. The animal
was then towelled up with sterile drapes.
Technique of operation (Diagram 8)
A longitudinal incision approximately 12 centimetres long was
made into the left side of the neck from the level of the first rib
along the jugular furrow. The subcutaneous fascia was divided in
the same line. Lying dorsally in the line of the incision was the
ventral edge of the brachiocephalic muscle. In the more caudal end
of the wound two vessels (omocervicalis artery and vein) ran at right
Plate 4 POSITION OF SHEEP FOR THORACIC DUCT EXPLORATION
IN THE LEFT SIDE OF THE NECK
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angles to the incision, and these vessels were divided between clamps
and tied. Deep to the divided vessels the external jugular vein was
exposed as it joins the brachial vein. The brachiocephalic muscle
was dissected carefully off the surrounding loose areolar tissue and
retracted. Careful dissection under the muscle in this area anterior
to the first rib, bounded medially by the external jugular vein, with
the carotid artery running posteriorly, revealed the ampulla of the
thoracic duct as it enters the external jugular vein. A ligature
was then tied round the ampulla, and the thoracic duct immediately
became distended and could be seen passing caudally down the
posterior mediastinum. A trocaflex cannula, 1.2 millimetres external
diameter and 30 centimetres long, with a sharp stilette was then
inserted into the thoracic duct. The stilette was then withdrawn
as the cannula was gently pushed down the main branch at least four
centimetres (occasionally there was more than one branch to the
thoracic! duct as it enters the ampulla) (plate 5a). The cannula was
fixed with another ligature distal to the site of entry to prevent
leakage of lymph, and was fixed to subcutaneous tissues by coiling
it around in a circle and enclosing the two lengths of tubing in
spiral cable wrapping. This was stitched to the subcutaneous fascia
in order to prevent the cannula being pulled out (plate 5b). Already
the flow of lymph was brisk and collection was started. An intravenous
cannula 1.65 mm. external diameter was inserted into the external
jugular vein about two centimetres cephalad from the entrance to the
thoracic duct and fed in at least three centimetres and fixed by
tying it in the vessel. An infusion of heparinised saline (2,000
units of heparin to 500 mis. of saline) was commenced. The
subcutaneous tissues were closed with 2/0 chromic catgut, the skin
Plate 5a) THORACIC DUCT LIGATED WITH BLACK LIGATURE
CANNULA INSERTED
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Plate 5b) THORACIC DUCT CANNULA SECURED WITH SPIRAL
CABLE WRAPPING
was closed with michel clips and sprayed with nobecutane. A netelast
bandage was applied encircling the neck and upper chest and the
cannulae were protected under this. The thoracic duct cannula was
placed with added connection tubing into the collection bag. The
venous cannula was connected to an infusion bottle on a drip stand.
The sheep was brought around from the anaesthetic and extubated.
Postoperative Management and Lymph Collection
The sheep was placed in a restraining pen (plate 6). It was
encouraged to stand up almost immediately and when fully conscious
a loose halter was placed around its neck to prevent it chewing the
cannulae.
The lymph was collected into six litre sterile bottles which
contained 5,000 units of heparin, bottles being changed daily.
The 3h^ep was given postoperative sedation (pentazocine 30 mgs.
intravenously) immediately after the operation. All the animals were
given penicillin 600,000 units and streptomycin 500 mgs. daily.
Intravenous infusion of normal saline was given, at least three litres
per day, varying according to the amount of lymph drained from the
sheep the previous day. The saline contained three grammes potassium
chloride per day. Also two bottles (500 mis. each) of Aminosol
vitrum was infused each day in an attempt to replace some of the
large quantity of protein lost in the lymph. Many of the sheep lost
a considerable amount of weight owing to protein loss. Heparin 2,000
units a day was also infused continuously.
At the end of seven days the animal was sacrificed, an intravenous
injection of a large dose of nembutal 1.5 G. being given.
Plote 6 THORACIC DUCT CANNULATION AND DRAINAGE,
SHEEP IN A RESTRAINING PEN
A number of immunosuppressed sheep died before the end of the
thoracic duct drainage probably owing to sepsis.
3. Method of Renal Transplantatlon
Removal of Donor Kidney
Initially the donor sheep were wethers, and this was satisfactory
when the thoracic duct cannulation experiments alone were performed.
When experiments for cannulation of the renal lymphatics were begun
it was found that the lymphatics of kidneys from these sheep were
extremely small, therefore larger older rams were used.
Anaesthesia
The same anaesthetic was given as for thoracic cannulation (see
above).
Preparation and Position
The sheep was laid supine with all four limbs tied separately to
the side of the table. The abdominal skin was clipped closely and
scrubbed with savlon and then cleaned with chlorhexidine and draped
with sterile towsls. (Plate 7)
Technique of Operation
A left paramedian incision was made from the costal margin down
below the glans penis midway between this and the pubis. The tissues
were divided in the line of the incision and the peritoneum opened.
The kidney was found, and the ureter was also freed about ten
centimetres below the renal pelvis, divided between clamps and the
lower end tied. The upper end of the ureter was mobilised with it
blood supply. The renal vein was found and a ligature tied round
as close to the inferior vena cava as possible, tying any branches.
The renal artery was located and ligated near its origin and the
kidney removed; extra renal fat was cleared from the kidney. In the
experiments involving the cannulation of the renal lymphatics care
Plate 7 DONOR SHEEP - SUPINE POSITION ON THE OPERATING TABLE
was needed to avoid dissection around the renal vein and artery. Also
the renal lymph node which lies at the origin of the renal artery was
removed in continuity with the specimen. In no case was there
duplication of the renal arteries, although occasionally there was a
double renal vein.
After securing haemostasis the wound was then closed with a i
prolene suture to all layers, except the skin which was closed with
michel clips, and sprayed with nobecutane. The anaesthetic was
stopped and the animal woken up.
Perfusion of the Donor Kidney
Immediately after removal, the donor kidney was perfused with
low molecular dextran 40 5% in electrolyte solution (Perfudex)
cooled to 4° centigrade, one litre containing 1,000 units of heparin
and 2 mis. of lignocaine 2%. One hundred millilitres was run into
the artery through a Tibbs cannula until the perfusate from the renal
vein was clear. (Plate 8a)
The kidney was placed in a sterile bag containing cool perfusate
and then placed in crushed ice.
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Plate 8 a) DONOR KIDNEY PERFUSED
Magnification x Is
Transplantation of the donor kidney into the recipient
Anaesthetic
The anaesthetic (see above).
Position
In those sheep where the thoracic duct was cannulated at the same
operation, for collection of lymph during the first week after
transplantation, the kidney was transplanted into the left side of the
neck. The right side of the neck was used for those sheep whose
thoracic duct was cannulated one week later.
The sheep were positioned as for thoracic duct exploration and
the skin prepared in the same manner.
Technique of operation (plate 8b)
An incision was made from the ear caudally along the distal half
of the jugular furrow. In the upper part of the wound the external
jugular vein lay immediately under the skin, and was cleared. The
common carotid was then found just deep and lateral to the vein
lying under the brachiocephalic muscle, and was also cleared.
An intravenous cannula was inserted into the external jugular
using an available small branch proximal to the anastomosis as the
site of entry; a ligature was tied round the branch to fix the
cannula. An infusion of saline containing 10,000 units of heparin
was begun.
A length of the external jugular vein above this was occluded
between bulldog clamps, and the vein was opened in the line of the
vessel anteriorly, the length of opening matching the diameter of the
donor vein. The recipient vein was flushed with a few millilitres of













The artery was then tied distally and the proximal part of the
cleared area was clamped with a bulldog clamp, the vessel cut across
and the lumen flushed with heparinised saline.
The donor kidney was then removed from the ice. The vein was
anastomosed first, the end of the donor vein being sutured to the
side of the recipient vein with continuous 6/0 silk. The renal artery
was then sewn end to end with the carotid artery with 6/0 continuous
suture. Just prior to the last suture being inserted the vessels were
flushed with heparinised saline. The venous clamps were then removed,
the proximal first. If the bleeding was not marked the arterial clamp
was then removed. The kidney was then seen to be perfused with blood.
After haemostasia was satisfactory a small biopsy was taken from the
renal cortex. The subcutaneous tissues were then divided laterally
so that the kidney could lie comfortably under the skin.
The ureter was brought out through the skin through a separate
opening with a cannula of external diameter 1.65 millimetres inserted
and fixed inside with a catgut suture. The edges of the ureter were
then sutured to the skin. The subcutaneous tissues were closed with
catgut and the skin with continuous prolene suture.
Cannulation of the venal lymphatics
Those kidneys which were used for experiments cannulating the
lymphatics leaving the kidney, were perfused with low molecular
dextran 40 (see abovef). After perfusion a ligature was tied round the
renal efferents distal to and leaving the renal node, care also being
taken not to distrub the tissues around the renal artery and vein
when clearing the extrarenal fat. The kidney was transplanted into
the recipient.
After the kidney was perfused with arterial blood the lymphatics
leaving the kidneys were seen to become distended with lymph: usually
there were at least two small lymphatics. The longest and largest
was chosen and cut in half near the renal node. A fine cannula,
external diameter 0.75 millimetres, with an obliquely cut tip was
inserted and gently pushed up the lymphatic towards the kidney. Two
sutures of 4/0 silk were tied round tb keep the cannula in place.
The cannula was then brought out through the skin through a separate
opening and lymph collected in a small capped bottle with a fine hole
made in the lid. The bottle was attached to the skin by tying around
two nylon tapes which were sewn to the skin. The bottles contained
5,000 units of heparin to prevent the collected lymph from clotting.
Post-operative care
All the sheep received penicillin and streptomycin, the dose
being doubled initially in the sheep receiving immunosuppressive
drugs. The antibiotic was changed to gentamycin 80 mgs. daily for
the immunosuppressed sheep during the course of the experiments.
Renal transplantation with immediate thoracic duct cannulation
The post-operative management was the same as for animals which
had received thoracic duct cannulation alone (see above) except that
the dose of heparin was increased to 20,000 units daily in two divided
doses.
Renal transplantation awaiting thoracic duct cannulation
The sheep were placed in ordinary pens. The venous and ureteric
cannula were protected by netelast dressing. No intravenous infusion
was given during the first week, though heparin was given into the
cannula, 20,000 units daily.
Renal lymphatic cannulation
Sheep with renal lymphatic cannulation were kept in a restraining
pen. A very slow intravenous infusion of saline and mannitol 10% was
given at a rate of 500 mis. daily. The animal was again anti-
coagulated with heparin.
Immunosuppression
The sheep on immunosuppressive durgs had received 1 G. of
methylprednisolone and 200 mgs. of azathioprine intravenously before
the completion of the operation. They then received either orally
or intravenously prednisolone 200 mgs. on the first post-operative
day, decreasing by 10 mgs. a day, and azathioprine, 3 mgs. per Kg. of
body weight per day (mg/Kg/day). As this dose of immunosuppressive
drugs was found not to alter rejection on serial renal biopsies, the
dose was increased to 5 mgs/Kg/day (approximately 200 mgs. a day).
The dose was further increased to 10 mgs/Kg/day.
Renal biopsies
Initially there were a number of both allografted and autografted
kidneys which were found to be ischaemic at postmortem. Therefore
serial renal biopsies were taken on day two, four, and seven, also the
kidney was sent for histology after it was removed at postmortem
either on the eighth or fifteenth day. The biopsies were taken using
a disposable Trucut biopsy needle. The incidence of thrombosis in the
renal vessels leading to renal ischaemia decreased after the sheep
were antiboagulated with heparin 20,000 units daily, although
occasionally a kidney still became ischaemic.
4. INVESTIGATIONS PERFORMED
On the Thoracic Duct and Renal Lymph
1. Total dally flow of lymph
2. Daily white cell count
3. Percentage of transformed cell on the first and eighth day of
drainage
4. Differential white cell counts on renal lymph
5. Cell populations in the thoracic duct lymph, macrophages, B cells
and T cells
6. Graft versus Host popliteal node weight assay (section 2)
On Venous Blood
1. Total white cell counts and differential counts
2. Coombs Test
Histology
Histological examination of serial renal biopsies taken during
operation, on the second, fourth and seventh post-operative day,
plus macroscopic and microscopic examination of the post mortem
kidney.
Investigation of Lymph
1. Total daily flow of lymph
The total quantity of lymph collected either from the thoracic
duct or renal lymphatic was measured every 24 hours starting on the
day of operation (day 0). The daily speciments were collected from
09.00 hours to 09.00 hours.
2. Daily white cell count
An aliquot of each days lymph from the thoracic duct, which had
been collected as one specimen in a six litre bottle, was taken,
making certain that the whole specimen was mixed well. Heparin had
been added to the collecting bottle to prevent clotting of the lymph.
The aliquot was diluted 1:20 in a white cell counting pipette (thoma);
lymph was drawn up to the 0.5 mark, then trypan blue to the 11 mark,
The trypan blue had been diluted 1 aliquot to 4 of 4.25% saline.
The pipette was agitated and a small amount placed under the cover
slip of a haemocytometer (Neubauer Improved). The cells in the 4
large outer corner squares (each with 16 small squares) were counted.
The total and the viable cells were counted, the non-viable cells
taking up the trypan blue; care was taken not to count the small
number of red cells which were sometimes present. The number counted
was divided by 20 and this result was then equivalent to the number
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x 10 per cm (ml). The much lower lymph counts at the end of the
seven days drainage was diluted 1:10 with trypan blue, and the number
0
was then divided by 40 to get the cell count x 10 per ml. The
viable cells were expressed as a percentage of the total.
An aliquot of lymph from the renal lymphatic was taken. Owing
to the large numbers of red cells in the renal lymph, counting
visually in a haemocytometer was difficult. Therefore 20 pi.
specimen was diluted in 10 mis. saline (1:500 dilution). Zaponin,
2 drops, was added to lyse the red cells, and the white cells
counted in a Coulter counter at the following settings attentuation 1,
aperture 16, threshold 23.
3. Percentage of transformed cells
An aliquot of lymph collected in sterile bottles was dropped on
a slide and a smear made, and allowed to dry in the air. The smear
was fixed in methanol for five minutes. May Grunwald stain
(diluted 50:50 in S0rensen buffer was applied for one minute, then
Giemsa (diluted 1:50 with S0rensen buffer) was added for half a
minute. The slide was washed and left in buffer for one minute and
dried in air. The slides were examined under the oil immersion lens
of a light microscope. The larger cells with deep basophilic cytoplasm
were recognised as transformed cells and the number of these cells
out of a hundred lymphocytes was counted.
4. Differntial white cell counts
An aliquot of lymph was dropped on to a slide and a smear made
and dried in air. The slide was then flooded with Leishmans stain
for two minutes and two volumes of 6.8 buffer was added, mixed and
left for seven minutes. The slide was washed for two minutes with
continuous gentle flow of buffer, and dried. The slide was counted
under the microscope, using the oil immersion lease. A hundred cells




Plate 9. i-ymph smear showing transformed cells, Magnification XSOO
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5. Cell populations in the thoracic duct lymph
Macrophages
The method used has been described by Golstein and Blomgren
(1973). An 0.1% solution of acridine orange was diluted 1:10 with
Waymouth plus 10% foetal calf serum (ICS). Five million viable cells
were counted and added to 2 mis. of this solution and incubated for
half an hour at 37° C.
The cells were then washed twice, resuspended in media and
looked at under ultraviolet (U.V.) light (see below). The macrophages
appear as cells with the cytoplasm stained orange, and the nucleus
green. The lymphocytes owing to their small content of cytoplasm
appear green only.
B and T cells
A B cell marker was used to Identify the B cells, and the
remainder of the mononuclear cells in the thoracic duct lymph
(excluding the macrophages) were considered to be T cells. Fluores¬
cent antiglobulin (RAsh/FITC)* was used as the B cell marker. This
was diluted 1:10 with isotonic saline. Four drops of the solution
6
was added to 5 x 10 viable cells in 0.1 ml. Hanks medium and the
cells were put in ice for 30 minutes. The cells were washed once
with Hanks plus azide 0.02% and a few drops of glycerol P.B.S. were
then added to the pellet. The cells were then examined under a
Reichart "Zetapan" fluorescent microscope using as a light source
an H.B.0. 200 mercury lamp employing a U.G.X./1.5 mm. exciter filter.
Dark ground illumination was used in conjunction with a colourless
Sp. 2 barrier filter, and the cells were examined under a x 100
objective. Glycerol was used as immersion medium for both
*XEAsh/FITC) Sera Service, Maidenhead
condenser and objective, owing to its non fluorescent properties.
Investigations on blood
1. Total white cell and differential count
The blood was collected in a sequestrene bottle. An aliquot
of blood was diluted 1:20 in a blood diluting pipette with white
cell diluting fluid (2% acetic acid with a very small amount of
crystal violet stain) which lyses the red cells. The white cells
were then counted in a haemocytometer (see 2 above). The
differential count on the blood smears was performed as for the
lymph (see 4 above).
2. Coombs' Test
Donor sheep red cells were washed three times in isotonic
saline and made up to 10 to 15% suspension in isotonic saline. One
volume of this suspension was incubated with one volume of recipient
sheep serum for one hour at 37° C. The controls used were: Positive
control Human blood group B cells incubated with sheep serum,
Negative control (a) Human group B cells incubated with human
neutral AB serum, (b) Sheep cells washed but untreated. The cells
were then washed three times in isotonic saline. Two drops of anti-
sheep globulin reagent (RAsh/FITC) were added to each tube, mixed
and spun at 1,000 r.p.m. for li minutes. The tests were examined
microscopically, agglutination indicating a positive result. Two
drops of sensitised cells were added to each negative test and the
tubes spun again, agglutination indicating that the anti-sheep
globulin had not been neutralised i.e. that the negative result was
not due to experimental error.
Histological examination of the kidneys
Biopsy specimens of the kidneys were taken with a biopsy needle
(Trucut) at operation after revascularization of the kidney. Further
biopsies were also taken on the second, fourth and seventh post¬
operative days. The whole kidney was removed at postmortem on
either the eighth or fifteenth day. All specimens were fixed in
10 per cent formalin phosphate buffered at pH 7. Blocks were
embedded in paraffin wax and cut on a sledge microtome at 4 p.
Sections were stained with Ehrlichs haematoxylin and 2 per cent
aqueous eosin Y. Some sections were stained by the methyl green -
pyronin method to show the presence of pyroninophilic, RNA rich,
large lymphoid cells.
RESULTS
Thoracic duct cannulation - total lymphocyte flow.
Renal lymphatic cannulation - renal lymphocyte flow.
White cell counts in peripheral blood.
Renal transplants and histology.
E. RESULTS
1. Thoracic duct cannulation (TOTAL LYMPHOCYTE FLOW)
There are 34 sheep in which the thoracic duct flow was measured for
7 whole days.
Group 1 Normal sheep 7
Group 2 Immunosuppression 6
Group 3 Renal autograft 3
Group 4 Renal allograft 10
Group 5 Renal allograft plus immunosuppression 8
There were also 13 sheep in which the thoracic duct was cannulated
but did not drain for 7 whole days but drained for 4-6 days.
Group 1 Normal sheep 1
Group 2 Immunosuppression 1
Group 3 Renal autograft 2
Group 4 Renal allograft 5
Group 5 Renal allograft plus immunosuppression 4
Flew rate and cellularity of lymph
The flow rates and cellularity of lymph from the thoracic duct
are shown in a normal (Figure 13) sheep and an immunosuppressed sheep
(Figure 14). The lymph flow rates varied each day but the range was
2,000 to 6,400 mis. in all groups of sheep. The flow rate remained
fairly steady through the whole period of thoracic duct drainage and
in the successful cannulations no blocking of the cannulae occurred.
The cellularity of lymph (i.e. the lymphocyte count) was always
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initially higher at approximately 1 x 10 lymphocytes per ml. and the
number decreasing over the 7 days period. The product of the total
flow x cellularity was calculated for each 24 hour period, giving the
total daily lymphocyte count.
Total daily lymphocyte count
In all groups of sheep the total daily lymphocyte count was
initially high, the peak collection occurring either on the day of
operation, or on the first or second day. Thereafter the count
dropped to a much lower level and remained steady (see Figures 13 and
14). The level of the peak varied for each sheep but the range was
g
12 to 40 x 10 lymphocytes a day.
In the allografted sheep there was very little difference in the
total daily count during the first and second week of collection
(Figure 15). The lymph was collected during the first 7 days after
transplantation during the period of developing rejection, and the
second 7 days during the period of advanced rejection and necrosis of
the graft (see below Histology).
In those sheep which received both an allograft and immuno¬
suppression there was also no difference between the total daily count
tehen collection of lymph was in the first and the second week after
transplantation (Figure 16). This figure also shows in two sheep that
the dose of azathioprine, either 100 mgs. daily intravenously or 400
mgs. daily intravenously, did not alter the lymphocyte flow. The
variations of daily lymph counts were however considerable and Figure
17 shows a marked reduction in the cellularity, but not the volume, of
lymph in a sheep receiving 400 mgs. azathioprine daily, during the











Figure 15 and 16
The to Lai daily lymphocyte counts in sheep receiving an
allograft (Figure 15) and an allograft and immunosuppression
(Figure 16). The daily lymphocyte flow rates are compared during
the first e—• and second week ■—m after transplantation.
daily dose of Azathloprine
THE FLOW RATE AND CELLULAR ITY OF LYMPH T. D.








Thoracio duct eannulations for 7 days (Total lymphocyte flow)
The total dally lymphocyte flow for seven days should reflect the
total body lymphocyte flow. After an initial high number, the
lymphocytes remain steady at a much lower level (Figures 13 and 14).
Sheep not receiving renal transplantation (Group 1 and 2)
There were 7 normal sheep, in which the thoracic duct alone was
cannulated for seven days, acting as controls for group 2. The total
lymphocyte flow in the seven days for each of the normal sheep is
9
shown in (Figure 18) and the mean is 140.6 x 10 lymphocytes
(Table XIV). There was also one normal sheep in which the thoracic
duct was drained for 4 days (Table XV).
There were 6 sheep which received immunosuppressive drugs for 2
weeks prior to thoracic duct drainage. In 5 of these sheep the dose
of immunosuppression was prednisolone 100 mgs. daily and azathioprine
100 mgs. daily either intravenously or orally. The individual total
9
lymphocyte flow is shown in Figure 18 and the mean is 126.6 x 10
(Table XIV). There is no obvious difference in the total lymphocyte
flow between sheep receiving the immunosuppression orally or
intravenously. There is also no statistically significant difference
between the mean of either the normal sheep or the immunosuppressed
sheep (low dose) as measured by Student T test for unpaired data.
Subsequently the dose of immunosuppression was increased to prednisolone
100 mgs. and azathioprine 400 mgs. daily. There were 2 sheep
receiving this higher dose of immunosuppressive drugs. The thoracic
duct of one of these drained for 7 days (Table XIV) and the other for
5 days (Table XV). There was no obvious reduction in the total
lymphocyte flow with the increased dose of azathioprine.
Sheep receiving a renal transplant (Groups Z, 4 and 5)
The sheep receiving a renal autotransplant (Group 3) were the
controls for groups 4 and 5. The total lymphocyte flow in each of
the 3 sheep is shown in Table XIV, and there are 2 sheep in addition
whose thoracic duct drained for 5 days (Table XV). There was no
autografted sheep whose thoracic duct drained for 7 whole days during
the first week after transplantation. There were 3 sheep which had
the thoracic duct drained during the second week after transplantation
g
and the mean of their total lymphocyte flow is 92.8 x 10 .
Ten sheep received allotransplants alone (Group 4) - 4 had their
thoracic duct drained during the first week, and 6 during the second
week after transplantation. The total lymphocyte flow of each group
are shown in Tables XIV and XV. There is no difference in the results
from the sheep receiving either a renal allograft or autograft.
Eight sheep received both a renal allograft and immunosuppression.
The doses of immunosuppression varied. Although there appears to be
a reduction of the total lymphocyte flow in the first week, the mean
is little different from the lymphocyte flow in the autografted group;
the number of sheep in this group however is too small (and there is
no autograft control for the first week), for the results to be
analysed statistically. It should be noted however that the total
lymphocyte flow for one sheep receiving an allograft and immuno¬
suppression (intravenously 400 mgs. azathioprine) was very low 16.8 x
9
10 (Table XV, Figure 17) the thoracic duct in this sheep was
cannulated during the secohd week after transplantation and the
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TableXV
Transformed cells on the thoracic duct lymph
The percentage of large basophilic cells (transformed cells)
have been counted in the thoracic duct lymph on the first and seventh
day of drainage. In 3 normal sheep the percentages of transformed
cells on the first day were 3, 4, and 7; these percentages were only
slightly altered on the seventh day (Figure 19). Thoracic duct lymph
from sheep on immunosuppression only, and after a renal allograft,
usually showed an increase in the percentage of transformed cells by
the seventh day of drainage. The percentage of transformed cells in
lymph of sheep receiving an allograft and immunosuppression, remained
unaltered by the end of the first week but again was increased by
the seventh day if the thoracic duct was cannulated during the second
post transplant week (Figure 19). The means of the percentage of
transformed cells on the seventh day of thoracic duct drainage are
shown in Figure 20. These again show that the percentage of trans¬
formed cells is increased on the seventh day after allotransplantation.
There is however an even greater increase in the percentage of

















Cell populations in the thovaoic duct lymph
In three sheep the proportion of B lymphocytes and macrophages
were counted in the thoracic duct lymph. On the first day of
drainage the percentage of macrophages ranged from 17 to 23% and
the B cells from 16 to 21%. One of the sheep was on immunosuppressive
drugs and the other two received an allograft. The proportion of
these cells were not counted on the seventh day of drainage. Thoracic
duct drainage over seven days removed both T and B cells from the
body, histological sections of mesenteric lymph nodes on the eighth
day showed a reduction in the number of lymphoid follicles and fewer
lymphocytes in the paracortical areas.
2. Renal lymphatic cannulation (RENAL LYMPHOCYTE FLOW)
The lymphatics draining the kidney have been cannulated success¬
fully in 9 sheep. A successful cannulation was one in which the
lymph flowed continuously for 5 or more days. Three of these were
allografted kidneys, and 3 were in sheep which received both an
allograft and immunosuppression,azathioprine plus prednisolone,and
three in sheep receiving an allograft and prednisolone only. The
total lymphocyte flow and the number of days drainage, with the day
of maximum flow rate of while cells is shown in Table XVI.
The drainage in the allografted sheep number 3, 6 and 7 was the
most successful, continuing for 9 days. Figure 21 shows the daily
flow and cellularity of lymph from sheep 3. The peak total flow of
9
lymphocytes was on the second day when 7.8 x 10 white cells were
collected. The maximum lymph flow occurred on the sixth day when
277 mis. of lymph drained, but the number of white cells had decreased
7
considerably to 0.8 x 10 /ml. Renal biopsy taken on this day showed
that an advanced degree of rejection had taken place within the
kidney.
A comparison of the daily renal lymphocyte flow in sheep 2 with
an allograft only and sheep 5 with an allograft and immunosuppression
is shown in Figure 22.
The mean of the total flow of white cells over the first 5 days
9
in the allografted sheep is 12.3 x 10 , and in the sheep receiving
both an allograft and immunosuppression there is a decrease 3.1 x
9
10 (although the figures are not statistically significant). The
mean total flow of white cells over 5 days in sheep receiving an
9
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TableXVI
Differential white cell aount and transformed cells in renal lymph
The white cell counts performed on the renal lymph were total
counts. The cells were mostly lymphocytes, the range of polymorphs
in sheep 3, which received a renal allograft was 2% on the first
post-operative day to 10% on the seventh day of drainage. The
percentage of transformed cells in the renal lymph of the same sheep
was 3.3% on the first, 9.8% on the fourth and 16.5% on the sixth day
of drainage of lymph, when advanced rejection was demonstrated on
renal biopsy of the allografted kidney.
3. WMite cell total and differential count in peripheral blood
The peripheral blood total and differential white cell counts
were performed in all the groups of sheep. There was considerable
variation in the number of white blood cells, the range in normal
3 *4-3
sheep 4,000 to 11,500/mm with a mean in 6 sheep of 8,150 - 1,007 mm .
The percentage of mononuclear cells was higher than the polymorphs,
the range being 56 - 71% (mean 62.3 i 3.4%).
The means counts of the peripheral blood white cells and the
percentage of mononuclear cells in all groups of sheep is shown in
Table XVII. In the normal sheep the total number of white cells in
the peripheral blood was reduced by 7 days depletion of thoracic duct
lymphocytes, 4,000 cu.mm. The percentage of mononuclear cells
remained steady. In the immunosuppressed sheep the white cell count
2 weeks prior to thoracic duct cannulation at the time of starting
3
immunosuppressive drugs was 9,000/mm with 81% mononuclear cells.
There was very little alteration in this figure on immunosuppression
alone but after 7 days lymph drainage both the number of white cells
and the percentage of mononuclear cells were reduced.
With the exception of the allografted sheep during the first week
and the sheep receiving autografts, the peripheral white cell count
was reduced after 7 days lymphocyte depletion. There was very little
alteration in the percentage of mononuclear cells in these groups.
The comparison of the numbers of white cells in the peripheral
blood and the thoracic duct lymph from 1 normal sheep is shown in
Figure 23. Although the thoracic duct white cells dropped rapidly on
the second day, the white cell population in the blood was maintained
until the sixth day of drainage, and thereafter dropped considerably.
Figure 23 The effect of lymphocyte depletion by thoracic duct
drainage on the peripheral white cell count. The
figure in brackets is the percentage of mononuclear
cells counted.
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TableXVII
4. Renal Transplants
Immediately after renal transplantation the kidneys all passed
urine, which varied in amount. The urine was usually heavily blood
stained and the flow ceased after 48 hours, except in those kidneys
which were autotransplanted. The recipient sheep had their own
kidneys in situ. There were no biochemical tests performed for the
diagnosis of rejection, which was assessed solely on histological
grounds.
Histological findings in transplanted kidneys
Allografts
The diagnosis of rejection was made on histological grounds.
Since in the late stage of rejection the histological picture may be
predominantly ischaemic and undistinguishable from thrombotic
infarction, serial biopsies were taken from the transplant throughout
the period of each experiment. Only if a definite cellular
infiltrate was seen in each biopsy was a diagnosis of rejection made.
The kidneys which showed ischaemic changes without cellular infiltration
were deemed ischaemic due to early occlusion of the major vessels. As
an example of severe rejection developing in a grafted kidney plates
10 to 11 are shown. The operative renal biopsy in plate 10a shows mild
tubular damage only, the glomeruli are normal and there is no cellular
infiltrate. The biopsy from the same kidney on the second day shows
preservation of the glomeruli, continuing mild tubular damage and a
scanty infiltrate of inflammatory cells in the interstitial tissues
(plate 10b). By day 7 there is more severe tubular damage with a
heavier cellular infiltrate (plate 10c). This infiltrate is composed
of small and large lymphoid cells, plasma cells and histiocytes. Many
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Plate 10 REJECTION OF ALLOGRAFT IN SHEEP - HISTOLOGY
Magnification x 300
pyroninophilic cytoplasm (plate lib). Sections of the postmortem
kidney on day 15 show severe tubular damage with necrosis (plate lOd)
and an intense lymphoid cell infiltrate, and in some cases the small
vessels showed fibrinoid change (plate 11a) and thrombotic occlusion.
There was no occlusion of the renal artery or its main branches but
in several cases the renal vein was thrombosed.
At the time of postmortem the severity of rejection varied from
sheep to sheep. It was possible to assess the degree of rejection on
a semiquantitative basis as mild, moderate and severe. This assess¬
ment was carried out without knowledge of whether the sheep were
receiving immunosuppressive therapy. In mild rejection there was
little change in the renal structure, with a scanty infiltration of
lymphoid cells in the interstitial tissues. In moderate rejection
there was a heavier lymphocyte infiltration, with moderate tubular
damage and focal tubular necrosis. In severe rejection there was
extensive tubular necrosis and tubular degeneration, with an intense
lymphoid infiltration and in most cases fibrinoid damage of the
arterioles, with occlusion of the small renal vessels and the renal
vein.
A total of 23 allograft experiments were carried out on sheep
not receiving immunosuppression; 12 kidneys showed changes of
rejection and 11 were ischaemic. Most of the ischaemlc kidneys
occurred in the early part of the study, prior to routine anti¬
coagulation with heparin.
There were 18 allografts in sheep also receiving immuno¬
suppressive drugs (Table XVIII). Only 5 of these were ischaemic.
There were 3 sheep receiving a low dose of azathioprine (100 mgs. per
day) and, prednisolone and 3 sheep receiving prednisolone alone, and
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Histology of rejected kidneys. The severity of rejection on the 7th
post transplant day:+mild; ++ moderate; +++ severe (see text).
Table XVIII
there was no reduction in the severity of the rejection. There was
a reduction in the severity of rejection on histological assessment
in many of the kidneys transplanted into sheep receiving 400 mgs.
of azathioprine each day and prednisolone (plate 12).
(
Autografts
There were 7 autografted kidneys. Four were ischaemic and
apart from early mild tubular damage the other three showed no
histological abnormality.
Plate 12 HISTOLOGY - REJECTION ABROGATED
In a sheep on Immunos upression (Azat hi oprine and P rednisol one) Day- 7
Magnification x6 00
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TableXIX
Total lymphocyte flow in relation to ;the histological findings
The total lymphocyte flow in allografted sheep varied acoording
to the histology of the kidney. The lymphocyte flow during the
second week after transplantation in those sheep whose kidneys had
rejected was reduced (Table XIX).
Renal lymphocyte flow in relation to the severity of rejection
The use of immunosuppression reduced the severity of rejection
on histological examination. The severity of rejection was for the
main part determined by lymphocyte infiltration. A less marked
lymphatic infiltration into the renal parenchyma is reflected by a
reduction in the renal lymphocyte flow (Table XX).
Renal lymphocyte
Group flow x 109 Histology of




























Renal lymphocyte flow and the histology of the kidney
on the seventh day.
Table XX
F. DISCUSSION
1. Renal Transplantation in sheep
The reason for the choice of sheep for these experiments was
their docility; they can be kept in restraining pens with ease for
two weeks. They also have large enough, and easily identifiable,
renal lymphatics and thoracic ducts for cannulation. Male sheep
were chosen in order to prevent any previous sensitization from
pregnancy, which might alter the course of rejection. Sheep have
considerable drawbacks from the point of renal transplantation.
Studies on renal transplantation in sheep (Mitchell, 1959) showed
that of nine renal autografts, three were technical failures leading
to ischaemia of the kidney from renal artery and vein thrombobis;
three were successful and passed small amounts of blood stained
urine during the first two weeks, and after two weeks, when the
opposite normal kidney was removed, sustained normal life and renal
function in these sheep for many months. There were also three
sheep in which the autograft failed to function adequately to sustain
life after removal of the controlateral single remaining kidney.
In this work twelve renal allografts were also performed, of which
three were again technical failures due to vascular thrombosis; the
remaining grafts functioned initially; small quantities of blood
stained urine were passed for two to nine days. Rejection was
considered to have occurred when the animals were anuric, and the
kidneys were then removed for histological examination, three to nine
days after transplantation. The severity of rejection was marked and
even by the fourth post-operative day there was heavy interstitial
renal cell infiltration. Complete liquefaction of the kidney occurred
if the removal of the graft was delayed more than 24 hours after the
onset of anuria.
It has been shown that periods of renal ischaemia longer than
one hour cause a fatal uraemia in sheep (Mitchell and Woodruff,
1957). Mitchell (1959) felt that the problems arising in the
autografted kidneys were due to the period of occlusion (up to 1 hr.
20 mins.) of circulation to the kidneys during the operation. Two
methods of renal cooling were therefore tried, firstly intra¬
arterial perfusion with cold dextran and secondly surface cooling
by immersion in cold saline. Three kidneys cooled by the first
method all showed renal infarction. Surface cooling also described by
Mitchell and Woodruff (1957) appeared much more satisfactory.
In the results of the present experiments renal ischaemia was
also a considerable problem (see Appendix 3). The use of lignocaine
added to the dextran for intra-arterial perfusion reduced considerable
spasm of the arteries after circulation had been re-established. The
kidneys were usually reanastomosed within one hour of removal and
during that period were kept at 0° C. in ice. The main factor which
improved the blood supply to the kidneys and prevented thrombosis was
full anticoagulation with heparin. Heparin has been used for the
treatment of rejection episodes in man (Kincaid-Smith, 1967). There
-7
was no evidence to suggest that rejection was altered by the use of
heparin in these experiments, since a marked degree of rejection had
occurred by the second day in the sheep on anticoagulation but not
receiving immunosuppressive therapy.
The histology of allograft refection
Organ and tissue grafts transplanted to normal recipients behave
like autografts for the first frw days. First set renal allografts
produce urine, and if the recipient has no kidneys of its own, the
kidneys will pass considerable quantities of urine (Mitchell, 1969).
Renal allografts transplanted into an animal previously sensitised to
donor tissues are rejected in a rapid and dramatic manner (Pederson
and Morris, 1970). In this hyperacute rejection the allograft becomes
damaged within minutes of re-establishing the blood flow. The animals
used by us were young male sheep, and there is no evidence to suggest
that any of the recipients could be in any way presensitised to the
donor rams. There was no effort made to identify or take into account
the blood groups of the sheep although the results of the Coombs test
showed no evidence of incompatibility between the donor sheep red cells
and recipient sheep serum.
The macroscopic features of allograft rejection include oedema,
changes due to cellular infiltration and circulatory disturbances
t
(Herbertson, 1973). If rejection is rapid, necrosis of the parenchyma
is a major feature. If rejection is more gradual, atrophy and
eventual fibrosis occurs. The main microscopic changes during
allograft rejection are mononuclear cell infiltration, oedema,
vascular lesions and destruction of the parenchyma. As we have
shown, these changes can vary considerably in different donor/
recipient experiments. Herbertson (1973) described four types of
mononuclear cell within a rejecting allograft - lymphocytes, blast
cells, plasma cells and macrophages - most of these cells are
derived from the recipient. He suggested that the blast cells and
plasma cells found in allografts were formed within the graft from
infiltrating blood-bourne lymphocytes. The vascular lesions in an
allograft are due to fibrinoid necrosis and thrombosis within the
vessels. The parenchymal destruction may be due either to ischaemic
injury or to direct destruction by immune cells.
Immunosuppressive treatment alters the changes of rejection by
reduction in infiltration of mononuclear cells. The degree of
abrogation of rejection varies considerably in each donor/recipient
situation. Even in the presence of immunosuppressive therapy in
humans, mononuclear cell infiltration has been observed on the third
day in first set allografts. In the present experiments on sheep the
routine use of steroids and azathioprine (3 mgs./Kg./day) did not
alter the severity of the rejection process. Only by using high
doses of immunosuppression (methylprednisolone 1 G., prednisolone
200 mgs./day and azathioprine 400 mgs./day) did the virulence of the
rejection process appear to be reduced. Even this latter dose did
not completely abrogate rejection in all cases.
2. Total body and renal lymphocyte flow
The experiments reported here have confirmed the findings of
i
Pederson and Morris (1970) that there is an increase in the number
of white cells, mainly lymphocytesileaving a renal allograft. The
peak flow from the kidney is around the third day, at which time
histology shows lymphocyte infiltration of the interstitial tissues.
The lymphatic drainage of white cells from the kidney then decreases
to a very small number on the seventh day when severe rejection
with ischaemic changes is present.
This masSive rise in the number of lymphocytes flowing through
a rejecting graft is not reflected in an increase in the total body
flow of lymphocytes in the thoracic duct. This is surprising in that
Porter, Joseph, Rendall, Stolinski, Hoehn and Calne (1964) showed that
after canine renal allografts there was a generalised whole body
lymphoid response, especially in the spleen. There may be two reasons
for this. Firstly the daily renal lymphocyte flow is at maximum
9 3
8 x 10 cells/mm" whereas the daily total flow in the thoracic duct is
up to ten times greater than this; thus the local increase in the
area of rejection does not significantly after the massive total body
lymphocyte circulating pool. Secondly at the time of transplantation
into the neck only arterial and venous vascular reconnections are made.
The lymph flowing from the lymphatics collects around the operative
site. Most of this lymph no doubt is reabsorbed through the tissue
spaces into the nearest draining node - the prescapular (Pederson,
Adams and Morris, 1975) - but a proportion of the lymph collects
around the graft and therefore is lost to the total lymphcyte flow.
It has also been shown here that sheep with kidneys which were
rejecting had a smaller total lymphocyte flow than sheep with kidneys
which were ischmaeic. The possible explanation for this is that
the rejecting kidney is attracting and trapping many of the
lymphocytes from the peripheral blood.
There is seen an increase in the number of lymphocytes flowing
through the kidney in rejection; this increase is specific to the
graft area alone.
The effect of immunosuppressive agents on renal and total lymphocyte
flow
In the renal allograft, immunosuppressive drugs in the higher
dose (see Methods) reduced the number of lymphoid cells collecting
in the interstitial tissues as seen on histology. This reduction of
lymphoid cells in the graft was also mirrored in a marked reduction
of lymphoid cells in the renal lymph draining from the kidney. When
steroids only were used the number of lymphocytes in the renal lymph
was less than in the kidneys where no immunosuppression was used. The
reduction was not as great as when a combination of steroids and
azathioprine was given. This would appear to indicate that both
steroids and azathioprine are effective in reducing the mononuclear
cell infiltration which occurs at rejection.
Immunosuppressive drugs however did not alter the total body
lymphocyte flow, when given either alone or in conjunction with a
renal allograft. The measurement of the peripheral blood count did
however show that a combination of immunosuppressive drugs and
thoracic duct lymphocyte depletion reduced the peripheral white cell
count more than in normal sheep. The fall in the peripheral blood
count was four days after the marked fall in the thoracic duct
lymphocyte count, as the bone marrow was probably maintaining the
peripheral blood lymphocyte count during these four days.
It is considered that the main effect of the immunosuppressive
drugs is to reduce the number of lymphocytes in the allograft and
flowing from the graft. These drugs have little effect on the
numbers of lymphocytes flowing through the whole body.
3. Transformed cells in the renal and thoracic duct lymph
The production of transformed cells is part of the central
response of the body against antigen. The lymphocyte population is
incited to proliferate and divide by the presence of an allograft:
these dividing cells are given various names (see above - Background).
The renal lymph
There is a massive drainage of lymphoid cells from the kidney at
the time of rejection. Some of these cells are large basophilic cells
which we have called transformed cells. The percentage of transformed
cells rose from 3.3% on the first post transplant day to a maximum of
16.5% on the sixth day. The maximum rise in the percentage of
transformed cells occurred after the maximum lymphocyte flow (day 2)
and does not constitute an actual increase in the number on the sixth
day. The maximum flow of transformed cells occurred on the fourth
day when a total of 4 x 10 transformed cells were drained. This
drainage of transformed cells from a rejecting kidney confirms the
findings of Pederson and Morris (1970) in sheep, and Hamburger,
Dimitrui, Bankir, Debray-Sachs and Auvert (1971) in patients, with
renal transplants. The percentage of transformed cells in allo-
transplanted sheep in these present experiments is lower than the
60% recorded by Pederson and Morris (1970) and more in keeping with
the 15% reported by Hamburger et. al., (1971) although the patients
were also receiving immunosuppression. '
The thoracic duct lymph
There was an increase in the percentage of transformed cells in
the thoracic duct lymph of sheep receiving an allograft, from the
first to the seventh day of thoracie duct drainage. In none of the
sheep did the actual total number (rather than the percentage) of
transformed cells increase by the seventh day.
The effect of immunosuppressive drugs on transformed cells in
renal. and thoracic duct lymph
It has been suggested that one oftthe actions of azathioprine may
be the inhibition of DNA and RNA synthesis and therefore the
productinn of transformed cells (Hamburger, Crosnier, Dormont and
Bach, 1972). We might expect a decrease in the percentage of
transformed cells in sheep receiving immunosuppressive drugs.
Using azathioprine in conjunction with steroids, it has been
shown that in sheep receiving immunosuppressive drugs alone there was
an unexpected and considerable increase in the percentage of trans¬
formed cells after seven days thoracic duct drainage as compared with
normal sheep. In those sheep receiving both an allograft and immuno¬
suppressive drugs there appears to be a reduction in the percentage of
trabsformed cells in the thoracic duct lymph during the first week,
compared with sheep with an unsuppressed rejecting allograft, but
not during the second week after transplantation. In these experiments
we were unable to obtain results for the number of transformed cells
in the renal lymph of immunosuppressed sheep.
The mode of action of combined immunosuppressive therapy does not
appear to be upon DNA synthesis and cell division at the time of
allograft rejection.
G. CONCLUSION
There is a large number of white cells (mainly lymphocytes) in
a renal allograft and flowing through an allograft at the time of
rejection. This is specific to the kidney and not reflected in an
increase in total body lymphocyte flow. The daily renal lymphocyte
flow however is considerably less than the total body flow and thus
a local increase in the area of rejection does not alter the massive
body circulating lymphocyte pool.
The large number of lymphocytes draining from the kidney
correlate with the degree of rejection. Immunosuppressive drugs
have been shown to decrease the severity of rejection and also the
renal lymphocyte flow. The combination of immunosuppressive drugs
is more effective than prednisolone alone.
The percentage of transformed cells in total lymphocyte flow
is increased at the time of rejection of a renal allograft. This
is to be expected as there is a known increase in DNA and RNA synthesis
in animals and patients at the time of rejection as measured by
3
H thymidine uptake by the peripheral blood lymphocytes. The
percentage of transformed cells after seven days thoracic duct
drainage did not increase in sheep in which the thoracic duct alone
was cannulated, yet unexpectedly there was an increase in sheep
receiving immunosuppressive drugs. This is not fully explained but
may be due to the increase in sepsis in the immunosuppressed sheep.
It would appear however that the mode of action of combined
immunosuppression is not upon DNA synthesis and cell division at the
time of rejection. Immunosuppressive drugs may possibly work mainly
by diminishing lymphocyte flow through a transplanted organ.
APPENDIX H Difficulties in methods performed
Thoracic duct aannulation
There was a total of 74 sheep which had thoracic duct
cannulations. As shown in the results 47 of these were successful,
and there were also 27 other sheep in which the thoracic duct
cannulation failed for various reasons, ranging from death to blockage
of cannula, most of which occurred during the earlier part of the
study.
Causes of failure of thoracic duct cannulation and drainage
Operative deaths 3
Early deaths within four days 8





TJe causes of the operative and early deaths were not known,
possibly some were due to infection or occult haemorrhage. The
adequate fixation of the cannula (see Materials and Methods) prevented
the continuation of the complication of the cannula being pulled out
by the sheep. Blocking of the cannula was prevented by increasing
the amount of intravenous fluid infused each day to ensure an adequate
flow of lymph.
/
There were also a few post-operative complications which
occurred in the 47 successful cannulations.
Post-operative complications




Bilateral obstruction of the external
jugular vein
2
There were no wound infections.
Renal lymphatic eannulation
The lymphatics draining a renal transplant have been difficult
to cannulate, owing to their small size and the tendency of the
cannula to block. There have been 18 unsuccessful attempts due to
inability to cannulate the lymphatic, blockage or displacement of the
cannulae. Three attempts to collect lymph for five days from renal
autografts failed due to the markedly reduced lymph flow, maximum 20
mis. per day.
Renal transplants
Forty-eight renal transplants have been performed. The kidneys
became revascularised with arterial blood after the clamps were
released from the carotid vessels. Initially there were occasions
where the carotid or renal artery went into spasm, not at the
anastomosis site but on either side of the anastomosis. The vessels
were reopened and there was no evidence of intimal damage which
could give rise to such narrowing. This complication disappeared after
lignocaine was added to the perfusion fluid.
Among the first 18 transplants in all groups of sheep, there was
a high number of ischaemic kidneys even though the blood supply was
satisfactory at the time of closure of the wound. Fourteen kidneys
became necrotic very rapidly (within 7 days). The blood supply was
satisfactory on the seventh day in 4 kidneys. Further sheep were
therefore anticoagulated with 20,000 units of heparin daily,
intravenously, and this complication was thereafter markedly reduced.
A further 30 kidneys were transplanted into anticoagulated sheep, on
the seventh day only 5 of these were considered on histology to be
ischaemic, owing to arterial occlusion.
Transformed cell counts
The number of specimens of thoracic duct lymph from sheep
receiving immunosuppression and an allograft in which the percentage
of transformed cells was measured, was considerably lower than the
number of successful cannulations in this group. The large number
of bacteria in the lymph in a number of sheep from this group made
identification of the transformed cells difficult. The renal lymph
of sheep on immunosuppression also contained bacteria and no satis¬
factory transformed cell counts were obtained in these sheep after
the second post-operative day.
CONCLUSION
The action of lymphocytes on both tumour and allografted tissue
has been studied previously by many workers both by in vivo and in
vitro tests. The ability of lymphocytes immunised against a tumour
to specifically kill the tumour cells is well proven in animal
experiments. With lymphocytes sensitised against transplantation
antigens cytotoxicity has been claimed; however much of the previous
work has been done using tumour grafts; these tumour cells are more
easily killed than are cells derived from organ grafts.
Here using microcytotoxicity test^ in certain circumstances,
sensitised lymphocytes reduced the number of remaining target cells
in comparison with non sensitised lymphocytes, and we thus presume
to have achieved in vitro killing by lymphocytes. This circumstance
was found with hyperimmunization, where excellent cytotoxicity was
achieved with spleen cells against the tissue cells of the donor;
this fact comflrms that the technical basis of the experiments
reported here is sound. Cytotoxicity has also been obtained in half
the experiments where tumour allografts were performed, and the
sensitised lymphocytes of the recipient tested against both donor
tumour and tissue cells.
The limiting factors in obtaining cytotoxicity appeared to be
(i) the use of skin grafting as a method of primary sensitization
and (ii) the use of lymph node lymphocytes, rather than spleen cells,
as effector cells. The fractionation of lymph node lymphocytes to
obtain enriched population gave no greater cytotoxicity.
The cell counting technique (microcytotoxicity testing) proved
to be more effective than the chromium release assay method for the
determination of cytotoxicity, although other workers have found
this latter method to be more superior. Possibly the technique,
culture conditions and the ratio of effector lymphocytes to targets
cells may have been incorrect here.
In vitro cytotoxicity tests designed to measure the capacity of
lymphocytes, sensitised in vitro, to kill either syngeneic tumour,
allogeneic tumour or allogeneic tissue would appear to be limited.
These tests do not reproduce the massive lymphocyte effect against
allografts which is seen in vivo and they have at present no value
in the measurement of the lymphocyte response against an allograft
(for instance in the clinical situation for the prediction of
rejection episodes).
The graft-versus-host popliteal node weight assay has
theoretical advantages for the demonstration of the immune response,
over in vitro lymphocyte cytotoxicity tests, in that the activity
of the lymphocyte against antigenic tissue is observed in an in vivo
situation, and thus incorporates features missing in vitro - such as
tissue fixity, lymphokine activity, and recruitment of non specific
v lymphocytes and other cells. In allogeneic and xenogeneic experiments
when donor lymphocytes are injected into non identical hosts the
increase in node weight is mainly a host-versus-graft response. This
in many experiments has been abolished by host irradiation. Even in
the true graft-versus-host reaction between parent and hybrid rats
there has been a suggested host component in the increase in node
weight. This was not seen in the present experiments.
If the graft-versus-host popliteal node weight assay is to be
used as a measurement of the allograft response then the observed
action of the lymphocyte in vivo must be mirrored in this assay.
There should be a decrease in the lymphocyte activity on immuno¬
suppressive drugs and an increase in lymphocyte activity during
rejection of an allograft. Prior sensitization of lymphocytes by
allografting did not however give an enhanced g-v-h response on
injection to allogeneic rats. Immunosuppression of the lymphocytes
by taking them from animals on immunosuppressive drugs appeared to
slightly diminish the g-v-h response. The criteria mentioned above
have therefore not been met by this assay. This assay does not
measure the cytotoxic activity of the lymphocyte, but the ability of
the lymphocyte to divide in the presence of a foreign stimulus and
these actions are not the same.
The hypothesis that the g-v-h assay might be used as a test of
immune competence of the donor cell in the clinical situation has not
been confirmed.
The activity of the lymphocyte in the transplantation reaction
lies in both its abilities to kill antigeneic cells and to proliferate
in the face of an antigen. The effectiveness of each individual
lymphocyte may be multiplied by an enormous increase in the
concentration of lymphocytes at the graft site following trans¬
plantation. Indeed here a massive increase in the number of white
cells (mainly lymphocytes) flowing through the graft has been
shown to occur rapidly after grafting, when only early changes of
rejection have appeared on histological examination. This increase
in the lymphocyte flow appeared to occur only through the graft
Itself, as there is no alteration in the flow of lymphocytes through
the thoracic duct.
Immunosuppressive drugs used in transplantation reduces the
number of lymphocytes flowing from the graft, and reduces the
severity of rejection. This action is specific to the renal
lymphocyte flow, and is not reflected in a decrease in the number
of lymphocytes flowing through the whole body. As might be expected
the combination of azathioprine and prednisolone is more effective,
than prednisolone alone, both in abrogating rejection, and in
reducing the renal lymphocyte flow.
The percentage of transformed cells increased in the thoracic
duct lymph over a 7 day period of drainage in sheep, both in
immunosuppressed and in animals after an allograft, as compared
with normal sheep. Other workers have found a rise in the percent¬
age of transformed cells in the lymph during several days drainage
of the thoracic duct and where no other procedure has been
performed; this has not been confirmed in this work. The number
of transformed cells also increased in the renal lymph from an
allograft. Some infection was the rule in the immunosuppressed
sheep, despite prophylactic antibiotics, and this may be the
explanation for the increase in transformed cells in the thoracic
duct lymph in these animals.
The activity of the lymphocyte is therefore shown to be
concentrated in the area of the kidney after a renal allograft.
This increase in activity is due to an increase in the number of
lymphocytes in the graft and passing from the graft. This increase
in lymphocytes may be initiated primarily in the kidney by the
production of a lymphokine, or may be primarily a response from the
whole body as the increase in the number of lymphocytes flowing
from the graft precedes the appearance of marked rejection changes
in the renal histology.
One of the major actions of immunosuppressive drugs may be
their ability to reduce the number of lymphocytes flowing through
the transplanted organ.
GLOSSARY
Allograft - graft exchanged between two genetically dissimilar
individuals of the same species (allogeneic - genetically dissimilar
within the same species).
Autologous - derived from self.
Clone - a family of cells derived from a single ancestor. All the
cells of a clone are genetically identical.
E rosettes - erythrocyte rosettes around T lymphocytes.
EA " - erythrocyte and antibody rosettes to detect B
lymphocytes.
EAC " - erythrocyte, antibody and complement rosettes to
detect macrophages and certain B lymphocytes.
hybrid - animal produced from parents of animals genetically
dissimilar, first generation.
Lympholysis - destruction of a lymphocyte by disruption of the
cell membrane.
Mitogens - substances which induce mitosis, i.e. the division of
cells, e.g. phytohaemaglutinin (P.H.A.)
Passage - the successive transfer of tumour from one animal to
another, in series.
Syngeneic - genetically identical animals, usually applied to
grafts made within an inbred strain.
Xenogeneic - derived from different species.
EQUIPMENT LIST
1. Tissue Culture Techniques and Microcytotoxicity Tests
Anaesthetic Agents
Ether Anaesthetic (Macfarlane Smith Ltd., Edinburgh, Scotland)
Nembutal Veterinary 60 mgs/ml. (Abbott Laboratories,
Queensborough, England)
Antibiotics
Gentamycin - Cidomysin Injectable 40,000/ml. (Rousell
Laboratories Ltd., London, England)
Penicillin - Solupen, Benzyl Penicillin B.P. (Dista Products,
Liverpool, England)
Streptomycin - Streptaquaine, Streptomycin Sulphate (Dista
Products)
Terramycin (Pfizer Ltd., Sandwich, England)
Counters3 Centrifuges and Microscopes
Centrifuge M.S.E. minor (M.S.E., Crawley, Sussex, England)
p counter - Backmann L.S. - 100 Liquid scintillation system
(Beckmann, Croydon, England)
^ counter - Wallac 80,000 sample counter (L.K.B./Wallac,
Sweden)
Cell counting microscope - Olympus model SZ11 (Gallenkamp,
Birmingham, England)
Operating microscope - Nikon no. SMZ-6 (The Projectina Co. Ltd.,
Skelmorlle, Ayrshire, Scotland)
Constant infusion pump - Palmer (Analytical supplies, Derby,
England)
Drugs (other)
Dextran 40 in saline - Lomodex (Fisons Ltd., Loughborough,
England)
Heparin (with and without chlorocresol) (Weddel Pharmaceuticals
Ltd., London, England)
Papaverine 40 mgs/ml. (Macarthys, Romford, Essex, England)
Enzymes and Additives
Bicarbonate 4.4% (Wellcome Research Laboratories, Beckenham,
England)
Dnase (Sigma, Kingston upon Thames, England)




Hepes Buffer I.M. solution (Wellcome)
Trypsin (Difco Laboratories, West Molesly, Surrey, England)
Immunosuppressive Agents
Cortisone Acetate Injection B.P.; Cortistab (Boots Co. Ltd.,
Nottingham, England)
Cyclophosphamide - Endoxana (W. B. Pharmaceuticals Ltd., London,
England)
Plastics etc.
Small tubes: clinical test tubes with rim 5.0 x 9.5 mm. (G.W.S.)
Microtest plates Type II (Dynatech Laboratories, Billinghurst,
England)
Millex filters - 0.22 |im (Millipore (U.K.) Ltd., London,
England)
Sterilin universal containers (Sterilin Ltd., Teddington,
Middlesex, England)
Tissue Culture Bottles (Nunc U.K. Ltd., Stafford, England)
Radioactive Materials
Chrjg^um51 )
5 I Iodo 2 deoxyuridine )





Azide, NaN (B.D.H. Chemicals Ltd., Atherstone, Warwickshire,
England)
Crystal violet - Revector microscopical stain (Hopkin and
Williams, Chadwell Heath, Essex, England)
Ficoll 500 g. (Pharmicia, Upsalla, Sweden)
Glycerol - Analar (B.D.H.)
Methanol - Analar (B.D.H.)




Leucopak Leucocyte Filters (Fenwal Laboratories, Illinois,
U.S.A.)
Disposable needles - Gillette scimiter (Gillette, Isleworth,
Middlesex, England)
Scoville Lewis microvascular clips (Down Bros., Mitcham,
Surrey, England)
Sutures - ethilon, silk (Ethicon, Edinburgh, Scotland)
Syringes (Sherwood Medical Industries, St. Louis, U.S.A.)
Tubing - silastic 0.5 mm. external diameter (Dow Corning Corp.,
Midland, Michigan, U.S.A.)
Tissue Culture Media
Eagles M.E.M. x 10 strength (Wellcome)
Hanks (Oxold Ltd., London, England)
Phosphate Buffered Saline (Flow)
R.P.M.I. (Flow)
Waymouths without L-glutamine (Gibco Biocult Laboratories Ltd.,
Paisley, Scotland)
Glutamine (1 ml.) 200 mH. added to 100 mis. of Eagles and
Waymouths media
Hepes buffer added to Eagles at a final concentration of 20 mM.
2. Lymphatic Cannulation and Renal Transplantation in Sheep
Anaesthetic Agents
Fluothane - Halothane B.P. (Imperial Chemical Industries I.C.I.
Ltd., Macclesfield, England)
Nembutal Veterinary (Abbott Laboratories, Queensborough, England)
Antibiotics
Penicillin - Depocillin, Procaine benzyl penicillin (Mycofarm,
Delft, Holland)





for thoracic duct cannulation:- Trocaflex 0.8 x 1.2 mm.
diameter,30 cms. length (Vygon U.K. Ltd., Uxbridge
England)
for renal lymphatic cannulationj>- external diameter 0.75 mm.
(Portex, Hythe, England)
for intravenous and ureteric cannulation:- external
diameter 1.65 mm. size 10 (Portex)
2. Collecting bag - Aldron urine drainage bag (Ashford, Kent,
England)
3. Connection tubing - 60 cms. manometer line (Portex)
4. Netelast (Roussel, London, England)
5. Spiral cable wrapping bore (R.S. Components, London,
England)
Other drugs
Heparin - Mucous B.P. (Weddel Pharmaceuticals Ltd.)
Pentazocine - Fortral (Winthrop, Surbiton-on-Thames, England)
Potassium Chloride 1 G. in 5 mis. (Macarthys Ltd.)
Immunosuppressive Agents
Azathioprine - Imuran (Wellcome)
Methylprednisolone
_ Solumedrone (Upjohn Ltd., Crawley, England)
Prednisolone - oral - (Roussel, Wembley Park, Middlesex,
England)
Intravenous Infusion Fluids
Aminosol Vitrium 10% (KabiVitrum Ltd., Ealing, England)
Dextran 70 Injection B.P. in 0.9% Sodium Chloride (Fisons Ltd.)
Mannitol 10% - 500 mis. Baxter (Travenol Laboratories, Thetford,
Norfolk, England)
Intravenous Infusion Fluids (contd.)
Perfudex 5% - Dextran 40 for organ preservation (Pharmacia
(G.B.) Ltd., London, England)
Sodium Chloride - 500 mis. Baxter (Travenol Laboratories)
Miscellaneous
Acridine orange (B.D.H.)
Chlorhexidine 0.5% in 70 spirit (Nottingham General Hospital
Pharmacy)
Fluorochrome conjugated animal antiglobulin (Rash/FITC) (Sera
Service, Maidenhead, England)
Hibispray: clear plastic dressing (Avlex, Wigan, England)
Nobecutane (B.D.H.)
P.P.O. 100 g. (N.E.N. Chemicals, Frankfurt, West Germany)
Savlon (I.C.I.)
Toluene (Koch Light Laboratdries, Coinbrook, Bucks, England)
Trucut biopsy needle (Travenol)
Food for rats
41B DIET Rat and mouse cake
As supplied by Pilsbury's Ltd. (Edgbaston, Birmingham)
Barley )




English white fish meal 8%
Molasses to bind
Food for sheep






10 cwt. 561bs. Barley
7 cwt Oats
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